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Abstract
Defensins are a family of cysteine-rich vertebrate antimicrobial peptides 
which can be divided into two main families, a-defensins, found only in mammals, 
and /3-defensins, identified in all vertebrate species. In chickens, only /3-defensins 
have been reported, and are now named avian /3-defensins (AvBD). The project aim 
was to compare AvBDs mRNA levels in different chicken lines considered as 
susceptible and resistant to different Salmonella serotypes. Indeed, a previous study 
showed that a-defensins expressed in Paneth cells were inhibited after Salmonella 
infection in mice suggesting that the inhibition defensins is a virulence strategy of the 
intestine pathogen. Therefore, we wished to test the hypothesis that the susceptibility 
of chicken lines to Salmonella infection correlated with decreased AvBD transcript 
levels, as previously shown in mice.
To date, thirteen AvBDs have been already described in the literature. Here I 
describe a novel avian /3-defensin, named AvBD 14. The AvBD 14 has two exons and 
one intron and is only expressed at the mRNA level in the skin and spleen. I also 
propose that two /3-defensins, originally described as gallinacin 1 and 1 ot which differ 
by only three amino acids due to three nucleotide substitutions, actually represent 
polymorphic variants of the same gene, named AvBDl.
Because of their differential expression profiles as previously reported, 
AvBDs 1 and 2, originally isolated from heterophils, and AvBDs 3, 4 and 5, 
previously described as peptides expressed by epithelial tissues, were chosen to study 
their expression in a variety of in vitro and in vivo systems. In order to develop new 
bioreagents, I attempted to express AvBDs using the Baculovirus system. 
Unfortunately, the specific physicochemical characteristics of these antimicrobial 
peptides made them difficult to purify and they were, therefore, examined by 
measuring their mRNA expression levels.
In this study, inbred chicken lines 6i and N, previously characterized both for 
their resistance to systemic Salmonella disease and their levels of Salmonella 
colonization, were selected to analyze the expression of the AvBD panel chosen. Line 
6i and line N chickens are resistant and susceptible to Salmonella serovar 
Typhimurium colonisation respectively and, interestingly, mRNAs for AvBDs 2, 3 
and 5 were undetectable at 7 dpi in the caecal tonsil of line N chickens infected with 
S. Typhimurium. AvBDl mRNA expression was also down-regulated soon after 
infection suggesting that line N susceptibility is a deficiency in innate immunity.
In addition, the differential responses of inbred lines to Salmonella serovars 
indicate the involvement of a common mechanism of resistance. For this purpose, 
AvBD expression was also analysed in the resistant line, line 6j, and the susceptible 
line, line 12, following infection with different Salmonella serovars. In resistant and 
susceptible chickens infected with host-specific or broad host range Salmonella 
serovars, mRNA level of AvBDs was differentially expressed, but not inhibited.
In conclusion, we have demonstrated that the level of expression of AvBDs 
did not determine the resistance or susceptibility pattern of chicken line 61 and 12 to 
systemic salmonellosis. However, the expression of several of AvBDs may regulate 
the resistance of chicken line 61 to 5. Typhimurium colonisation.
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1Chapter 1 - Introduction
21.1 Principles of innate immunity and its components
The body, especially the gastrointestinal, respiratory and urogenital tracts, is 
constantly in contact with commensal bacterial microbiota and can be exposed to 
infectious organisms. The innate immune response, composed of macrophages, 
natural killer (NK) cells, neutrophils, mucosal epithelial cells, and endothelial cells, is 
the first line of defense against a large number of common microorganisms to control 
potential bacterial infections (Abreu & Arditi, 2004). Innate immunity was long 
considered as a non-specific response, acting over several days and characterised by 
engulfment of infectious agents by macrophages. Indeed, microorganisms invading 
the epithelial surface of the body are usually met by mononuclear phagocytes that 
recognize and bind conserved and invariant constituents of a class of microorganisms, 
defined as pathogen-associated molecular patterns (PAMPs). The binding of PAMPs 
to pattern recognition receptors (PRRs) on cells such as macrophages activates 
phagocytosis and the secretion of cytokines and chemokines that attracts neutrophils 
and monocytes, causing local inflammation. By contrast, adaptive immunity, 
mediated by T and B cells, is a more sophisticated defense mechanism, responding to 
a specific pathogen antigen and increasing protection against subsequent reinfection 
by generating memory T and B cells (Akira & Takeda, 2004; Froy, 2005; Hoebe et 
al., 2004; Williams et al., 2006).
Since the discovery of Toll-like receptors (Medzhitov, 2001), the innate immune 
response has been considered as the mechanism recognising a particular epitope as 
“dangerous” or “safe”, while the adaptive immune response has been redefined as the 
mechanism acting against any pathogenic components with a potential to cause host 
infection (Williams et al., 2006).
31.1.1 Innate cells
The white blood cells called leukocytes can move towards, interact with and 
engulf microorganisms. Leukocytes derive from a common progenitor, the 
pluripotential haemopoietic stem cells present in the bone marrow (Alberts, 2002). 
The division of haemaopoietic stem cells can produce other more specialised types of 
stem cells including myeloid progenitor stem cells, the precursors of granulocytes, 
macrophages, dendritic cells and mast cells (reviewed in Janeway, 2005).
Mast cells reside in connective tissue and mucous membranes. They play a role in 
pathogen defence, wound healing, and once activated, rapidly release granules 
containing histamine, heparin and other active agents to recruit neutrophils and 
macrophages. In addition, histamine dilates blood vessels, causing characteristic signs 
of inflammation including pain, redness, heat and swelling.
Macrophages are large phagocytic leukocytes, highly motile and able to cross the cell 
membrane of capillary vessels to pursue pathogens. In response to infection, 
macrophages differentiate from monocytes present in the blood and are activated by 
PAMPs binding to macrophage surface receptors, triggering phagocytosis and 
bactericidal mechanisms (reviewed in Janeway, 2005).
Neutrophils belong to the polymorphonuclear (PMN) cell family, also comprising 
eosinophils and basophils in mammals. By comparison, chicken PMN are composed 
of heterophils only, which are considered as neutrophil-like cells. Neutrophils 
represent 50 to 60% of the total circulating leukocytes but they are not present in 
healthy tissues. Similarly to macrophages, neutrophils recognize, ingest and destroy 
many pathogens by activating bactericidal mechanisms, without the aid of adaptive 
immune responses (reviewed in Janeway, 2005).
4Dendritic cells (DC) are phagocytic cells present in peripheral tissues such as skin, 
lungs, stomach and intestines in immature form (Alberts, 2002). The activation of 
dendritic cell maturation involves the uptake of foreign antigens or stimulation by 
effector molecules secreted by other phagocytic cells and induces the process of 
antigen presentation in lymph nodes, thus linking the innate and adaptive immune 
systems (reviewed in Janeway, 2005).
NK cells attack host cells that have been infected by microbes, tumor cells and virally 
infected cells. The process by which NK cells recognise infected cells is known as 
"missing-self', as infected cells express abnormally low levels of the cell-surface 
marker known as the MHC (major histocompatibility complex). NK cells therefore do 
not require activation to kill cells (reviewed in Janeway, 2005), hence their name.
1.1.2 Innate microbial effector system
The complement system is a biochemical cascade of the immune system 
consisting of a large number of plasma proteins that helps to fight infection. Many 
complement proteins are proteases activated by proteolytic cleavage. These enzymes, 
named zymogens, are widely distributed in body fluids and tissues and their 
subsequent cleavage induces the enzymatic cascade and amplifies the complement 
response. The complement system, involved in both innate immunity and acquired 
immunity, is composed of 35 soluble and cell-bound proteins and its activation leads 
to cytolysis, chemotaxis, opsonization, immune clearance and inflammation, as well 
as the marking of pathogens for phagocytosis.
Three biochemical pathways activate the complement system: the classical 
complement pathway, the alternate complement pathway, and the mannose-binding 
lectin pathway (Figure 1.1).
5Figure 1.1: The complement system, adapted from (Francis et al., 2003). 
Complement is an innate immune cascade, which is activated by one of the three 
pathways depending on the nature of the foreign molecule. The classical pathway is 
activated primarily by the interaction of Clq with immune complexes of antibody 
with antigen. The alternative pathway leads to the deposition of C3 fragments on the 
target cells, and the lectin pathway is activated by binding of MBL to carbohydrates 
expressed on pathogens. The end result of all three pathways is either the 
opsonisation, through formation of the lytic molecule C5b-9, of target organisms.
Classical pathway Lectin (MBL) pathway
Immune complex Microbial carbohydrates
+ +
C1 (C1q, C1r, C1s)
L _
MBL (MASP-1, MAS P-2)
+C4
+C2
+C3
C3a ' f
Alternative pathway
Activating surfaces 
+
C3b
+fB 
+fD 
+C3
” C3a
C5 -  convertase
(C4b2a3b) C5
C3bBbC3b
6These pathways require different molecules for their activation, such as antibodies for 
activation of the classical complement pathway and protease C3 hydrolysis or 
antigens for activation of the alternate pathway, but their enzymatic cascades produce 
the same set of effector molecules, homologous variants of the protease C3- 
convertase. C3-convertases, bound covalently to the pathogen surfaces, then cleave 
component C3 to generate a large amount of C3b, which binds to the surface of the 
pathogen and opsonizes the bacteria, and C3a, which is a peptide mediator of local 
inflammation. C3b also binds C3-convertase to form a C5-convertase that generate 
C5a, a chemotactic protein, that has anaphylatoxin activity associated with C3a, and 
C5b, that initiates the late events of complement activitation known as the membrane 
attack complex (MAC) and consisting of C5b, C6, Cl, C8, and polymeric C9. The 
MAC forms a pore in the cell membrane causing osmotic lysis of the pathogen.
The classical pathway is activated by the binding of Clq to IgM and IgG antibodies 
complexed with antigens or by binding directly to the surface of the pathogen. Clq, a 
lectin belonging to the collectin familly, is part of the Cl complex that is composed of 
Clq bound to two zymogens, Cl r and Cls. The activation of the Cl complex by 
binding of Clq leads to conformational changes in the (Clr:Cls)2 complex causing 
the activation of two C lr molecules, which are serine proteases. The active form of 
C lr cleaves Cls to generate another active serine protease. Cls then binds to and 
splits C2 and C4 to produce two large fragments, C2a and C4b, which together form 
the C3-convertase of the classical pathway. C4b binds covalently to the pathogen 
surface to form a C3-convertase that remains on the surface of the pathogen once 
complexed with the active serine protease, C2b, which cleaves C3 molecules.
The mannan-binding lectin pathway is activated by mannan-binding lectin, a serum 
protein, binding to mannose residues on the pathogen surface. The mannan-binding
7lectin is a six-headed molecule that forms a complex with two proteases, MASP-1 and 
MASP-2. Binding of the MBL-associated serine proteases to the pathogen surface 
initiates the cleavage of C4 and C2 by MASP-1 and MASP-2 into C4b and C2a. C4b 
and C2a then bind together to form C3-convertase and activate the complement 
cascade in the same way as the classical pathway.
The alternative pathway is triggered by C3 hydrolysis producing C3b molecules that 
coat the pathogen surface. The C3 protein is produced in the liver and C3b is 
produced by spontaneous cleavage. However, in the absence of pathogen C3b is 
inactivated. Once C3b coats the pathogen surface, it binds to factor B forming a 
complex, which is then cleaved by factor D into Ba and the alternative pathway C3- 
convertase, Bb. Some pathogens express complement-regulatory proteins on their 
surface that bind the C3b,Bb complex, remove Bb and inactivate C3b. If the bacterial 
surface does not express complement-regulatory proteins, factor P binds and stabilizes 
the C3b,Bb convertase activity.
The regulation of the complement system involves complement control proteins to 
protect the host against the complement components, which can be extremely 
damaging for the host. The complement control proteins are present at a higher 
concentration in the blood plasma than the complement proteins and act on different 
stages of the complement cascade. For example, Cl inhibitor dissociates Clr and Cls 
from the active Cl complex in the classical pathway and CD59 inhibits C9 
polymerisation and prevents the final assembly of the MAC complex (reviewed by 
Janeway, 2005).
In chickens, all the components of the classical and alternative pathway except C2 
were first detected in the serum (Barta & Hubbert, 1978). Evolutionary studies 
confirmed the lack of C2 and suggested that chicken factor B-like protease could be a
8common ancestral protein for mammalian complement components B and C2 (Kjalke 
et al., 1993). However, unpublished observations by K. Skjoedt and J. Kaufman 
identified homologues of both the C2 and factor B genes in the chicken genome 
(Lynch et al., 2005). In contrast, C9, which is a terminal complement component in 
mammals, was not identified in the chicken draft genome (Nonaka & Kimura, 2006). 
Chicken complement components of the lectin pathway were also described (Lynch et 
al., 2005). There is a single MBL gene in the chicken, while mammals have two 
different MBL forms (Laursen et al., 1998), and a MBL-MASP complex, constisting 
of MASP-2 and MASP-3 only (Lynch et al., 2005). The avian lectin pathway is 
deficient in MASP-1 but the absence of the protein did not affect the activation of C4 
(e.g. Table 1.1).
1.1.3 Innate microbial sensor molecules
Recognition of pathogenic microbes in mammalian mucosa is mainly 
conferred by membrane-bound Toll-like receptors. The receptors were named Toll­
like because of their similarity with a receptor from the Toll family firstly identified in 
the fruit fly Drosophila melanogaster. Toll plays an essential role in the innate 
immune response against fungal infection (Lemaitre et al., 1996) and has homology 
with the interleukin-1 receptor (IL-1R) in mammals (Gay & Keith, 1991). The 
identification of TLRs in human was first described by Nomura et al. (1994) and their 
functions were finally discovered in 1998 with the identification of TLR4 in mice 
responding to LPS (Poltorak et al., 1998). These transmembrane proteins are 
composed of a cytoplasmic region with a similar structure to the interleukin 1 
receptors and an external region composed of leucine-rich repeat (LRR) motifs. The 
conserved cytoplasmic region, known as the Toll/IL-IR (TIR) domain, is composed
9Table 1.1: Comparison of complement component genes in different groups of 
vertebrates (adapted from Nonaka and Kimura, 2006). +, presence of the component 
in the animal group; absence of the component in the animal group; ND, 
presence/absence has not been determined.
Mammalia Aves/Reptilia Amphibia
C3 + + +
C4 + + +
C5 + + +
Factor B + + +
C2 + + +
Clq Encoded by 3 genes Encoded by a single gene +
MBL Encoded by 2 genes Encoded by a single gene +
MASP-1 + - +
MAS P-2 + + +
MASP-3 + + +
Clr + + +
Cls + + +
C6 + + +
C7 + + +
C8a + + -l-
C8b 4- + +
C9 + - +
Factor D + ND ND
Factor I + + +
Factor H + + +
C4BP + + +
DAF + + +
MbCP + ND ND
CR1 + ND ND
CR2 + ND ND
Integrin aM + + +
Integrin aX + + +
Integrin b2 -1- + +
Properdin + - +
C3a R + + +
C5a R + + +
Cl in + + -
CD59 + + +
Clusterin + + +
Factor S + + +
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of three conserved boxes essential for signalling, named the R, A and S faces. The R 
and A interface would mediate the oligomerization of receptor TIR domains in 
response to the association of a ligand with the TLR to facilitate the interaction of 
downstream adapter molecules such as MyD88 with the TIR domain. The third 
interface, the S face, would mediate the association between the receptor and adapter 
TIR domains (Xu et al., 2000). Stimulation of TLRs triggers complex signalling 
pathways (Figure 1.2), either MyD88-dependent or-independent, allowing 
translocation to the nucleus of transcription factors including nuclear factor-xB (NF- 
kB), to induce the expression of target genes, such as tumour necrosis factor (TNF)-a, 
pro-inflammatory cytokines and antimicrobial peptides (Akira & Takeda, 2004). 
MyD88 is an intracellular adaptor molecule that binds the TIR domain and recruits 
IRAK4 (IL-lR-associated kinase), IRAKI and TRAF6 (tumour-necrosis-factor- 
receptor-associated factor). Phosphorylated IRAKI and TRAF6 dissociate from the 
TIR domain to form a complex with TAK1 (transforming-growth-factor-/3-activated 
kinase) and two binding proteins, TAB1 and TAB2. Once in the cytosol, TRAF6 is 
ubiquitylated and triggers the activation of TAK1, which in turns activates the IkB 
kinase kinase complex involved in the activation of transcription factors including 
NF-kB (Akira & Takeda, 2004; Froy, 2005). By contrast, the MyD8 8-independent 
pathway involves interferon-regulatory factor 3 (IRF3). The TIR domain interacts 
with the terminal region of TRIF (TIR-domain-containing adaptor protein inducing 
IFN-/3) that binds both TRAF6 and TBK1. TBK1, activated by TRIF, phosphorylates 
IRF3 that mediates the initial induction of type I IFNs, which in turn activate the 
expression of IFN-inducible genes. In parallel, TRAF6 mediates the activation of the 
NF-kB (Akira & Takeda, 2004). MyD88 is therefore an adaptor molecule that 
activates other molecules within the cell. Three other adapter molecules are also
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Figure 1.2: MyD88-depcndcnt and independent pathways of different TLRs
(Akira & Takeda, 2004). The TIR-domain-containing adaptor molecule MyD88 
mediates the Toll-like receptor signalling pathway. TLR1, TLR2, TLR4, TLR5, 
TLR6, TLR7 and TLR9 use this pathway that releases NF-kB from its inhibitor so 
that it translocates to the nucleus and induces expression of inflammatory cytokines. 
TIRAP-domain is also involved in the MyD88-dependent signalling pathway through 
TLR2 and TLR4. By contrast, TLR3 and TLR4 activate the interferon 1RF3 in a 
MyD88-independent manner. In addition, TLR3 use a third TIR-domain-containing 
adaptor, TRIF, which is essential for the MyD88-independent pathway. While TLR4 
use a fourth TIR-domain-containing adaptor, TRAM, which is specific to the 
MyD88-independent/TRIF-dependent pathway.
Nuclear
membrane
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involved in the MyD88-independent pathway, including TIRAP, TRIF and TRAM. 
Each TLR uses one or multiple adapters according to the type of stimulation by 
different ligands. To date, thirteen TLRs, TLR1 to TLR13, have been identified in 
humans and mice together (Du et al., 2000). TLRs 11,12, and 13 are expressed in 
mice but they have not been found in human. TLRs are stimulated by different 
ligands. TLR1 is stimulated by triacyl lipoproteins. TLR2 responds to a variety of 
ligands including peptidoglycan, lipopeptides and lipoproteins. TLR3 is stimulated by 
double-stranded RNA. TLR4 recognizes Gram-negative enteric LPS. TLR5 binds 
bacterial flagellin from Gram-negative and Gram-positive bacteria. TLR6 is 
stimulated by diacyl lipoproteins. TLR7 and 8 respond to single-stranded RNA. TLR9 
binds unmethylated cytosine-guanosine (CpG) DNA. TLR11 recognizes profilin, 
while the ligands that stimulate TLR 10, 12 and 13 are still unknown (Abreu & Arditi, 
2004; Froy, 2005; Hoebe et al., 2003). Most TLRs appear to function as homodimers, 
except TLR2, which forms heterodimers with TLR1 or TLR6 allowing recognition of 
different microbial components.
In chickens, TLR2 type 1 and 2, which are thought to have arisen from recent gene 
duplication (Fukui et al., 2001), and TLR4 were characterised first (Boyd et al., 2001; 
Leveque et al., 2003). ESTs with homology to human TLR1/6/10, TLR3, TLR5 and 
TLR7 were then identified (Iqbal et al., 2005; Lynn et al., 2003). Chicken TLR8 was 
also identified but sequence analysis showed that the chTLR8 gene was disrupted by 
6-kilobase insertion containing chicken repeat 1 retroviral-like insertion elements 
(Philbin et al., 2005). In addition to the identification of various chicken TLRs, 
MyD88, TIRAP, IRAK-1, IRAK-2, IRAK-4 and NF-kB signalling components were 
also characterised (Smith et al., 2004). All the chicken TLRs were shown to be 
expressed at the mRNA level in various chicken tissues (Iqbal et al., 2005) and
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heterophils (Kogut et al., 2005) and showed to be functional in response to different 
ligands (e.g. Table 1.2). Chicken cells respond to CpG-ODN, but analysis of the 
chicken genome failed to identify TLR9 (He et al., 2003; He et al., 2007; Xie et al., 
2003). Recently, two novel TLRs were identified in chicken; TLR21 (Roach et al.,
2005) and TLR15, which was expressed in the spleen, bursa, and bone marrow of 
healthy chickens and up-regulated in the caeca of chickens infected with S. 
Typhimurium (Higgs et al., 2006).
TLR-independent systems also have roles in the recognition of certain pathogens, 
such as the family of cytosolic nucleotide-binding oligomerization domain (NOD) 
proteins. The NOD system contains two proteins, NODI and NOD2, composed of an 
N-terminal caspase recruitment domain (CARD), a central nucleotide-binding domain 
(NOD) and a C-terminal LRR domain (Inohara et al., 2005). NOD2 recognizes 
bacterial peptidoglycan by detecting dipeptide muramyl (Girardin et al., 2003), while 
NODI recognize peptidoglycans containing mesodiaminopimelic acid (Chamaillard 
et al., 2003). In addition, these sensor proteins modulate expression of cationic 
antimicrobial peptides, particularly defensins (Boughan et al., 2006; Voss et al.,
2006) , and mutations in these proteins affected defensin expression and could trigger 
the development of intestinal inflammatory diseases (Wehkamp et al., 2004b).
To date, a sequence in the chicken genome, LOC420677, was identified to be similar 
to NODI and located on chromosome 2.
1.1.4 Innate microbial effector molecules
In response to microbial infection, the innate immune system secretes a range 
of effector molecules with different functions, such as cytokines, alarm proteases and 
antimicrobial peptides (AMPs).
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Table 1.2 Summary of known mammalian and chicken TLRs, ligands and 
adapters. TLR1/6/10 are used in mammals as homodimers or heterodimers. In chicken, 2 
TLRs were identified to be homologous to human TLR1/6/10 group.
Receptor Ligand(s) Adapter(s) In the chicken
TLR1 triacyl lipoproteins MyD88/TIRAP TLR1/6/10,2 genes (Iqbal et 
al., 2005; Lynn et al., 2003)*
TLR2 lipoproteins; gram positive 
peptidoglycan; lipoteichoic acids;
MyD88/TIRAP TLR2 type I and 2,2 genes 
(Fukui et al., 2001)
TLR3 dsRNA, poly I:C TRIF TLR3 (Iqbal et al., 2005; Lynn 
eta l., 2003)
TLR4 lipopolysaccharide; viral 
glycoproteins
MyD88/TIRAP/TRIF/TRAM TLR4 (Boyd et a/., 2001; 
Leveque et al., 2003)
TLR5 flagellin MyD88 TLR5 (Iqbal et al., 2005; Lynn 
eta l., 2003)
TLR6 diacyl lipoproteins MyD88/TIRAP See above
TLR7 synthetic compounds; ssRNA MyD88 TLR7 (Philbin et al., 2005)
TLR8 synthetic compounds; ssRNA MyD88 TLR8, disrupted (Philbin et al., 
2005)
TLR9 unmethylated CpG DNA MyD88 No
TLR10 unknown unknown See above
TLR11 Profilin MyD88 No
TLR12 unknown unknown No
TLR13 unknown unknown No
TLR15 unknown unknown TLR15 (Higgs et al., 2006)
TLR21 unknown unknown TLR21 (Roach et al., 2005)
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Cytokines are a group of small water-soluble proteins and glycoproteins of 8-30 kDa 
involved in both innate and adaptive immune responses. They are secreted by many 
types of cells in response to immunological, inflammatory and infectious diseases and 
act by binding to specific cell-surface receptors. The action of cytokines can be 
autocrine, if the cytokine acts on the cell that secretes it; paracrine, affecting the 
behaviour of another cell; or endocrine, affecting the behaviour of cells distant in the 
body. The binding of cytokines to specific receptors induces an intracellular signalling 
response that upregulates or downregulates several inflammatory genes in response to 
pathogen infection. Cytokines and their receptors can be classified in three main 
families: firstly, the haematopoietin family composed of the interleukin and the IFN 
subfamilies; secondly, the TNF family; finally, the chemokine family which can be 
subdivided into pro-inflammatory chemokines, induced by the immune response, and 
homeostatic chemokines. They can be released by many different types of cells and 
recruit leukocytes to the site of infection. Chemokines are structurally divided into 
two main groups - CC chemokines (or /3-chemokines) with two adjacent cysteines 
near the amino terminus of the protein, and CXC chemokines (or of-chemokines) in 
which the two cysteines are separated by any amino acid other than proline or 
cysteine. The CC chemokines bind to CC chemokine receptors (CCR), with ten CCR 
identified to date in mammals, and induce the migration of monocytes and other cell 
types such as NK cells and dendritic cells. The CXC chemokines bind to CXCRs, 
with seven indentified to date in mammals, and induce the migration of neutrophils 
(reviewed by Janeway, 2005).
In the chicken, the immune system is different to that of mammals and lacks a number 
of organs, cells and molecules identified in mammals, such as functional eosinophils, 
IgE and lymph nodes, suggesting a reduce cytokine repertoire. For example, the IL-1
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family in human include IL-1 a, IL-1/3 and the IL-1 receptor antagonist (IL-lra) 
located on chromosome 2 with six other IL-1 family members, IL-1F5-10 (Dunn et 
al., 2001), IL-18 (Bazan et al., 1996) that lies on chromosome 11 (Nolan et al., 1998), 
and IL-33 (IL-1 FI 1) that mediates its biological effects via the IL-1 receptor and lies 
on chromosome 9 (Schmitz et al., 2005). Only two IL-1 family members have been 
cloned in the chicken; IL-1/3 (Weining et al., 1998), encoded on chromosome 4 
(Kaiser et al., 2004) and IL-18 (Schneider et al., 2000). The IL-10 family, composed 
of IL-10, IL-19, IL-20 and IL-24 on chromosome 1 and IL-22 and IL-26 on 
chromosome 12 in human (Fickenscher et al., 2002), is also reduced in the chicken 
with four members; IL-10 and IL-19 on chromosome 26, and IL-22 and IL-26 on 
chromosome 1 (Rothwell et al., 2004). Similarly, the ChIL-17 family is composed of 
four members - IL-17A, IL-17B, IL-17C and IL-17F (Kaiser et al., 2005), while the 
human IL-17 family contains six members, IL-17A-F (Moseley et al., 2003). In 
contrast, interleukins involved in Thl responses, such as IL-23 and IL-27, were not 
identified in chickens (Kaiser et al., 2005), while the Th2 interleukins, IL-3, IL-4, IL- 
5, IL-13 and GM-CSF in mammals (Avery et al., 2004) have an extra family member 
in the chicken, KK34 (Koskela et al., 2004). The type I interferons, originally 
discovered to interfere with viral replication, include IFN-a, IFN-/3 and IFN- X., which 
have been identified in the chicken as well (Kaiser et al., 2005). However, the chicken 
has at least nine IFN-a genes and one IFN-/3 gene, located on chromosome Z (Kaiser 
et al., 2005; Sick et al., 1996), while the human genome contains thirteen IFN-a genes 
and one IFN-/3. A single copy IFN-A. gene is encoded on chromosome 7 in the chicken 
(Kaiser et al., 2005), while three IFN-A genes are found in the equivalent single locus 
on human chromosome 19 (Kempuraj et al., 2004). To date, chicken IFN-a and IFN-/3 
have been shown to have antiviral activity (Sick et al., 1996), while the biological
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activity of IFN- X remains to be determined. Other cytokines, including transforming 
growth factors (TGF) and colony-stimulating factors (CSF), have also been identified 
in the chicken. The CSF family is involved in the development of myeloid cells, and 
includes granulocyte-macrophage (GM)-CSF, granulocyte (G)-CSF and macrophage 
(M)-CSF in mammals. Chicken GM-CSF was identified on chicken chromosome 13 
(Avery et al., 2004) and the chicken myelomonocytic growth factor is the chicken G- 
CSF orthologue (Santos et al., 2006). The TGF-/3 family contains three genes in 
chickens, as in mammals. Chicken TGF-/3 are TGF-/32, TGF-/33 and TGF-/34 and in 
mammals the TGF-¡3 family contains TGF-/31-3 (Kaiser et al., 2005). Mammalian 
TGF-/31 and chicken TGF-/34 are orthologues with anti-inflammatory properties (Pan 
& Halper, 2003).
The second class of cytokines, the tumor necrosis factor (TNF) superfamily, is 
composed of 17 genes in mammals. Some of them have been identified in chickens, 
including CD40L, CD30L, VEGI, TRAIL, RANKL, FASL, 0X40 and BAFF. The 
AITRL orthologue in the chicken has weak percentage identity with the mammalian 
gene, but TNF-a, lymphotoxin (LT)-a, LT-/3, 4-IBBL, CD27L, LIGHT, TWEAK and 
APRIL were not identified in the chicken genome (Kaiser et al., 2005). Despite 
chicken TNF-a not being identified to date, characterisation of the chicken 
homologue of LPS-induced TNF-a factor (LITAF) allowed the expression of TL1A 
(TNFSF 15) in vitro, suggesting that chicken LITAF may play a role in the regulation 
of expression of TNF family members (Hong et al., 2006). In addition, potential 
receptors for 4-IBB and TNF-a were also identified, suggesting that TNF-a and 4- 
IBB may be present and that more investigations are needed (Kaiser et al., 2005). 
However, the receptors for six other members of the TNF family were not identified, 
suggesting that these TNF superfamily genes are definitely absent from the chicken
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genome. Interestingly, a novel TNF member was identified in chicken, TRAIL-L, but 
this member lacks an apparent receptor and a mammalian orthologue (Kaiser et al., 
2005).
Finally, the chemokine repertoire in chicken is also reduced with fourteen CC ligands, 
of which four are in the macrophage inflammatory protein (MIP) family and six in the 
monocyte chemoattractant protein (MCP) family. The chicken MIP and MCP families 
lie on chromosome 19 in two clusters and correspond to two clusters of genes on 
human chromosome 17, with nine members in MIP family and six in the MCP family 
(Hughes et al., 2007). Four other CC ligands were identified in chickens with clear 
orthologous relationships to mammalian CC ligands, with CCL17 and CCL20 located 
on chromosome 11 and chromosome 9 respectively, and CCL19 and CCL21 located 
on the chicken sex chromosome Z. Interestingly, orthologues of CCL11, CCL24 and 
CCL26, which are required for eosinophil and basophil attraction, are missing in the 
chicken genome, matching with the lack of functional eosinophils (Kaiser et al.,
2005). The CXC ligands which play a role in inflammation in human, CXCL1-8, are 
located on chromosome 4 (Moser et al., 2004). The chicken contains in the equivalent 
region of the genome three CXCL genes, with two of them encoding the previously 
described CAF and K60 (Sick et al., 2000). Chicken chromosome 4 also contains 
three adjacent genes that cluster with mammalian CXCL13, a homeostatic CXCL B 
cell chemoattractant. Two other homeostatic CXCL chemokines were identified as 
chicken orthologues of mammalian CXCL12 and CXCL14, located on chromosomes 
6 and 13 respectively. The chicken genome also contains single copy genes for both 
XC ligand and CX3C ligand, five CC receptors and three CXC receptors (Kaiser et 
al., 2005).
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Phylogenetic analysis of chicken cytokine genes, compared to human and mouse 
cytokine genes, showed that some cytokines, such as IL-1, IL-19 and IFN-X, were in 
higher numbers in the mammalian genome, presumably because of gene duplication 
events. In comparison, the relationship between the relative small number of 
chemokines in chicken genome, particularly the CC ligands, and the mammalian 
chemokines is still not clear after phylogenetic analysis (Kaiser et al., 2005).
Alarm Proteases, which are secreted by the host, limit tissue damage after an 
inflammatory response. Indeed, the degradation of ingested pathogens by phagocytic 
inflammatory cells triggers the secretion of proteases that degrade the tissues 
(Dallegri & Ottonello, 1997). In order to limit tissue damage, the host then secretes 
antiprotease proteins that neutralize any excess protease expression and protect the 
epithelial barrier. Antiprotease proteins are classified in two groups, the “systemic” 
and the “alarm” antiprotease proteins. The systemic antiproteases, including a l- 
proteinase inhibitor and al-antichymotrypsin, are mostly secreted by hepatocytes, 
while the alarm antiproteases, including secretory leucocyte protease inhibitor (SLPI) 
and elafin, are synthesised by epithelial cells at the inflammation site (Sallenave,
2000). SLPI and elafin are small peptides, 11.7 kDa and 9.9 kDa respectively, and 
members of the four-disulphide core family. However, their antiprotease activity was 
not the only bioactivity identified. Alarm antiproteases also have antimicrobial 
activity, anti-inflammatory activity, tissue remodelling activity and exhibit influence 
on adaptive immunity as well as AMPs (Williams et al., 2006). In the chicken, the 
presence of alarm proteases has yet to be determined.
AMPs, including cathelicidins, lysozyme and defensins, are different in structure and 
their regulation is still under study but they all show additional functions to their 
antimicrobial activities. Cathelicidins are expressed as precursor peptides,
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approximately 18 kDa in size, containing an NH2-terminal signal peptide, a pro­
peptide domain and a variant COOH-terminal antimicrobial functional domain 
encoding a mature peptide between 12 and 80 amino acids long that gives a bioactive 
peptide with variant bactericidal potential. In human, the mature peptide, LL-37, was 
identified in myeloid cell granules, skin and respiratory epithelia and bound LPS to 
neutralize its endotoxin activity, was chemotactic for neutrophils, monocytes and mast 
cells and activated denditric cell differentiation, in addition to its antimicrobial 
activity against gram-negative and gram-positive bacteria. Similarly, lysozyme is a 
multifunctional protein of 14.3 kDa involved in the activation of the immune system 
by interacting with antigen-presenting cells and stimulating phagocytic activity of 
neutrophils and macrophages. First identified as an ancient enzyme, lysozyme 
contains four cysteines forming disulphide bridges and is expressed by circulating 
leukocytes and certain tissues such as gastric and pyloric glands, Bruner’s glands and 
Paneth cells. The third group of AMPs, defensins, are to date the most abundant and 
the best characterised family. In human, six odefensins including four neutrophil o  
defensins and two intestinal odefensins have been identified so far (Dommett et al., 
2005) and thirty nine /3-defensins genes and pseudogenes have been discovered (Patil 
et al., 2005) but to date only four /3-defensins have been intensively studied with some 
of them showing differential regulation in response to pathogen infection.
1.2 Defensins
Defensins are a family of vertebrate antimicrobial peptides. The two main 
subfamilies of defensins are ot- and /3-defensins, with an additional distinct subfamily 
identified in rhesus macaque monkey leukocytes, the 0-defensins (Figure 1.3). The ct- 
and /3-defensins consist of a triple-stranded /3-sheet and a framework of six
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Figure 1.3: Defensin peptides. Numbers above the disulphide schemes indicate the 
disulphide connections (adapted from Selsted and Ouellette, 2005). The three- 
dimensional structures are the human neutrophil 3 dimer, an a-defensin, human /3- 
defensin 2 and 9-defensin RTD-1 (Ganz, 2003a) respectively.
a-defensin 
1-6,2-4,3-5
/?-defensin 
1-5, 2-4, 3-6
—C-C— c~ -cc-
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disulphide-linked cysteines (Ganz, 2003a). The a-defensins are 29-35 amino acids in 
length, while the /3-defensins are longer and consist of 38-42 amino acids (Raj & 
Dentino, 2002). The o*- and /3-defensins differ both in the length of peptide segments 
between cysteines and the pairing of cysteines: the cysteines of the ot-defensins are 
linked in a 1-6, 2-4 and 3-5 pattern, while the cysteines of /3-defensins are linked in a 
1-5, 2-4 and 3-6 pattern. In contrast, the 0-defensin structure is cyclic, forming a 
simple /3-sheet (Ganz, 2003a).
Only /3-defensins (also known as gallinacins) have been discovered in birds, 
suggesting they are the oldest defensin family (Zhao et al., 2001). Gallinacin 1,1a 
and 2 are present in heterophil granules (Harmon, 1998), while gallinacin 3 is 
produced constitutively in chicken tissues such as the skin, tongue, oesophagus and 
bursa of Fabricius or in response to microbial infection in the trachea (Zhao et al.,
2001). More recently, ten more sequences coding for defensins were identified in the 
chicken genome (Lynn et al., 2004; Xiao et al., 2004), all thirteen gallinacin genes 
being encoded on chromosome 3. Similarly to the human and mice defensin loci, the 
CTBS gene, coding for Cathepsin B, and a human EST sequence (accession no. 
BE072524) were localised on either side of the chicken defensin cluster. These 
conserved genes were first identified in defensin gene clusters on human chromosome 
8p22 and mouse chromosome 14C3 (Xiao et al., 2004). Phylogenetic analysis of 
vertebrate /3-defensins showed that the bootstrap support was very weak for the 
clustering of chicken /3-defensins with mammalian homologues, suggesting that the /3- 
defensin family arose before the divergence of birds and mammals, and a-defcnsins 
evolved after the divergence of mammals from other vertebrates.
Defensin-like antibacterial peptides have also been identified in plants and insects, 
with a characteristic four-disulphide linkage, and designated as y-thionins (Raj &
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Dentino, 2002). Such defensins have not been yet found in vertebrates. Defensins 
with six cysteines in disulphide linkages have also been identified in plants and 
insects (Ganz, 2003a). Insect defensins include phormicins, sapecins, royalisin and 
spodoptericin and they appear to be secreted by different insect species such as 
Díptera, Coleóptera, Hymenoptera, Hemiptera and Lepidoptera. Insect defensins 
showed antimicrobial activity against Gram-positive bacteria and filamentous fungi 
and, similarly to mammalian defensins, the killing mechanism involves interaction of 
the peptide with the pathogen surface, disrupting the permeability barrier of the 
cytoplasmic membrane and killing the microorganism. Insect defensins are small 
cationic peptides synthesized as precursor propeptides and, interestingly, they contain 
six or eight cysteine residues, which stabilize the defensin structures by formation of 
disulphide bridges and increase the variety of insect defensin structural features, 
which can be classified in three groups including oj3/3 or /3oj3/3 defensins, triple- 
stranded antiparallel /3-sheet defensins and hairpin-like /3-sheet structure defensins 
(Dassanayake et al., 2007). Defensins have also been identified in a variety of plants, 
including wheat, barley, spinach, pea, and several members of the Brassicaceae 
family, inhibiting the growth of fungi without being toxic to either mammalian or 
plant cells. The first plant defensins identified were Rs-AFPl and Rs-AFP2, isoform 
peptides isolated from radish seeds belonging to the Brassicaceae family (Solis et al., 
2006). Because plants lack an adaptive immune system, they evolved an antimicrobial 
defence mechanism that includes the production of pathogenesis-related (PR) proteins 
by the hypersensitive response (HR) or the systemic acquired resistance (SAR) 
system induced by pathogen infection. Eleven PR protein families were first 
discovered (Fritig et al., 1998), then three more PR protein families were included 
such as the plant defensin family PR-12 (van Wees et al., 1999). A recent genome
24
analysis of Arabidopsis thaliana revealed 317 homologous defensin-like sequences 
and that a subset of these defensins was expressed. Therefore, defensins may have 
evolved into such a large multigene family in order to provide non-host resistance, 
which is a phenomenon where the entire plant is resistant to a specific pathogen, 
providing durable protection in the field. In addition, plant defensins seem also to be 
involved in the protection of symbiotic bacteria such as Rhizohium. Indeed, the 
nodule, which is nutrient-rich, can attract many pathogens. However, some defensins 
are expressed in the nodule of the Medicago truncatula plant, suggesting that the 
antimicrobial peptides were secreted to protect the nutrient-rich environment 
(Silverstein et al., 2005).
Therefore, because of the variety of multicellular organisms, from the vegetable to the 
animal kingdom, capable of producing defensin peptides, the antimicrobial peptides 
can be considered as an ancient first line of host defence against pathogen infection.
1.2.1 Cellular distribution
Defensins are synthesised in granulocytes or secreted by epithelial cells and 
contribute to host defence against microbial colonisation and infection. Leukocytes, 
such as neutrophils and macrophages in mammals and heterophils in poultry, are 
components of the innate immune system. They produce either Of- or /3-defensins: 
avian heterophils produce /3-defensins, human neutrophils synthesise owlefensins, 
while human monocytes, macrophages and dendritic cells secrete /3-defensins (Duits 
et al., 2002) and mice neutrophils do not express any defensins (Table 1.3). Epithelial 
cells also secrete defensins either constitutively or in response to infection, acting as 
an important antimicrobial barrier as part of innate immunity. They may also act as 
important effector cells of the adaptive immune system (Kamal et al., 2001). One of
Table 1.3: Diverse patterns of a- and /3-defensin expression in human, mice and 
chicken (Ganz, 2003a).
Species Neutrophils/ heterophils Paneth cells Epithelial tissues
Human a-defensins odefensins a- & /3-defensins
Mouse none Of-defensins ot- & /3-defensins
Chicken /3-defensins not determined1 /3-defensins
'it is not c ear if chickens possess Paneth cells.
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the epithelial cell types involved in the primary defence of the small intestine in 
mammals is the Paneth cell. These cells are located at the base of the intestinal crypt 
and are generated by stem cells, which produce intestinal epithelial cells, including 
goblet cells, which produce mucin, the absorptive enterocytes and enteroendocrine 
cells. Paneth cells differentiate as they migrate down to the crypt base, while the three 
other cell types migrate from the crypt to the villus tip. However, Paneth cells have 
not been described in the chicken yet. The protective role of Paneth cells may explain 
the difference in their migration pattern and their ability to secrete defensins. These 
cells tend to secrete o-defensins in response to pathogen infection. Other epithelial 
tissues secrete mostly /3-defensins in mammals, including the tongue epithelium in 
pigs and sheep (Ganz, 2003a; Meyerholz et al., 2004) or trachea in the cow and sheep 
(Ganz, 2003a; Meyerholz et al., 2004), suggesting a generalised protective role for 
defensins for mucosal surfaces as part of the innate immune system.
1.2.2 Expression and maturation
Defensins are expressed either constitutively or in response to pathogen infection. 
The Of-defensins are generally synthesised and stored in granules of mature 
leukocytes. They are also synthesised by Paneth cells in an inactive form (Raj & 
Dentino, 2002). The immature defensins consist of a tripartite prepropeptide with a 
precursor sequence of 90-100 amino acids containing an amino (NH2)-terminal signal 
sequence of about 19 amino acids, an anionic propiece of about 45 amino acids and a 
carboxy (COOH)-terminal mature cationic defensin of about 30 amino acids. The 
negative charge of the propiece usually neutralises the positive charge of the mature 
defensin preventing the premature interaction of defensins with the membrane of 
neutrophils and Paneth cells. The process of maturation involves enzymes such as the
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metalloproteinase, matrilysin, in mice (Wilson et al., 1999) or three forms of trypsin 
in human (Ganz, 2003a).
The avian /3-defensins stored in heterophil granules consist also of tripartite 
prepropeptide sequences with a precursor sequence containing an NH2-terminal signal 
sequence, a basic or neutral propiece and a mature cationic defensin of about 40 
amino acids. However, the avian /3-defensin propeptide is probably unable to 
neutralise the mature peptide. For example, gallinacin 1 is not negatively charged 
whereas gallinacin 2 has only one negative charge. Therefore, some other mechanism 
must be involved in neutralising premature activity of the chicken /3-defensin 
(Brockus etal., 1998).
1.2.3 Defensin activities
Most defensins exhibit antimicrobial activity against bacteria, fungi, parasites and 
viruses. Under optimal conditions of low ionic strength, and low concentrations of 
interfering substances such as plasma protein or divalent cations, defensin activity is 
observed at low concentrations, e.g. 1-10 fig ml'1 (Ganz, 2003a). The avian defensins 
including gallinacin 1 and 2, were found to be >90% effective against Escherichia 
coli, S. Typhimurium and Listeria monocytogenes at 16 /ig ml'1 (Evans et al., 1995; 
Sugiarto & Yu, 2004).
The antimicrobial activity of defensins is usually associated with their ability to 
depolarise and permeabilise microbial membranes (Devine, 2003). In bacteria, 
defensins appear to bind electrostatically to components of the outer membrane, such 
as LPS in gram-negative bacteria or teichoic acid in gram-positive bacteria (Wimley 
et al., 1994). These monomeric peptides, composed of positively charged and
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hydrophobic amino acid side chains, aggregate to form multimeric pores in 
prokaryotic cells and disrupt the bacterial membrane’s function (Ganz, 2003a). 
Therefore, the resistance of bacteria to defensins is dependent on the outer membrane 
structure and charge density (Devine, 2003). The antimicrobial activities of defensins 
are essential for the protection of the epithelium against pathogens at the early stage 
of infection (Wilson et al., 1999). Defensins play an important role in the elimination 
of intestinal infection since matrylisin-deficient (MAT'a) mice, which lack the ability 
to produce mature intestinal defensins (cryptidins), showed an increase in 
susceptibility to Salmonella infection (Wilson et al., 1999).
However, this is not the only role attributed to defensins. /3-defensin 2 (SBD-2) is 
expressed in the intestine and extra-intestinal tissues such as trachea, kidney and lung 
of foetal and neonatal sheep, but its expression was only detected in the intestine of 
adult sheep. Therefore, the wide distribution of expression SBD-2 in young, 
developing sheep suggested the involvement of /3-defensins in cellular 
growth/differentiation (Meyerholz et al., 2004). In addition, various defensins have 
chemotactic activity for monocytes, T cells and dendritic cells (Ganz, 2003a). Indeed, 
in mammals /3-defensins are chemotactic through the chemokine receptor CCR6 
(Yang et al., 1999) and can act as ligand for Toll-like receptors (TLR). Murine /3- 
defensin 2 acts directly on immature dendritic cells through TLR-4, inducing the 
release of mediators and dendritic cell maturation (Biragyn et al., 2002). Human 
neutrophil defensin, HNP-1, also inhibits the activation of the classical complement 
pathway by binding Clq (van den Berg et al., 1998). This specific signal gives 
defensins a role in enhancing host immunity by bridging innate and adaptive 
immunity (Lillard etal., 1999) (Figure 1.4).
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Figure 1.4: Biological activities of defensins.
1. Bacteria attach to villi of the intestine and are attacked by defensins secreted from 
Paneth cells located in the intestinal crypts. (Ganz, 2003b).
2. Interactions between defensins and bacterial cells. Peptides bind to the divalent 
cation-binding sites on LPS disrupting the outer membrane and allowing passage of 
defensins through it. Defensins then bind to the interfacial region of the cytoplasmic 
membrane, aggregate within the membrane causing depolarisation and 
permeabilisation, allowing some peptides to access to the cytoplasm (adapted from 
(Devine, 2003). a. Outer membrane of bacterial cell; b. Peptidoglycan; c. Cytoplasmic 
membrane of the bacterial cell.
3. Defensins are chemotactic for lymphocytes, neutrophils, monocytes and dendritic 
cells.
SalmonellaChemoa traction
Defensm
crypts
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Paneth cells
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Differential expression of defensins also occurs in response to certain diseases. 
Inflammatory bowel disease, a genetically-dependent chronic inflammation of the 
intestine, is described as Crohn’s disease (CD) or ulcerative colitis (UC) according to 
the site of inflammation. UC takes place in the colon, while CD occurs at different 
sites of the intestine. The inflammation is induced by a perturbation in the balance of 
commensal bacteria in the intestine, which might be triggered by a defect in defensin 
expression observed in CD patients. Indeed, defensin expression by intestinal 
enterocytes and Paneth cells is considered to play a role in the protection of the 
epithelial barrier but antimicrobial activity in the ileal mucosa in CD was reduced and 
associated with a decrease in odefensin secretion by Paneth cells (Wehkamp et al., 
2005). /3-defensin induction was also impaired in colon enterocytes of CD patients 
(Wehkamp et al., 2003a). In addition, the decrease of odefensin expression by Paneth 
cells increased the risk of diarrhoea in a cohort of Zambian adults confirming the 
protective role of o-defensins for the intestinal mucosa (Kelly et al., 2006). In 
contrast, the elevated expression of a-defensins was also considered to be involved in 
the spread of cancer cells in colorectal tissues. Indeed, human Gf-defensins expressed 
by neutrophils (HNPs) inhibited NK cell activity and downregulated CD4 expression 
in T lymphocytes, both involved in the activation of adaptive immune responses. 
Therefore, the elevated concentration of HNPs observed in human colorectal cancer 
tissues suggests that HNPs might downregulate the adaptive immune response and 
favour evasion of that response by cancer cells (Zhang et al., 2004).
1.2.4 Regulation of defensin expression
A variety of signalling pathways inducing the expression of innate effector 
molecules, such as defensins, in response to pathogen infection has been identified
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(Figure 1.5). They can be classified as TLR-dependent and independent pathways 
(Peyrin-Biroulet et al., 2006).
In the lung, stimulation with peptidoglycan or lipopeptide increases TLR2 expression 
and induces hBD-2 expression, which reduces bacterial counts (Hertz et al., 2003; 
Homma et al., 2004). Other TLRs are involved in the increase of HBD-2 expression 
in response to different ligands, such as TLR3 in response to synthetic dsRNA (Duits 
et al., 2003), TLR4 stimulated by LPS (Jia et al., 2004) and TLR9 after stimulation 
with microbial DNA (Platz et al., 2004). Other tissues have also been shown to 
express defensins after stimulation of certain TLRs. Intestinal cells express hBD-2 
expression after stimulation of TLR2 and TLR6 with peptidoglycan (Vora et al.,
2004) and TLR5 with Salmonella enteritidis flagellin (FliC) (Ogushi et al., 2001) and 
uterine epithelial cells express hBD-2 and hBD-1 in response to the TLR3 agonist 
poly(I:C) (Schaefer et al., 2004). The TLR-dependent pathway also induces the 
expression of a-defensins. Human natural killer cells express TLRs on their surface, 
which were stimulated with TLR2 and TLRS ligands, outer membrane protein A from 
Klebsiella pneumoniae and flagellin respectively, inducing the secretion of at- 
defensins (Chalifour et al., 2004). All these studies show the importance of TLRs in 
the induction of defensin expression. In addition, downstream TLR-signalling 
pathways, including the NF-kB signalling pathway, the IL-1R signalling pathway and 
the MAPK signalling pathway, are involved in defensin expression. Stimulation of 
TLR triggers a signalling cascade leading to increased expression of proinflammatory 
genes via transcriptional factors such as NF-kB, activated by the NF-kB pathway, and 
AP-1, activated by the MAPK pathway. By contrast, the IL-1R, which shares 
homology with TLRs, activates both NF-kB and MAPK signalling pathways. In 
epithelial cells, IL-1/3 up-regulates hBD-2 via activation of the transcription factor
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Figure 1.5: Regulation of HBD-2 expression via TLR-dependent and 
independent signalling pathway (Froy, 2005). TLRs (red) induce HBD2 expression 
by activating NF-kB via the MyD88-dependent pathway. IL-1R (blue) activates NF- 
kB (purple) via the MyD88-dependent pathway, the P13K pathway and the ERK 
pathway. IL-17R (yellow) activates NF-kB (purple) via the JAK pathway. NOD2 
(green) induces HBD2 by mediating NF-kB (purple), MAPK/p38 and MAPK/ERK 
activation via TAK.1. HBD2 can also act as a ligand for CCR6 (green) to chemoattract 
DC and memory T cells or TLR4 (red) to activate DCs.
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NF-kB as well as activation of signalling proteins, particularly MAPK/PKC, p38 
MAPK, MAPK/JNK and PI3K (Jang et al., 2004). The MAPK/ERK pathway is also 
involved in hBD-2 and -3 expression and the MAPK/JNK pathway plays a crucial 
role in defensin expression in response to Helicobacter pylori (Boughan et al., 2006). 
Similarly, the MAPK/ERK and p38 MAPK pathways increase hBD-2 expression in 
response to S. Enteritidis flagellin (FliC) (Ogushi et al., 2004). Finally, the p38 
MAPK pathway was also involved in the production of of-defensins in mice (Salzman 
etal., 2003a). In parallel, TLR-independent pathways, including the IL-17, protease- 
activated receptor (PAR) (Froy, 2005), IL-18 (McDonald et al., 2006), and NOD 
signalling pathways (Peyrin-Biroulet et al., 2006), are also involved in defensin 
expression. For example, the NOD system was linked to the deficiency of defensin 
expression observed in CD patients and in mice infected with H. pylori (Peyrin- 
Biroulet et al., 2006).
Taken as a whole, these findings show a complex proinflammatory signalling 
pathway in response to PAMPs. However, to the knowledge of the author, the 
pathways that induce the expression of defensins in response to Salmonella infection 
remain to be determined. Enteric Salmonella is well known to activate the NF-*B 
pathway that regulates the expression of pro-inflammatory genes including cytokines 
(IL-1/3, IL-2, IL-6, TNF-<*, and IFN-7), chemokines (IL-8, MCP-1), and antimicrobial 
peptides involved in the inflammatory response such as the recruitment of PMNs (Sun 
et al. 2005). These data suggest that defensins may also be induced via NF-*B 
pathway. Similarly, the MAPK/ERK and p38 MAPK pathways may be involved in 
the regulation of transcription of defensins in response to Salmonella infection in vivo 
as they were described to be involved in the increase of hBD-2 expression in response 
to S. Enteritidis flagellin (FliC) in vitro (Ogushi et al., 2004). By contrast, the
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inhibition of of-defensins expressed by Paneth cells has been recently described 
involving the activation of the p38 MAPK pathway in response to Salmonella 
infection (Salzman et al. 2003a). These suggest that ct- and /3-defensins may be 
regulated by different pathways, which might be activated in TLRs-dependent 
manner. Therefore, further investigation of inducible defensins other than hBD-2, 
which has been extensively studied, will allow understanding of the synergy and/or 
redundancy between the TLR-dependent and -independent pathways in regulation of 
defensin production.
1.3 A food-borne pathogen, Salmonella enterica
Salmonella are rod-shaped motile Gram-negative enterobacteria that cause 
typhoid fever, paratyphoid fever and food-borne illness. Salmonella enterica is an 
important pathogen of humans and animals responsible for a variety of diseases, 
which include gastroenteritis and systemic infections like typhoid fever (Hansen- 
Wester & Hensel, 2001). Around 16 millions case of typhoid fever, causing 600,000 
deaths, have been estimated per year (Pang et al., 1995) and around 30,000 cases of 
salmonellosis are notified per year in the UK (Barrow, 2000). In addition, non­
typhoid Salmonella enterica serovars are the first cause of mortality from infected 
food, killing 268 people in 1995 and 119 people in 2000 in England and Wales (Adak 
et al., 2002). Classification of Salmonella spp. results in around 2100 serovars, named 
according to the host and the disease symptoms or the place they were originally 
found. However, there is high percentage identity at the genomic level between many 
serovars, leading to the proposition that most Salmonella serovars should be grouped 
under Salmonella enterica species (Edwards et al., 2002). Salmonella enterica can be 
then classified in two groups according to the nature of the infected host. The broad- 
host range Salmonella, such as S. Typhimurium and S. Enteritidis, infect human, mice
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and chickens and cause different infections according to the host, such as 
gastroenteritis in humans, systemic infection in mice and asymptomatic infection in 
certain chicken lines. The second group, or “host-specific” serovars, generally infects 
only a single host, such as S. Dublin infecting cattle, S. Typhi infecting human and S. 
Gallinarum or S. Pullorum infecting chickens, while they rarely cause disease in other 
animals (Edwards et al., 2002). Consequently, Salmonella have also been used as a 
model to study host-pathogen interactions at the molecular level, particularly S. 
Typhimurium that causes gastroenteritis in human and typhoid-like disease in mice 
(Hansen-Wester & Hensel, 2001).
1.3.1 Elements of Salmonella entérica virulence
Salmonella have a complex life cycle in infected animals with two main 
virulence characteristics, including invasion of epithelial cells and survival and 
replication in phagocytic cells. In addition, food poisoning serovars are able to 
colonise the alimentary tract of food animals in the absence of clinical disease. This 
characteristic is poorly understood, although genes contributing to colonisation are 
being identified (Morgan et al., 2004; Turner et al., 1998). The extent to which 
interaction with the host is a component of this is controversial. The penetration of 
intestinal epithelial cells is an initial step for Salmonella after an oral infection. For 
this purpose, the bacteria adhere to and invade the epithelial cells using different 
mechanisms encoded by a large number of genes implicated in Salmonella virulence. 
The survival and replication of Salmonella inside phagocytic cells, particularly inside 
the phagosomal vacuole, also requires a complex mechanism to resist environmental 
changes, such as decrease in pH, nutritional deprivation, oxidative burst and secretion 
of AMPs (Hansen-Wester & Hensel, 2001). Salmonella spp. genome analysis reveals
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many insertions, named islands, which were presumably acquired via horizontal gene 
transfer (Edwards et al., 2002). Several virulence determinants are are encoded by 
these islands, which are called Salmonella pathogenicity islands (SPI). SPIs are large 
segments of DNA only present in pathogenic species, which can transform a 
nonpathogenic species into a pathogen after insertion in their genome. To date, 
seventeen SPIs have been identified in Salmonella (Vemikos & Parkhill, 2006), 
including SPI1 involved in Salmonella invasion (Galan & Curtiss, 1989), SPI2 in the 
survival and replication of Salmonella inside phagocytic cells (Ochman et al., 1996), 
SPI3, containing the high-affinity magnesium transport system MgtCB, which is 
important for intracellular replication of Salmonella in the nutrient-poor environment 
of the phagosome (Blanc-Potard et al., 1999), SPI4, including a macrophage survival 
locus (Wong et al., 1998) and SPI5, harboring effector proteins of SPI 1 and SPI2 
(Knodler et al., 2002) and involved in Salmonella enteropathogenesis (Blanc-Potard 
et al., 1999). Five other SPI were then identified in the S. entérica serovars Typhi and 
Typhimurium, named SPI6 to SPI 10 (McClelland et al., 2001; Parkhill et al., 2001). 
SPI11 and SPI 12 were identified in S. Choleraesuis (Chiu et al., 2005) and SPI 13 and 
SPI 14 in S. Gallinarum (Shah et al., 2005). More recently, three other SPIs were 
identified, SPI 15, SPI 16 and SPI 17. Interestingly, SPI 17 is absent from the genome of 
S. Typhimurium LT2, SPI 16 is present in all the Salmonella lineages tested except 
Salmonella entérica subsp. arizonae, Salmonella bongori and E. coli, and SPI 15 is 
only present in S. Typhi CT18 and TY2, and Shigella flexneri (Vemikos & Parkhill, 
2006).
However, only SPI1 and SPI2 encode functionally related genes, including the type 
III secretion systems (TTSSs) (Figure 1.6). SPI1 is 40 kb in length and encodes 39 
genes including those encoding Mxi and Spa proteins involved in Shigella invasion of
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Figure 1.6: Relationship between SPI1, SPI2 and SPI5 functions of S. enterica. 
Effector proteins (o) from SPI1 system (blue □) are translocated by the SPI1 TTSS 
and Effector proteins (o) from SPI2 system (yellow □) are translocated by the SPI2 
TTSS. SPI-5 contains genes encoding effector proteins for the SPI1 and the SPI2 
system. Substrate proteins (pink o) are secreted by the SPI1 and SPI2 TTSS (Schmidt 
& Hensel, 2004).
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eukaryotic cells, proteins involved in TTSS function, including proteins required for 
the needle complex and secreted effectors (Hansen-Wester & Hensel, 2001), and 
regulatory proteins, such as HilA, HilC, HilD and InvF, which are induced according 
to the host environment (Ellermeier & Slauch, 2007). SPI2 is also 40 kb in size and 
contains 4 opérons encoding proteins involved in TTSS function, molecular 
chaperones, effector and the regulatory proteins, SsrA and SsrB (Hensel et a l, 1998). 
The order of the TTSS genes and their secreted proteins has homology with 
components of Yersinia and Shigella spp. TTSSs (Hueck, 1998). TTSSs contain more 
than 20 different subunits, which are constructed similarly to the flagella system and 
allow the translocation of substrate proteins after attachment of Samonella to the 
target cell. SPI1 substrate proteins, including SipA and SptP, were identified as 
inhibitors of host cell actin cytoskeleton to lead the invasion process (Fu & Galan, 
1999; Zhou et a l, 1999). SipA may also induce the production of PMN 
chemoattractants by epithelial cells (Lee et a l, 2000), SipB is involved in macrophage 
apoptosis and the subset of SopA, SopB and SopD are involved in the secretion of 
chloride and loss of fluid into the intestinal lumen contributing to the diarrheal 
phenotype in calves (Zhang et a l, 2002). Although the contribution of most of the 
SPI2-translocated proteins has yet to be established (Waterman & Holden, 2003),
SpiC inhibits cellular trafficking (Uchiya et a l, 1999), the SifA protein is required for 
Salmonella-containing vacuole (SCVs) membrane integrity and regulated by the two- 
component regulatory system SsrAB (Beuzon et a l, 2000), and SseF and SseG 
contribute to the formation of Salmonella-induced filaments (Sif) (Kuhle & Hensel,
2002) and are also necessary for perinuclear localization of SCVs (Deiwick et al, 
2006). Interestingly, phylogenetic analysis showed that SPI-1 sequences were 
identified in all Salmonella species, despite secondary loss in certain S. enterica. In
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contrast, SPI2-like sequences were not identified in S. bongori, which is the most 
divergent lineage of Salmonella (Groisman & Ochman, 1996), suggesting that SPI2 
might have integrated into the Salmonella genome later, as a crucial event in 
Salmonella's evolution as an intracellular pathogen.
More recently, several genes involved in enteritis and systemic disease were analysed 
using a modified differential fluorescence induction technique (Rollenhagen & 
Bumann, 2006). In enteritis disease models, specific genes involved in the activation 
of SPI-1, flagellum synthesis, anaerobic growth of Salmonella and in the utilisation of 
ferrichrome siderophores due to the limited avaibility of iron during gut invasion were 
identified. In comparison, in a systemic disease model, genes involved in the 
activation of SPI2, in the regulation of PhoPQ system that induces changes of 
Salmonella membrane surface to be resistant to antimicrobial peptides and in the 
production of different nucleases to modulate mRNA turnover for regulation of 
virulence gene expression, were analysed. Therefore, this gene-disease specific 
analysis suggests that these specific genes may be involved in Salmonella in vivo 
infection.
1.3.2 Host-Salmonella interactions
In mammals, Salmonella invasion of host epithelial cells requires SPI1 
effector proteins to change the host cell cytoskeleton. After internalization of the 
bacteria, the SPI2 TTSS allows the replication of Salmonella in the lamina propria. 
The invasion process induces a proinflammatory response characterised by the release 
of cytokines, chemokines and antimicrobial peptides, either by stimulating TLR- 
independent pathways at the entrance of the bacteria into epithelial cells or by 
activating TLR signalling pathways in the lamina propria. Indeed, an S. Typhimurium
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SPI2 mutant (but with functional SPI1) caused colitis in MyD88‘/_ mice, excluding the 
stimulation of MyD88-dependent TLR signalling pathways. In parallel, an S. 
Typhimurium SPI1 mutant (but with functional SPI2) did not cause colitis in MyD88' 
*' mice, despite its presence in the lamina propria, suggesting the stimulation of 
MyD88-dependent TLR signalling pathways by S. Typhimurium during its replication 
in the lamina propria (Hapfelmeier et al., 2005). In addition, the absence of a 
proinflammatory stimulus by commensal bacteria, particularly in the intestine, could 
be explained by the lack of TLR4 and TLR2 expression on the surface of intestinal 
epithelial cells, the expression of TLR5 only on the basolateral surface of epithelial 
cells and by the secretion of antimicrobial peptides by epithelial cells creating a 
protective barrier (Mahida & Rolfe, 2004).
Different roles, including the regulation of commensal bacteria and the protection of 
the epithelial crypt from enteric pathogens, have been attributed to AMPs. If the first 
role is difficult to evaluate, the protective role against pathogen, particularly 
Salmonella, has been demonstrated. Indeed, mice deficient in matrilysin 7, MMP-7, 
involved in cryptidin processing, were more susceptible to Salmonella infection than 
wild-type mice (Wilson et al., 1999). In addition, macrophages are a reservoir of 
Salmonella Typhimurium infections causing systemic disease in mice. A recent study 
showed that inhibition of S. Typhimurium cell division was the result of antimicrobial 
effector expression, such as cathelicidin induced by an increase of intracellular 
reactive oxygen intermediates (Rosenberger et a l, 2004). Finally, transgenic mice 
expressing human defensin 5 (HD-5), an odefensin secreted by human Paneth cells, 
were infected orally with S. Typhimurium. Interestingly, HD-5 transgenic mice 
showed few signs of illness and recovered after 12 h, while the wild-type control mice 
reached a mortality rate of 100% by 24 h, suggesting that the expression of ct-
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defensins by Paneth cells conferred resistance to Salmonella infection by increasing 
innate immune efficiency (Salzman et al., 2003b).
However, a few studies have shown that Salmonella can be resistant to cationic 
antimicrobial peptides (CAMP), which can be classified as «-helical peptides, such as 
C18G peptide, and /3-sheet peptides such as the defensins and protegrins. Indeed, the 
presence of sublethal doses of CAMP, including the ohelical peptide C18G and the 
/3-sheet peptide protegrin-1, induces PhoP (Bader et al., 2003), which is one 
component of the PhoPQ regulator system able to translate environmental signals into 
changes in gene expression. Activation of the PhoPQ system induced the repression 
of the SPI1 TTSS genes, inhibiting the invasion of S. Typhimurium (Rakeman & 
Miller, 1999) and changing the bacterial cell surface. Modification of S. enterica LPS 
was observed at the anionic lipid A level. The pmrE and pmrHFIJKL genes are 
involved in the production of aminoarabinose, which is then inserted into lipid A.
This modification of the LPS core alters the net charge of the bacterial surface and 
reduces antimicrobial peptide binding. The incorporation of fatty acid into lipid A, 
which is dependent on the pagP gene, reduces the permeability of the S. enterica 
outer membrane to CAMP. In addition to the bacterial cell surface changes, S. 
enterica produces a protease, PgtE, that cleaves the «-helical CAMP (Peschel, 2002), 
and a Mig-14 protein associated with the inner membrane of S. enterica, which is 
essential in CAMP resistance (Brodsky et al., 2005). Therefore, CAMP might be 
environmental signals to stop the invasion of epithelial cells and induce a complex 
response, allowing S. Typhimurium to resist innate immune mechanisms (Bader et al.,
2003). Salzmann et al. showed that the inhibition of «defensin expression by Paneth 
cells by S. Typhimurium was SPI1 TTSS dependent, via the activation of the p38 
MAPK pathway (Salzman et al., 2003a). Therefore, resistance to CAMP, by altering
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the LPS surface or by inhibiting CAMP expression, involves the secretion of effector 
molecules by Salmonella to modulate the host innate immune response via cellular 
signalling pathways. The virulence mechanisms involved need further studies but, so 
far, the SPI1 TTSS seems to be essential.
In the chicken, the molecular mechanisms involved in Salmonella invasion are 
little known. The S. Enteritidis yfg-eng locus, composed of four open reading frames 
including yfgM, yfgL, engA and yfgJ, is involved in chicken colonisation, particularly 
yfgL. Indeed, invasion of a yfgL mutant was reduced in vivo and in avian HD11 
macrophage-like cells. The motility and the secretion of SPI1 and flagellar proteins 
was also abnormal, suggesting a role for the S. Enteritidis yfg-eng locus in the 
regulation of SPI1 TTSS and flagellar TTSS (Amy et al., 2004). In addition, the 
importance of the YfgL outer membrane lipoprotein was also observed in vitro and in 
vivo in mice, with the same characteristics as shown in chickens (Fardini et a l, 2007). 
Recently, virulence genes of S. Gallinarum were identified in vivo (Shah et al., 2005). 
SPI1, SPI2 and SPI10 mutants were analysed, as well as mutants in the newly 
identified SPI13 and SPI14. SPI1 and SPI2 contributed to S. Gallinarum virulence in 
chickens. Indeed, SPI1 seems to be important at the early stage of intestinal invasion 
and to initiate systemic infection in young chickens. Interestingly, the SPI2 genes 
involved in S. Gallinarum virulence in chickens are different from the SPI2 genes 
involved in S. Typhimurium chicken colonisation, suggesting different mechanisms of 
virulence. SPI10, which codes for fimbriae proteins involved in the adhesion of 
Salmonella to host cells, also plays a role in S. Gallinarum virulence. Finally, SPI13 
and SPI14 have not yet been shown to be involved in S. Typhimurium virulence and 
not all of the genes they encode have been characterised. Except for the SPI13 gacD 
gene, that shares 100% homology with the cat-2 gene involved in invasion and
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survival of S. entérica in chicken macrophages, the role of the other genes in S. 
entérica virulence is still unknown. However, the specific discovery of these new 
SPIs in S. Gallinarum might suggest they have an important role in the virulence of 
this non-motile, avian host-adapted serotype, compared to all motile Salmonella 
serotypes (Shah et al., 2005).
However, the mechanism by which host-specific S. Gallinarum and S. Pullorum cause 
systemic disease and death, compared to broad-host range Salmonella such as S. 
Typhimurium, which cause asymptomatic infection, is still unknown (Chadfield et a l, 
2003). The intestinal invasion of Salmonella serotypes is highest in the caecal tonsil, 
composed of lymphoid cells, but the quantitative measure used did not detect any 
difference in intestinal colonisation between host-specific and broad-range Salmonella 
(Chadfield et al., 2003). In addition, S. Gallinarum did not survive in greater numbers 
in HD11 macrophage-like cells compared to other Salmonella serotypes. However, 
survival in macrophages should be essential for host-specific serotypes to cause 
systemic disease in chickens.
Previous studies identified certain chicken lines as resistant to systemic salmonellosis, 
such as lines Wl, 6i and N, while other lines were susceptible, including lines C, l i  
and 151 (Bumstead & Barrow, 1988; Bumstead & Barrow, 1993). Interestingly, 
macrophages from the resistant lines were more efficient at clearing S. Gallinarum, 
compared to macrophages from the susceptible lines (Wigley et al., 2002). The 
resistance/susceptibility pattern is genetically dependent, at least partially encoded by 
the SALI locus mapped to chromosome 5 (Mariani et al., 2001), and resistant-line 
macrophages showed a higher oxygen-dependent antimicrobial activity (Wigley et al.,
2002). In contrast, differences in S. Typhimurium colonisation of the intestine is not 
related to the SALI locus. Line 6j chickens, resistant to Salmonella colonisation,
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showed higher numbers of circulating heterophils compared to line N chickens 
(Barrow et al., 2004). As discussed earlier, heterophils secrete AMPs that may play a 
role in resistance to gut colonisation (Wigley, 2004). Cytokines and chemokines have 
been already analysed in the gastrointestinal gut (Withanage et al.,2005; Beal et al., 
2004; Haghighi et al., 2007) and showed a correlation between their expression 
profiles and the resistance to S. Typhimurium in the chicken (Table 1.4). In addition, 
chicken TLRs are involved in resistance to Salmonella infection as TLRs are in 
mammals. TLR4 is involved in the resistance/susceptibility of chickens to Salmonella 
infection (Leveque et al., 2003) and TLR5 restricts the entry of flagellated Salmonella 
into the systemic site of chickens (Kogut et al., 2005). Finally, Salmonella infection 
upregulates TLR15 in the chicken caecum, as previously observed for TLR2 (Higgs et 
al., 2006). TLR are an important component in the regulation of defensin expression 
and the TLR signalling pathway tends to be targeted by Salmonella to resist AMP in 
mammals. Therefore it will be interesting to analyse the expression of chicken 
defensins or gallinacins, as this ancient component of innate immunity seems to play a 
crucial role in Salmonella invasion in mammals, and its role might be similar in 
chickens.
1.4 Project aims
Salmonella enterica is a facultative intracellular pathogen, usually motile and 
the primary cause of food poisoning, mainly through consumption of infected poultry 
meat and eggs, in Europe. Salmonellosis in chickens can be induced either by broad 
host-range Salmonella such as S. Typhimurium or host-specific serotypes such as S. 
Gallinarum. Mammalian defensins play an important role in innate immune defence, 
particularly in response to gastrointestinal infection such as salmonellosis. Gallinacins
Table 1.4: Cytokines/ chemokines expression in response to Salmonella infection 
in the gastrointestinal tract of chickens. Y, Expression up-regulated; N, No 
significantly change in expression observed; ND, not detected in the experiment.
Cytokines/
chemokines
References
IL-1/3 N Whitanage, 2005; Beals, 2004
IL-4 ND Whitanage, 2005
IL-6 N Whitanage, 2005; Haghighi, 2007
IL-10 N Whitanage, 2005
IL-12 Y (a t 1 and  5 dpi) Haghighi, 2007
IFN-y Y  (depend ing  o f  the ch ick en  age a t  the 
tim e o f  in fec tion)
Whitanage, 2005; Beals, 2004; 
Haghighi, 2007
TGF-/34 Y  (a t 1 dpi) Whitanage, 2005; Beals, 2004
Chemokine K60 N Whitanage, 2005
IL-8 ND Whitanage, 2005
MIP-1/3 N Whitanage, 2005
46
are the chicken’s /3-defensins, expressed by heterophils (the avian neutrophil 
equivalent) and epithelial cells, and therefore presumably play a role in the chicken’s 
innate immune response against Salmonella infection. The project aim was to 
compare AvBDs mRNA levels in different chicken lines considered as susceptible 
and resistant to different Salmonella serotypes. Indeed, a previous study showed that 
odefensins expressed in Paneth cells were inhibited after Salmonella infection in 
mice suggesting that the inhibition defensins is a virulence strategy of the intestine 
pathogen. Therefore, we wished to test the hypothesis that the susceptibility of 
chicken lines to Salmonella infection correlated with decreased AvBD transcript 
levels, as previously shown in mice.
In the present study, inbred chicken lines 61 and N, previously characterized for their 
resistance to systemic disease and their differences in levels of Salmonella 
colonisation, were selected to analyse gallinacin expression. Line 61 and line N 
chickens are resistant and susceptible to Salmonella serovar Typhimurium 
colonisation respectively (Barrow et al., 2004; Beal et al., 2005). An important 
difference in response between the lines
was the number and activity of circulating heterophils, suggesting the involvement of 
these cells and their secreted components, such as avian /3-defensins, in resistance to 
gut colonization. Therefore, gallinacins 1/1 a  and 2, originally isolated from 
heterophils, were chosen to study their expression in chickens. However, a role for j8- 
defensins expressed by epithelial tissues cannot be ruled out and gallinacin 3 was 
therefore also studied. In addition, three other gallinacins were selected. Identified 
originally by Dr N. Bumstead at IAH, two were then described as gallinacins 7 and 9 
(Lynn et al., 2004), while a third new defensin, not yet published, was characterised 
in this study and named gallinacin 14.
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Recently, a new nomenclature for chicken /?-defensins has been proposed, using the 
numbering system of Xiao et al. (2004) and changing the term “gallinacin” into 
“avian beta-defensin”, abbreviated AvBD (Lynn et al., 2007) (Table 1.4). This 
nomenclature will be used from now on throughout this thesis.
In this study, AvBD genomic DNAs were first characterised and cloned in an 
appropriate vector to determine the structure of the genes and to enable the design of 
primers and probes to study AvBD expression at the mRNA level using real-time RT- 
PCR. The potential development of bioreagents, such as monoclonal antibodies, to 
visualize AvBD expression by histochemistry in tissues of uninfected chickens and 
chickens infected with Salmonella, required the production of AvBD peptides, which 
would also permit testing of the killing and chemotactic activities of the AvBDs. The 
second part of the project was then to clone AvBDs 1/la, 2, 3 ,4 ,5  and 14 into an 
expression vector pTriExl.l, and to express AvBD peptides using the baculovirus 
expression system designed by Prof I. Jones at the University of Reading. However, 
the specific physicochemical characteristics of these antimicrobial peptides makes 
obtaining biologically active AvBD peptides difficult. Therefore, the expression of 
AvBDs at the mRNA level was analysed. A panel of tissues including lung, bursa, 
bone marrow, jejunum, ileum, ceaca wall, ceacal tonsil and skin was collected from 
uninfected chickens to assess the distribution of AvBD expression. In addition, two 
lines of chickens, line 6i and N, were infected with S. Typhimurium to analyse AvBD 
M\a, 2, 3, 4 and 5 expression in chickens both resistant and susceptible to Salmonella 
colonisation. In parallel, production of AvBDs in resistant and susceptible chickens 
following systemic infection was analysed to assess their expression in response to 
host-specific Salmonella and broad-host range Salmonella serotypes.
Table 1.5: New nomenclature of chicken jS-defensins (Lynn et al., 2007).
New gene/protein name Lynn/Higgs et al. 
definition
Xiao et al. 
definition
RefSeq definition Accession no.
A v ia n  b e ta -d e fe n s in  1 ( A v B D l) G a ll in a c in  1 (G  A L I ) G a llin a c in  1 (G A L 1 ) G a ll in a c in  1 (G A L 1 ) N M  2 0 4 9 9 3
A v ia n  b e ta -d e fe n s in  2  (A v B D 2 )) G a llin a c in  2 (G A L 2 ) G a llin a c in  2  (G A L 2 ) G a llin a c in  2  (G A L 2 ) N M  2 0 4 9 9 2
A v ia n  b e ta -d e fe n s in  3 (A v B D 3 ) G a llin a c in  3 (G A L 3 ) G a llin a c in  3 (G A L 3 ) B e ta -d e fe n s in N M  2 0 4 6 5 0
A v ia n  b e ta -d e fe n s in  4  (A v B D 4 ) G a ll in a c in  7 B e ta -d e fe n s in  4
p re p ro p e p tid e  (G A L 3 ) 
G A L 4  (G A L 4 ) N M  0 0 1 0 0 1 6 1 0
A v ia n  b e ta -d e fe n s in  5 (A v B D 5 )
prepropeptide(GAL7) 
G a ll in a c in  9
(GAL4)
B e ta -d e fe n s in  S G A L  5 (G A L 5 ) N M  0 0 1 0 0 1 6 0 8
A v ia n  b e ta -d e fe n s in  6  (A v B D 6 )
p re p ro p e p tid e (G A L 9 )  
G a llin a c in  4
(G A L 5 ) 
B e ta -d e fe n s in  6 G A L  6  (G A L 6 ) N M  0 0 1 0 0 1 1 9 3
A v ia n  b e ta -d e fe n s in  7  (A v B D 7 )
p re p ro p e p tid e (G A L 4 )  
G a ll in a c in  S
(G A L 6 ) 
B e ta -d e fe n s in  7 G A L  7  (G A L 7 ) N M  0 0 1 0 0 1 1 9 4
A v ia n  b e ta -d e fe n s in  8 (A v B D 8 )
p re p ro p e p tid e (G A L 5 )  
G a ll in a c in  12
(G A L 7 ) 
B e ta -d e fe n s in  8 G A L  8 (G A L 8 ) N M  0 0 1 0 0 1 7 8 1
A v ia n  b e ta -d e fe n s in  9  (A v B D 9 )
p re p ro p e p tid e (G  A L I  2 ) 
G a ll in a c in  6
(G A L 8 )  
B e ta -d e fe n s in  9 G A L  9  (G A L 9 ) N M  0 0 1 0 0 1 6 1 1
A v ia n  b e ta -d e fe n s in  1 0 (A v B D I0 )
p re p ro p e p tid e (G A L 6 )  
G a ll in a c in  8
(G A L 9 )
B e ta -d e fe n s in  10 G A L  1 0 ( G A L I 0 ) N M  0 0 1 0 0 1 6 0 9
A v ia n  b e ta -d e fe n s in  1 l (A v B D I  1)
p re p ro p e p tid e (G A L 8 ) ( G A L I 0 )  
B e ta -d e fe n s in  11 G a ll in a c in  11 (G A L 1 I ) N M  0 0 1 0 0 1 7 7 9
A v ia n  b e ta -d e fe n s in  1 2 (A v B D 1 2 ) G a ll in a c in  10
(G A L 1 1 )  
B e ta -d e fe n s in  12 B e ta -d e fe n s in  12 N M  0 0 1 0 0 1 6 0 7
A v ia n  b e ta -d e fe n s in  1 3 (A v B D 1 3 )
p re p ro p e p tid e (G A L l 0 ) 
G a ll in a c in  11
(G A L 1 2 )  
B e ta -d e fe n s in  13
(G A L 1 2 )  
B e ta -d e fe n s in  13 N M  0 0 1 0 0 1 7 8 0
A v ia n  b e ta -d e fe n s in  1 4 (A v B D 1 4 )
p re p ro p e p tid e (G A L l 1) (G A L 1 3 ) (G A L 1 3 )
G a ll in a c in  14 (G a i 14) A M 4 0 2 9 5 4
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Chapter 2 - Materials and Methods
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2.1 Bacterial strains, plasmids, restriction enzymes and oligonucleotides
The bacterial strains used in this thesis are listed in Table 2.1. All were grown 
aerobically in SOC medium (2% Tryptone, 0.5% Yeast Extract, 10 mM NaCl, 2.5 
mM KC1, 10 mM MgCk, 10 mM MgSC>4, 20 mM glucose) or in Luria-Bertani (LB) 
broth or agar for 24 h at 37°C. Where appropriate, ampicillin was added to the 
medium at 50 pg/ml. For long-term storage, 150 pi of glycerol was added to 850 pi 
of overnight culture and stored at -80°C.
Table 2.1: E. coli strain characteristics.
Strain Genotype Antibiotic
resistance
Source
TOPI OF’ F' mcrA A(mrr-hsdRMS-mcrBC) 4>80/<acZAM15
AlacXIA recA\araD\39
A(ara-leu)l 697 galXJ galK rpsL endA\ nupG
None Invitrogen
DH5a F- $80/acZAM15 A(lacZYA-arg¥)V\69 recAX 
endAX /uc/R17(rk-, mk+)phoA supE44 thi-X 
gyrA96 relAX X-
None Invi trogen 
Dr D. Devine,
BUE55 Unavailable- originally isolated because of its 
sensitivity to polymoxin B.
None University of 
Leeds
The plasmids used are listed in Table 2.2 and were stored at -20°C. 
Table 2.2: Characteristics of plasmids used for cloning.
Plasmids Description Antibiotic
resistance
Source
pCR 2.1-TOPO 3.9 kb cloning vector (see Appendix 1) ampicillin and 
kanamycin
Invitrogen
pTriEx-1.1 5.3 kb expression vector, which can be used in 
multiple expression systems: E .coli, insects 
and vertebrate cells. It carries optional C- 
terminal His*Tag and HSV*Tag sequences (see 
Appendix 2).
ampicillin No vagen
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The restriction enzymes used are listed in Table 2.3 and they were stored at -20°C. 
Table 2.3: Characteristics of restriction enzymes (RE) used for cloning.
RE_______ Description_______
Ncol 5'-CAC A T G G-3'
3'-G G T A CAC-5'
Buffer_________________________
lx NEBuffer 4 (20 mM Tris-acetate;
50 mM potassium acetate; 10 mM Magnesium 
Acetate;! mM Dithiothreitol; pH 7.9)
Bsal 
BglII 
Xhol
NcoVBgtll
NcoVXhol
BsaVBgRl
BsaVXhol
5'-G G T C T C NAN N N N-3' 
3'-C C A G A G N N N N  NA-5'
5'-AAG A T C T-3' 
3'-T C T A GAA-5'
5'-CAT C G A G-3' 
3'-G A G C TAC-5'
lx NEBuffer 3 (50 mM Tris-HCl; 100 mM NaCl; 
10 mM MgCl2; 1 mM Dithiothreitol; pH 7.9)
lx  NEBuffer 3 (50 mM Tris-HCl; 100 mM NaCl; 
10 mM MgCl2; 1 mM Dithiothreitol; pH 7.9)
lx NEBuffer 2 (10 mM Tris-HCl; 50 mM NaCl; 
10 mM MgCl2; 1 mM Dithiothreitol; pH 7.9)
lx NEBuffer 3
lx NEBuffer 2
lx NEBuffer 3
lx NEBuffer 3
The oligonucleotides used to obtain the genomic sequences of AvBDs 1,2 and 3, the 
cDNAs of the AvBD and for sequencing reactions are listed in Table 2.4. In order to 
obtain the genomic DNA of AvBDs 1,2 and 3, the oligonucleotides were designed 
according to the cDNA sequences already published. AvBD 1 and la  differ by only 
3 amino acids. The primers are therefore similar for both defensins. The forward 
primers used to clone the AvBD cDNAs into the expression vector pTriEx 1.1 were 
designed with a Bsal or Ncol restriction site at the 5 ' end of the sequence. A Bglll 
restriction site was also introduced into the 5'end of the reverse primers for AvBDs 3
and 5.
52
Table 2.4: Oligonucleotide sequences used in cloning and sequencing AvBDs.
Underlined nucleotides are the restriction sites used to clone AvBD sequences into 
thepTriEx 1.1 expression vector.
Primers_______
AvBDl/la gDNA
AvBD2 gDNA
AvBD3 gDNA
AvBDl/la cDNA
AvBDl/la
expression
AvBD2 cDNA
AvBD2
expression 
AvBD3 cDNA 
AvBD 3
expression
AvBD4 CDNA 
AvBD 4
expression
Forward sequence_____________
5'-ATGCGGATCGTGTACCTGCT-3'
5'-TCTCTCCTCTTCCTGGCACT-3'
5'-TCTTGTTTCTCCAGGGTGCT-3'
5'-GATCCATGGATGCGGATCGTGTACC 
TGCT3'
5'-GATGGTCTCACATGCGGATCGT-3'
5'-GAGCCATGGATGAGGATTCTT 
TACCTGCTTTTC-3'
5'-GATGGTCTCACATGAGGATT-3'
5'-GTACCATGGATGCGGATCGTGTAC 
CTGCTCATCCCCTTCTTCCTCTTG-3'
5'-GATGGTCTCACATGCGGATCGT-3'
5'-CTGCCATGAAAATCCTTTGCTT-3' 
5'-GATCCATGGCTGCCATGAAAAT-3'
Reverse sequence______________
5'-ATCTTGAGGATTTCCCACTGA-3'
5'-GCCATTTGCAGCAGGAA-3'
5'-ATTCAGGGCATCAACCTCATA-3'
5'-TCAGCCCCATATTCTTTTGC-3'
5'-TCAGCCCCATATTCTTTTGC-3'
5'-TATGCATTCCAAGGCCATTT-3'
5'-TATGCATTCCAAGGCCATTT-3'
5'-GATAGATCTTCAATGGGGGTTGTT 
T C CAG GAG C GAGAAG C CAC G GC GA-3'
5'-GATAGATCTTCAATGGGGGTTGTT 
TCCAGGAGCGAGAAGCCACGGCGA-3'
5'-TTACCATCTACAGCAAGAATA-3'
5'-GGAGATCTTTACCATCACAGCAA-3'
AvBD5 cDNA
AvBD14 cDNA
AvBD14
expression
-40 primer 
(M13)
5'-GATCCATGGATGCAGATCCTGCCTC 
TCCT-3'
5'-ATGGGCATATTCCTCCTGTTTC-3'
5'-GATCCATGGGCATATTCCTCCT-3' 
5'-GTTTTCCCAGTCACGAC-3'
5'-GATAGATCTCTACCTCCGGCAGCA 
GAAGT-3'
5'-TCACCAAAAGGGTCTGCAGCA-3'
5'-TCACCAAAAGGGTCTGCAGCA-3' 
5'-CAGGAAACAGCTATGAC-3'
pTriEx primer 5 *-GTTATTGTGCTGTCTCATCA-3 5'-TCGATCTCAGTGGTATTTGTGA-3'
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For both AvBDs and 28S rRNA-specific amplification in Taqman reactions, primers 
and probes were designed using the Primer Express software program (PE Applied 
Biosystems, Foster City, CA) (Table 2.5). All AvBD probes were designed to lie 
across intron-exon boundaries, according to the sequence of the relevant genes, to 
avoid any amplification from genomic DNA contaminants in the RNA samples.
Table 2.5: Real-time RT-PCR probes and primers. °P; Probe, F; Forward primer, 
R; Reverse primer. ^Genomic DNA sequences.
RNA
target
Probe/primer sequence" Exon
boundary
Accession
no.*
AvBDl P 5'-(FAM)-ATCCTGCAGCACCCTGGGCCA-(TAMRA)-3' 1/2 AY621315
F 5'-TGCTCCTCCCCTTCATCCT-3'
R 5'-GAAAACAATCTGACTTCCTTCCTAGAG-3'
AvBD2 P 5'-(FAM)-CCAGGTTTCTCCAGGGTTGTCTTCGC-(TAMRA)-3' 1/2 AY621317
F 5'-CCTGCTTTTCTCTCTCCTCTTCCT-3'
R 5'-CCCTCCTTTACAGAAGAGCATGT-3'
AvBD3 P 5'-(FAM)-TGGCAGTTCCTGCAGCACCCTG-(TAMRA)-3' 1/2 AY621318
F 5'-CATCCCCTTCTTCCTCTTGTTTC-3'
R 5'-CACGACAGAATCCTCCTCTTATTCT-3'
AvBD4 P 5'-(FAM)-GAACGGGAAAAGCCCACAGCTCCA-(TAMRA)-3' 1/2 AY621319
F 5'- TGCTCCTCTTTGTGGCAGTTC-3'
R 5'- TCCCGCGATATCCACATTG-3'
AvBD 5 P 5'-(FAM)-CAGCCCTGGTTCTGCCCGGA-(TAMRA)-3' 1/2 AY621320
F 5'-AGATCCTGCCTCTCCTCTTTGC-3'
R 5'-CCCACGGCGCTCACAGT-3'
AvBDl4 P 5'-(FAM)- CCCAGGCTGCACCAGAGTCGGA -(TAMRA)-3' 1/2 AM402953
F 5'- CTGTTTCTTGTTCTCCTGGCAGTA -3'
R 5'- CTTCATCTTCCGACATGTGACAGT-3'
28S P 5' -(FAM)-AGGACCGCTACGGACCTCCACCA-(TAMRA)-3' X59733
F 5'-GGCGAAGCCAGAGGAAACT-3'
R 5'-GACGACCGATTGCACGTC-3'
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2.2 Polymerase Chain Reaction (PCR)
Genomic DNA (1 pg/pl) from line N and 6i chickens was diluted 1:5 for PCR 
reactions. cDNA from HD11 macrophage-like cells, peripheral blood monocyte- 
derived macrophages from 1-week-old line 72 chickens, and spleen and lung from 7- 
week-old line N chickens was used to obtain defensin cDNAs. Defensin primers 
(Table 2.4) were diluted 1:10 in sterile water from a stock solution of 100 pmol/pl. 
The enzyme Taq polymerase was used at 2.5 units/pl (Promega). Reactions were set 
up by adding 2 pi of cDNA, 2.5 pi of lOx Buffer (proprietary formulation supplied at 
pH 8.5, magnesium free; Promega), 1.5 pi of MgC^ (25 mM), 2.5 pi of dNTPs (10 
mM), 1 pi of each primer and 0.5 pi of Taq polymerase in a final reaction volume of 
25 pi. Initial denaturing of the DNA was carried out at 94°C for 4 min; this was 
followed by 30 cycles of denaturing at 94°C for 1 min, annealing of primers at an 
appropriate temperature for 1 min and new DNA synthesis at 72°C for 1 min. The 
synthesis was then completed by a final cycle at 72°C for 7 min.
The proofreading enzyme Pfu polymerase was used at 2 units/pl (Promega).
Reactions were set up by adding 2 pi of cDNA, 5 pi of 1 Ox Buffer (Promega), 1 pi of 
dNTPs (10 mM), 1 pi of each primer and 0.5 pi of Pfu polymerase in a final reaction 
volume of 50 pi. Initial denaturing of the DNA was carried out at 95°C for 5 min; 
this was followed by 30 cycles of denaturing at 94°C for 30 sec, annealing of primers 
at an appropriate temperature for 30 sec and new DNA synthesis at 72°C for 2 min. 
The synthesis was then completed by a final cycle at 72°C for 5 min.
2.3 Gel electrophoresis
DNA products were separated on a 2% agarose gel (1 g agarose dissolved in 
50 ml IX TAE buffer) while the genomic DNA of AvBD 3 was separated on a 1.5 % 
agarose gel (0.75 g agarose dissolved in 50 ml IX TAE buffer) with ethidium
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bromide (0.5 fig ml'1) as the staining agent. 50X TAE buffer is composed of 2 M 
Tris, 50 mM EDTA pH 8.0 and 6% (vol vol'1) glacial acetic acid.
The samples were electrophoresed at 100 V for 30 min (Bio-Rad V.H-N 
Elektrophorese, UK) and DNA bands were observed under ultraviolet light using an 
Epi Chemi II Darkroom (UVP Laboratory Products, UK). The samples were 
prepared by adding 3 pi of loading dye (GelPilot; Qiagen- proprietary formulation), 
containing bromophenol blue, xylene cyanol and orange G, to 5 pi of sample. A 100 
bp DNA ladder (Promega) was used as marker.
2.4 Gel extraction
Gel extraction was carried out using the QIAquick gel extraction kit 
(Qiagen). The DNA fragment was excised from the agarose gel with a clean and 
sharp scalpel, the gel slice weighed in a colourless tube and an appropriate volume of 
buffer QG added (3 volumes to 1 volume of gel). Buffer QG (proprietary 
formulation), containing guanidine thiocyanate, solubilizes the agarose gel slice and 
provides the appropriate conditions for binding of DNA to the silica membrane.
Once the gel had dissolved completely after incubation at 50°C for 10 min, the 
sample was applied to a QIAquick column and centrifuged for 1 min at 16,000 x g. 
The flow-through was discarded and 0.75 ml of buffer PE (proprietary formulation), 
containing ethanol, was added to wash the column. The sample was centrifuged for 1 
min at 16,000 x g, the flow-through discarded and an additional 1 min centrifugation 
at 17,900 x g  was carried out to remove residual ethanol. The column was then 
placed into a clean 1.5 ml microcentrifuge tube and the DNA eluted by adding 30 pi 
of sterile distilled water to the centre of the column membrane followed by 
centrifugation for 1 min at 17,900 x g.
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2.5 Plasmid extraction
Plasmid DNA was extracted using a QIAprep miniprep kit (Qiagen). An 
overnight culture of transformed cells (10 ml) was centrifuged 10 min at 1800 x g. 
The pellet was resuspended into 250 pi of buffer PI (50 mM Tris-HCl, pH 8.0, 10 
mM EDTA) containing RNase A (100 pg/ml; 7000 U/ml) and transfered to a 
microcentrifuge. Buffer P2 (200 mM NaOH, 1% SDS (w/v)) (250 pi) was then 
added to the mixture. The NaOH/SDS in the presence of RNase A produces bacterial 
lysis under alkaline conditions. The SDS solubilizes the phospholipids and protein 
components of the cell membrane, while the alkaline conditions denature the 
chromosomal and plasmid DNA, in addition to proteins. The lysate is then 
neutralised by adding 350 pi of buffer N3 (proprietary formulation), containing 
guanidine hydrochloride and acetic acid, which gives high-salt binding conditions 
and causes the precipitation of denatured components except the plasmid DNA that 
renatures correctly and stays in solution.
The mixture was centrifuged for 10 min at 16,000 x g  to precipitate all the cell 
debris. The supernatant was applied to the QIAprep column and centrifuged for 1 
min at 16,000 x g. The flow-through was discarded and 0.75 ml of buffer PE 
(proprietary formulation), containing ethanol, was added to wash the column. The 
sample was centrifuged 1 min at 16,000 x g, the flow-through discarded and an 
additional centrifugation for 1 min at 16,000 x g  was carried out to remove residual 
ethanol. The column was then placed into a clean 1.5 ml microcentrifuge tube and 
the DNA eluted by adding 30 pi of sterile distilled water to the centre of the column 
membrane and centrifuging for 1 min at 16,000 x g.
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2.6 PCR purification
DNA purification after a PCR reaction was carried out using a QIAquick 
PCR purification kit. Five volumes of Buffer PB (proprietary formulation), 
containing guanidine hydrochloride and isopropanol, were added to 1 volume of the 
PCR sample, allowing the efficient binding of products as small as 100 bp and 
removal of primers up to 40 bp. The mixture was added to the column and 
centrifuged for 1 min at 16,000 x g. The flow-through was discarded and 0.75 ml of 
buffer PE, containing ethanol, was added to wash the column. The sample was 
centrifuged for 1 min at 16,000 x g, the flow-through discarded and an additional 
centrifugation for 1 min at 16,000 x g was carried out to remove residual ethanol.
The column was then placed into a clean 1.5 ml microcentrifuge tube and the DNA 
eluted by adding 30 pi of sterile distilled water to the centre of the column membrane 
and centrifuging for 1 min at 16,000 x g.
2.7 Reverse transcriptase reaction
cDNA was obtained from tissue RNA using a reverse transcription system 
(Promega). RNA (1 pg) was incubated for 10 min at 70°C to obtain linear RNA for 
optimal annealing of primers. The mixture was then placed on ice and the reaction 
was set up by adding 2 pi reverse transcription lOx buffer (100 mM Tris-HCl, pH
9.0, 50 mM KC1, 0.1% Triton X-100), 4 pi MgCl2 (25 mM), 2 pi dNTP mixture (10 
mM), 0.5 pi Rnasin Ribonuclease inhibitor, 1 pi Oligo(dT) primer and 1 pi AMV 
Reverse Transciptase (15 U/pl) in a final volume of 20 pi. The mixture was then 
incubated at 42°C for 15 min for the reverse transcription. The reaction was then 
heated at 95°C for 5 min and incubated at 5°C for 5 min to inactivate the AMV 
Reverse Transcriptase.
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2.8 Cloning inserts
2.8.1 Cloning inserts in TOPO vector
PCR products were cloned using a TOPO TA Cloning kit (Invitrogen). PCR 
product (4 pi) was mixed gently with 1 pi of salt solution (1.2 M NaCl, 0.06 M 
MgCl2) and 1 pi of TOPO vector and incubated at room temperature for 30 min. The 
TOPO cloning reaction mixture (2 pi) was then mixed gently with 30 pi of One Shot 
E. coli TOPI OF’, and incubated for 30 min on ice. The cells were then heat-shocked 
for 30 sec at 42°C, mixed with 250 pi of SOC medium (2% Tryptone, 0.5% yeast 
extract, 10 mM NaCl, 2.5 mM KC1, 10 mM MgCl2, 10 mM MgS04, 20 mM glucose) 
and incubated for 2 h at 37°C with shaking. Finally, 50 pi cells were spread on LB 
agar plates containing 50 pg/ml of ampicillin, 40 pi 40 mg/ml X-gal and 40 pi of 100 
mM IPTG, and incubated overnight at 37°C. Any white colonies were tested by PCR 
with gene-specific primers and an M13 (-40) primer, and analysed on agarose gels at 
an appropriate percentage to check the presence and the size of the cloned insert. The 
positive clones were cultured overnight in LB medium containing 50 pg/ml of 
ampicillin. Glycerol stocks of positive clones were then prepared and stored at -80°C.
2.8.2 Cloning inserts in the expression vector pTRiEx-1.1
All digestions were carried out in 0.5 ml tubes with 20 units of each 
restriction enzyme: NcoVXhol, Ncol/Bglll, Bsal/Xhol or BsaVBglll (NEB), 2 pi of 
the corresponding lOx buffer (NEB), 3 pi of plasmid DNA (10 ng/pl) or 1 pi of 
pTriEx vector (50 ng/pl), made up to 20 pi with sterile water. The reaction was then 
carried out for 2 h at 37°C and the digestion products run on an agarose gel. The 
inserts were purified using a QIAquick gel extraction kit, while the pTriEx-1.1 vector 
was purified with a QIAquick PCR Purification Kit.
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The cDNA was then ligated to the pTriEx-1.1 vector in the following reaction: 1 pi 
of pTriEx-1.1 digested vector, 10 pi of digested cDNA, 1.5 pi of lOx buffer ligase 
(Promega), 1 pi of T4 DNA ligase and 1.5 pi of sterile water. A control without 
cDNA was included and all samples were incubated overnight at 16°C.
E. coli DH5a competent cells were produced chemically. Bacteria were grown 
overnight (37°C, 165 rpm) in 10 ml of LB containing no antibiotics. This culture was 
diluted 1/100 in 250 ml of fresh LB which was then grown at 37°C (165 rpm) until 
the OD600 reached 0.4-0.6. The culture was transferred into two 300 ml bottles (GSA 
rotor) and centrifuged (5 min, 6000 x g). The pellet was gently resuspended in 1:25 
of the original culture volume of ice-cold TFB1 (30 mM potassium acetate, 10 mM 
CaCb, 50 mM MnCL, 100 mM RbCl and pH adjusted to 5.8) and incubated at 4°C 
on ice for 5 min. The bacteria were again centrifuged (5 min, 6000 x g) and 
resuspended gently in 1:25 of the original culture volume of ice-cold TFB2 (10 mM 
MOPs pH 6.5, 75 mM CaCl2, 10 mM RbCl, 15% glycerol and pH adjusted to 6.5), 
incubated on ice for a further 15-60 min and dispensed into 200 ml aliquots which 
were flash-frozen on dry ice and then stored at -70°C until required.
The competent cells were then transformed with the ligation product. E. coli DH5a 
cells (50 pi) were mixed with 2 pi of ligation product. The cells were incubated on 
ice for 30 min, heat-shocked at 42°C for 30 sec and returned to ice for a further 2 
min. SOC medium (250 pi) was then added to the reaction tube, the vials shaken 
(200 rpm) for 1 h at 37°C and then placed on ice until required. For each 
transformation, 20 pi and 40 pi of medium plus cells were plated onto two separate 
plates of LB agar containing 50 pg/ml of ampicillin and the plates were incubated at 
37°C overnight.
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2.9 Sequencing on the CEQ 8000 Sequencer
Reactions were set up with 1 pi plasmid (200 ng), heat-treated for 1 min at 
96°C in 13 pi of distilled water, then 1 pi of M13 (-40) forward primer, 4 pi of 
quickstart and 1 pi of dilution buffer from CEQ DTCS Quick Start Kit (Beckman 
Coulter, CA, USA) were added. Initial denaturing of the DNA was carried out at 
96°C for 2 min. This was followed by 30 cycles of denaturing at 96°C for 20 sec, 
annealing of primers at 50°C for 20 sec and new DNA synthesis at 60°C for 2 min. 
Following the cycle sequencing, 5 pi of a stop solution (2 volumes of 100 mM 
EDTA, 2 volumes of 3 M sodium acetate pH 5.2 and 1 volume of glycogen at 20 
mg/ml) were added to each sample. Ice-cold 95% ethanol (60 pi) was added to the 
samples and they were centrifuged at 16,000 x g for 15 min to precipitate the DNA. 
The pellets obtained were washed twice with 200 pi of ice-cold 70% ethanol and air- 
dried for 1 h. Finally, 40 pi of Sample Loading Solution from CEQ DTCS Quick 
Start Kit (Beckman Coulter, CA, USA) was added to each sample with a drop of 
mineral oil to stabilise the reaction and they were loaded on the CEQ 8000 
Sequencer (Beckman Coulter).
2.10 Plasmid purification using a QIAGEN plasmid Midi kit
Plasmid purification was carried out by inoculating 25 ml medium with a 
starter culture diluted at 1/500 and incubating at 37°C for 12 h with vigorous shaking. 
The cells were centrifuged at 6000 x g  for 15 min at 4°C and the pellet resuspended 
into 4 ml of buffer PI, containing RNase A. Buffer P2 (NaOH/SDS) (4 ml) was then 
added to the mixture. The NaOH/SDS in the presence of RNase A produces bacterial 
lysis under alkaline conditions. The SDS solubilises the phospholipids and protein 
components of the cell membrane, while the alkaline conditions denature the
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chromosomal and plasmid DNA, in addition to proteins. The lysate was then 
neutralised by adding 4 ml of buffer P3 (3 M potassium acetate, pH 5.5), which gives 
high-salt binding conditions and causes the precipitation of denatured components, 
except the plasmid DNA that renatures correctly and stays in solution. The mixture 
was centrifuged at 20,000 x g  for 30 min at 4°C to precipitate all the cell debris. The 
supernatant was again centrifuged at 20,000 x g  for 30 min at 4°C to eliminate 
suspended or particulate material that can clog the QIAGEN-tip. The supernatant 
was applied to a QIAGEN-tip 100, previously equilibrated with 4 ml of buffer QBT 
(pH 7.0). The QIAGEN-tips contain an anion-exchange resin that interacts with the 
negatively charged phosphates of the DNA plasmid via positively charged DEAE 
groups present in the resin surface. The binding, washing and elutions steps are 
therefore strongly influenced by pH. The column was washed twice with 10 ml of 
buffer QC (1 M NaCl, 50 mM MOPS,pH 7.0,15% isopropanol (v/v)) and DNA was 
finally eluted with 5 ml of Buffer QF (1.25 M NaCl, 50 mM Tris-HCl, pH 8.5, 15% 
isopropanol (v/v)). Finally, the plasmid DNA was precipitated with 3.5 ml of 
isopropanol, centrifuged at 15,000 x g  for 30 min at 4°C, washed with 2 ml of 70% 
ethanol and centrifuged again at 15,000 x g  for 10 min. The pellet was air-dried for 
10 min and redissolved in 1 ml of sterile water.
2.11 Expression of defensin mRNA in COS-7 cells
The COS-7 cell line is an African green monkey kidney cell line, derived 
from the CV-1 cell line by transformation with an origin-defective mutant of SV40. 
The cells were cryopreserved at 1.5 x 106 cells/ml after 6 passages and thawed in a 
water-bath at 37°C. They were then washed with COS-7 cell growth medium (360 ml 
DMEM medium, 200 mM L-glutamine, 4.5 g/1 glucose, 110 mg/1 sodium pyruvate,
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3.7 g/1 sodium bicarbonate) containing 10% foetal calf serum (FCS) and incubated at 
37°C in 5% CO2 in a T75 flask for 4 days. The cell layer was washed twice with pre­
warmed PBS (12 g/1 PBSa powder, BioWhittaker) and detached from the flask after 
5 min incubation at 41°C with ~5 ml of trypsin (0.25% trypsin in PBS)/versene (9.95 
g PBSa powder, 0.2 g EDTA) solution at a 1:10 dilution. The trypsinisation was 
stopped with ~15 ml of growth medium containing FCS and the cells pelleted at 900 
x g  for 5 min to determine the viable cell concentration using a haemocytometer. T75 
flasks were seeded with 7.5 x 105 cells in 15 ml of growth media and incubated at 
37°C in 5% CO2 for 2 days. The trypsinisation and viable cell count procedures were 
repeated until the COS-7 cell concentration was sufficient to seed the appropriate 
number of T25 flasks with 2 x 106 cells each to carry out the transfection procedure. 
T25 flasks with 2 x 106 cells were incubated at 37°C in 5% CO2 for 24 h and washed 
twice with PBS. To each T25 flask was added 5 ml of serum-free growth medium 
containing 37.5 pg DNA, 50 pi of chloroquine and 30 pi of DEAE/dextran and 
incubated for 3 h at 37°C in 5% CO2. The cells were washed with PBS and 10% 
DMSO was added for 2 min. The mixture was then removed, replaced with 5 ml 
growth medium containing 10% FCS and the T25 flasks were finally incubated for 
24 h at 37°C in 5% CO2. The growth medium was changed for serum-free medium 
and cells were harvested 3 days post-transfection to obtain defensin mRNA using an 
RNeasy kit (QIAGEN).
2.12 Experimental plan
All birds were from specified-pathogen-ffee (SPF) inbred flocks reared in the 
Institute for Animal Health (IAH) experimental animal house. Line 61 and N 
chickens were inoculated orally at one day of age with 0.1 ml of gut flora to avoid
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the development of different flora in the different lines. The gut flora was obtained 
from the caecal contents of an adult out-bred SPF chicken from the IAH flocks, 
incubated statically overnight in 10 ml LB broth.
In a first experiment, non-infected chickens from each line (n = 3) were killed at 6 
weeks of age by cervical dislocation and the following tissues were collected for 
quantification of AvBD mRNA levels: lung, bursa, bone marrow, jejunum, ileum, 
caeca and caecal tonsil.
In a second experiment, non-infected chickens from each line (n = 3) were killed at 6 
and 7 weeks of age as controls. Housed in a separate room, a group of 10 birds from 
each line, reared in the same cage, were infected orally at 6 weeks of age with 0.1 ml 
of S. Typhimurium F98 overnight culture and killed after 1,2 and 7 days post­
infection (n = 3 for each-time point). These time points were chosen according to the 
bacteriological results previously obtained by Barrow P. A. et al, 2004. A similar 
experiment was done in parallel with chickens infected with S. Gallinarum 9 (n = 5 
for each-time point). The caecal contents and caecal tonsils were collected for 
quantification of bacterial load and AvBD mRNA levels respectively.
In a third experiment, 27 chickens from each of line 6i and N were housed in 
separate cages in the same room. Every week for nine weeks, 3 birds from each line 
were killed to collect caeca and caecal tonsils for quantification of AvBD mRNA 
levels.
Finally, in a fourth experiment, designed and performed by Dr P. Wigley and Ms L. 
Chappell, 60 line I 2 chickens were housed in separate cages in the same room. 
Twenty chickens were then infected orally at 1 week of age with 0.1 ml of S. 
Pullorum 449/87 overnight culture and killed after 24 h, 1,2 and 4 weeks post­
infection (n = 5 for each time-point). A similar experiment was done in parallel with
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chickens infected with S. Enteritidis p i25109 (n = 5 for each time-point) and 20 
other birds were inoculated with 0.1 ml of LB broth as controls. The caecal tonsils 
and spleen were subsequently analysed for AvBD mRNA levels.
2.13 Bacterial enumeration
Bacterial load was assessed as previously described (Barrow et al., 2004). 
Caecal contents were plated on Brillant Green agar containing sodium nalidixate (20 
pg/ml) and novobiocin (1 pg/ml). For quantitative enumeration, caecal contents were 
diluted and homogenised in phosphate-buffered saline (PBS). The viable count of 
Salmonella in the samples was estimated by plating aliquots of ten-fold dilutions 
onto selective Brillant Green agar. The plates were finally incubated at 37°C for 24 h.
2.14 RNA extraction
2.14.1 From COS-7 cells
Cells were harvested after trypsinisation and mixed with 600 pi of buffer 
RLT (proprietary formulation), containing guanidine thiocyanate and 0.01% /3- 
mercaptoethanol (v/v), which lyses the cell membrane. The lysate was homogenised 
with a QIAshredder spin column and centrifuged for 2 min at 16,000 x g. One 
volume of 70% ethanol was added to the supernatant for optimal absorption of RNA 
to the RNeasy mini column. The sample (700 pi) was applied to the column and 
centrifuged for 15 sec at 16,000 x g. The flow-through was discarded, 700 pi of 
buffer RW1 (proprietary formulation), containing ethanol, added to the column, and 
centrifuged for 15 sec at 16,000 x g  to remove contaminants. The collection tube was 
removed with the flow-through and the column placed into a new collection tube to 
wash the column with 500 pi of buffer RPE (proprietary formulation). The tube was
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centrifuged for 15 sec at 16,000 x g, another 500 p.1 of buffer RPE added to the 
column and finally centrifuged for 2 min at 16,000 x g  to dry the RNeasy silica-gel 
membrane and obtain high quality RNA, which was eluted in 30 pi of water.
2.14.2 From tissues
In order to obtain total RNA, tissues were immediately stabilized in 
KNAlater RNA Stabilisation Reagent (Ambion, Huntingdon, UK) and stored at - 
20°C until extraction of RNA using an RNeasy Kit (Qiagen, Crawley, UK) After 
thawing the samples, 30 mg of tissues were mixed with 600 pi of buffer RLT, 
containing /3-mercaptoethanol, which lyses the cell membrane. A Mixer Mill MM 
300 (Retsch GmbH & Co., Germany) was then used to disrupt tissue and 
homogenize the lysate for 4 min at 20 Hz. The tissue lysate was centrifuged for 3 
min at 16,000 x g  to pellet the cell debris and the supernatant was transferred into a 
new microcentrifuge tube. One volume of 70% ethanol was added to the supernatant 
for optimal absorption of RNA to the RNeasy mini column. The sample (700 pi) was 
applied to the column and centrifuged for 15 sec at 16,000 x g. The flow-through was 
discarded, 700 pi of buffer RW1 added to the column, and centrifuged for 15 sec at 
16,000 x g  to remove contaminants. The collection tube was removed with the flow­
through and the column placed into a new collection tube to wash the column with 
500 pi of buffer RPE. The tube was centrifuged for 15 sec at 16,000 x g, another 500 
pi of buffer RPE was added to the column and finally centrifuged for 2 min at 16,000 
x g  to dry the RNeasy silica-gel membrane and obtain high quality RNA, which was 
eluted in 30 pi of water. The samples were stored at -20"C until quantification by
real-time RT-PCR.
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2.15 Optimising primer concentrations for TaqMan assays
Optimisation was carried out with an ABI Prism 7700 Sequence Detector in a 
Thermofast 96-well plate. Firstly, 19 pi of master mix, containing lx Master mix 
(proprietary formulation, Eurogentec S.A., Belgium), 0.25 units/pl Moloney Murine 
leukaemia virus reverse transcriptase and 0.1 units/pl RNase inhibitor, 0.1 pM probe 
and the remainder of the volume made up with RNase-free water, were added to each 
well. Each primer (1 pi), diluted to obtain the following final concentrations, 1, 0.8,
0.6, 0.4, 0.2 and 0.1 pM, was added to the appropriate wells. Finally, 5 pi of RNA 
samples, previously prepared with serial ten-fold dilutions from 10'1 to 10-6 from a 
stock concentration around 2 mg/ml, were added to the wells so that each dilution of 
RNA sample was added to the wells containing the different primer concentrations.
In addition, 5 pi of RNase-free water was added to six no template control wells. The 
RT-PCR conditions were set up with an initial step at 50°C for 2 min to prevent the 
amplification of contaminants, followed by the reverse transcriptase step at 60°C for 
30 min. The following PCR activated the Ampli Taq polymerase at 95°C for 5 min, 
followed by 40 cycles to denaturize and extend the DNA respectively at 94°C for 20 
sec and 59°C for 1 min (see Appendix 3).
2.16 Quantification of AvBD mRNA expression by real-time quantitative RT- 
PCR
AvBD mRNA expression in tissues from chickens uninfected or infected with 
S. Typhimurium and S. Gallinarum was quantified using real-time quantitative RT- 
PCR as previously described (Kaiser et al., 2000; Kaiser et al., 2002; Kogut et al., 
2003; Swaggerty et al., 2004; Swaggerty et al., 2006). Primer and probe sequences
are shown in Table 2.5.
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Real-time quantitative RT-PCR was performed using the Reverse Transcriptase 
qPCR Master Mix RT-PCR kit (Eurogentec, Seraing, Belgium). Amplification and 
detection of specific products were performed using the ABI PRISM 7700 Sequence 
Detection System (PE Applied Biosystems, Foster City, CA, USA) with the 
following cycle profile: one cycle of 50°C for 2 min, 60°C for 30 min, and 95°C for 5 
min, and 40 cycles of 94°C for 20 sec, 59°C for 1 min or the 7500 Fast Real-Time 
PCR System (PE Applied Biosystems, Foster City, CA, USA) with the following 
cycle profile: one cycle of 50°C for 2 min, 60°C for 15 min, and 95°C for 5 min, and 
40 cycles of 94°C for 20 sec, 59°C for 1 min. Quantification was based on the 
increased fluorescence detected due to hydrolysis of the target-specific probes by the 
5'-exonuclease activity of the rTth DNA polymerase during PCR amplification (see 
Appendix 4). The passive reference dye 6-carboxy-c-rhodamine, which is not 
involved in amplification, was used for normalization of the reporter signal. Results 
are expressed in terms of the threshold cycle value (Ct), the cycle at which the 
change in the reporter dye passes a significance threshold (ARn)
To account for variation in sampling and RNA preparation, the Ct values for AvBD- 
specific product for each sample were standardised using the Ct value of 28S rRNA 
product for the same sample. To normalise RNA levels between samples within an 
experiment, the mean Ct value for 28S rRNA-specific product was calculated by 
pooling values from all samples in that experiment. Tube-to-tube variations in 28S 
rRNA Ct values about the experimental mean were calculated. The slope of the 28S 
rRNA logio dilution series regression line was used to calculate differences in input 
total RNA. Using the slopes of the respective AvBD logio dilution series regression 
lines, the difference in input total RNA, as represented by the 28S rRNA, was then 
used to adjust AvBD-specific Ct values, as follows:
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Corrected Ct value = Ct + (Nt-Ct')* S/S' where Ct = mean sample Ct; Nt = 
experimental 28S mean; C t-  mean 28S of sample; S = AvBD slope; S -  28S slope. 
Results were then expressed as 40-Ct values.
2.17 Expression of AvBDs in Baculovirus system
AvBDs were expressed using a baculovirus system at the University of 
Reading in Proflan Jones’ lab (see Appendix 5). Bacmid DNA (500 ng) was 
linearised by digesting at the unique Bsu36\ site with 1 pi of Bsu36l (NEB), 2 pi lOx 
NEB buffer 3 and 0.2 pi lOOx BSA (10 mg/ml) in a final reaction volume of 20 pi, 
incubating at 37°C for 3 h followed by heat inactivation of the enzyme at 80°C for 20 
min. For the transfection, 500 ng of transfer vector DNA, AvBD cDNA cloned into 
pTriExl.l, was mixed with 500 ng bacmid and 12 pi of lipofectin, diluted 2:1 
(Invitrogen), in a final reaction volume of 25 pi and incubated at 25°C for 30 min.
Sf9 insect cells at 106 cells/well were incubated for 1 h at 28°C to allow the cells to 
adhere. Insect-Xpress medium (BioWhittaker, Walkersville, MD) with 2% FCS and 
2% penicillin-streptomycin was then removed, replaced with the DNA 
mixture/lipofectin previously mixed with serum-free media and incubated at 28°C. 
After 24 h incubation, serum-free media was replaced with 2% FCS media and the 
cells were incubated at 28°C for 4 days. The cells were finally centrifuged for 10 min 
at 16,000 x g  and the supernatant transferred to a new eppendorf tube and stored at 
4°C. This contains low titre recombinant baculovirus, named P0.
The recombinant baculovirus P0 was then amplified by infecting 15 x 106 cells per 
T150 tissue culture flask with 1 ml of recombinant virus P0 mixed with 10 ml of 
media with 2% FCS, and incubated at 28°C for 30 min. Media (19 ml) containing 2% 
FCS were added and the cells incubated for 1 week at 28°C. The cells were finally
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centrifuged for 20 min at 5,000 x g  and the supernatant transferred to a new 
eppendorf tube and stored at 4°C. This contains high titre recombinant baculovirus, 
named PI.
Finally, small and large-scale production of AvBDs was carried out. The small-scale 
production was performed by infecting 1 x 106 cells per well in a 6-well plate with 
250 pi of recombinant virus PI mixed with 250 pi of serum and antibiotic-free 
medium and incubated at 25°C for 1 h. The large-scale production was carried out by 
infecting 15xl06 cells per T150 tissue culture flask with 500 pi of recombinant virus 
Pi mixed with 9.5 ml of media with 2% FCS and incubated at 25°C for 1 h. The 
recombinant virus PI/media was then removed and changed to serum- and antibiotic- 
free media for large and small-scale production respectively. After 3 days at 28°C, 
the cells were finally centrifuged for 20 min at 5,000 x g and both supernatant and 
pellet were stored at -20°C until purification.
2.18 Analysis of baculovirus DNA
To prepare the DNA template, the virus is lysed and treated with proteinase
K. For this purpose, 10 pi of virus stock were mixed with 89 pi of lysis buffer (10 
mM Tris-HCl, pH 8.3,100 pg/ml of gelatine, 0.45% TritonX-100,0.45% Tween 20 
and 50 mM KC1) and 1 pi proteinase K (6 mg/ml in water) added last and mixed 
with a pipette tip. The mixture was incubated for 1 h at 60°C then for 10 min at 95"C 
to heat-inactivate the proteinase K. Finally, the product obtained was used as a 
template for PCR reactions with AvBD-specific primers.
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2.19 Purification
2.19.1 Cationic exchange chromatography
For small-scale purification, 5 ml of supernatant were mixed with 5 ml of 
start buffer and the cell pellet was mixed with 4 ml of start buffer and 80 pi of 
inhibitor cocktail tablet (ROCHE), sonicated 10 min and made up to 10 ml with start 
buffer. The start buffer is the buffer used in the first step of ionic purification and 
described in the each figure legend. For large-scale purification, 30 ml of supernatant 
were mixed with 20 ml of start buffer and the pH adjusted to the pH noted in the 
figure legend for each experiment. Finally, the samples were centrifuged at 15000 x 
g  for 15 min at 4°C. The start buffer was either composed of 50 mM bicine or 32 mM 
ammonium acetate.
A 5 ml HiTrap SP HP (Amersham Biosciences) cationic exchange column, used for 
small-scale purification, was placed on the FPLC system, washed with filter- 
sterilised distilled water and equilibrated with 2 x column volumes of start buffer.
The samples were applied to the cationic column and washed with 5 column volumes 
of start buffer at a 5 ml/min flow rate. The elution was then carried out with a 
continuous ionic gradient of 0 to 0.5 M NaCl (start buffer, 0.5mM NaCl) at 5 ml/min 
flow rate and a gradient volume of 10 x column volumes. The eluate was collected in 
2 ml fractions and those containing the elution peak were mixed and further purified 
by RP-HPLC.
For large-scale purification, a 25 ml CM Sepharose™ Fast Flow (GE Healthcare) 
cationic exchange column was placed on the FPLC system, washed with filter- 
sterilised distilled water and equilibrated with 3 x 50 ml of start buffer. The samples 
were applied to the cationic column and washed with 2 x 50 of start buffer at a 20 
ml/min flow rate. The elution was a one step elution carried out with 2 x 50 ml of
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elution buffer (start buffer, 0.8 M NaCl) at a 10 ml/min flow rate. The eluate was 
collected in 5 ml fractions and those containing the elution peak were mixed and 
further purified with RP-HPLC.
2.19.2 Reverse Phase-HPLC
Reversed phase separations were performed by loading the products of the 
ion exchange chromatography onto a 4.6 x 250mm Vydac Cl 8 column (Biocad 
Sprint HPLC, Perceptive Biosystems, Cambridge, USA). The separations were 
achieved using the following gradient: 2 min of 0% solvent B, 20 min gradient from
0 to 80% of solvent B then a 4 min gradient from 80 to 0% of solvent B and finally a
1 min step of 0% solvent B. Solvent A was composed of 0.1% TFA in distilled water 
versus solvent B composed of 0.1% TFA in acetonitrile.
2.20 Tris-Tricme SDS-PAGE
Samples were mixed with SDS loading buffer (200 mM Tris-HCl, pH 6.8,
2% SDS, 40% glycerol and 0.04% Coomassie Brilliant Blue), boiled for 10 min and 
centrifuged at 16,000 x g  for 1 min. A 16.5% Tris-Tricine SDS-PAGE Ready gel 
(Bio-Rad Laboratories Ltd, Hemel Hempstead, UK) (Schagger & von Jagow, 1987) 
was placed in an electrophoresis tank, which was then filled with lOx 
Tris/Tricine/SDS Buffer (100 mM Tris, pH 8.3, 100 mM Tricine, 0.1% SDS) diluted 
to lx. The sample mixtures were then loaded into the SDS gel and one well was used 
to load the marker, Precision Plus Protein standards (Bio-Rad Laboratories Ltd, 
Hemel Hempstead, UK). The gel was then run for 90 min at 65 mA. SDS gels were
then Coomassie Brillant Blue or silver stained.
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2.20.1 Coomassie Blue staining
The proteins were first fixed by incubating the gel in 5 gel volumes of fixing solution 
(50% methanol, 10% acetic acid) for 2 h at 25°C with gentle shaking. The fixing 
solution was then replaced with Coomassie Brillant Blue (CBB) staining solution 
(0.25 g of CBB R250 in 45% methanol and 10% acetic acid) and incubated for 4 h at 
25°C with gentle shaking. The gel was rinsed in fixing solution and destained in 5 gel 
volumes with destaining solution (30% methanol, 10% acetic acid) for 4-8 h, 
changed 3-4 times during this period. Finally, the gel was stored in 7% acetic acid 
and photographed with a digital camera.
2.20.2 Silver staining
Proteins were first fixed by incubating the gel in 5 gel volumes of fixing 
solution (50% methanol, 12% acetic acid, 0.02% formaldehyde) for 16 h at 25°C 
with gentle shaking. The gel was then washed twice in 5 gel volumes of 50% ethanol 
for 30 min at 25°C, pretreated in fresh 0.02% sodium thiosulphate for 1 min, rinsed 
thoroughly 3 times in distilled water and incubated for 30 min in 5 gel volumes of 
silver nitrate solution (0.2% silver nitrate, 0.03% formaldehyde in an air-tight, dark 
bottle) at 25°C with gentle shaking. The gel was rinsed twice in distilled water and 
incubated for 2-5 min in fresh developing solution (6% sodium carbonate, 0.02% 
formaldehyde, 0.0005% sodium thiosulphate). Once the desired contrast has been 
reached, the gel was stored in stop solution (16% acetic acid, 50% methanol) until 
photographed.
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2.21 Antimicrobial assay
An E. coli BUE55 (Devine et al., 1999; Moore et al., 1996) overnight culture 
was diluted ten times in fresh LB media and incubated for 2 h at 37°C. The culture 
was centrifuged for 10 min at 2000 x g, washed with 5 ml of ice-cold PBS and 
diluted to 2xl05 cfu/ml. The bacterial concentration was determined by spectrometry 
at OD620 and calculated with the following formula: cfu/ml = OD620 x 2.5 xlO8, 
according to Lehrer et al., (1991). Then, 100 pi of E. coli BUE55 were mixed with 
either an appropriate concentration of human /3-defensin 3 (Peptide Institute, Inc., 
Osaka, Japan), from 20 pg/ml to 1.25 pg/ml, or 50 pi of peak sample and then 
incubated for 2 h at 37°C. HBD3 was diluted in 50 pi PBS, 50 pi LB, while the 
samples tested were added to 25 pi PBS, 25 pi LB. In parallel, a control without 
HBD3 and a second control with 0.01% acetic acid only were also set up and 
incubated for 2 h at 37°C. The cells were then counted by diluting the cells from 10'1 
to 10'3 in PBS and plating 50 pi of each dilution on two LB plates, which were 
incubated for 24 h at 37°C. The percentage of killing was determined with the 
following calculation: % killing = ((cfu control - cfu tes/)*100)/cfu control (when 
cfu test > cfu control = 0%) with cfu = number of cells * dilution factor * 20.
2.22 Mass spectrometry
Samples were loaded onto Waters QTOF Premier from vials in 1 or 5 pi 
volumes and separated using the manufacturer’s own trap, which consisted of a 180 
micron x 20 mm 5 micron Symmetry Cl 8 and a reverse phase column of 100 micron 
x 100 mm BEH130 C l8. Gradients were pumped at 350 pl/min by a Waters nano 
Acquity; 1% solvent B for 1 min, a gradient of 1-50% solvent B for 59 min, 50-85 %
solvent B for 1 min then 85-1% solvent B for 1 min. Solvent A was 0.1% TFA in
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5% acetonitrile, 95% water, versus solvent B composed of 0.1% TFA in 95% 
acetonitrile, 5% water.
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Chapter 3 - Characterisation of 
AvBDs 1, 2,3, 4, 5 and 14 genomic 
sequences and cloning of their
cDNAs
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3.1 Introduction
Chicken /3-defensins have recently been renamed avian beta-defensins 
(AvBDs) (Lynn et al., 2007). Like mammalian /3-defensins, they are composed of six 
cysteine residues that form three pairs of disulphide bridges with a triple-stranded /13- 
sheet structure. In 1994, three AvBDs were first isolated from chicken leukocytes; 
gallinacin 1, gallinacin l a  (also named chicken heterophil peptide (CHP) 1 and CHP 
2 respectively) and gallinacin 2 (Evans et al., 1994; Harwig et al., 1994). These 
antimicrobial peptides inhibited gram-positive and gram-negative bacteria such as 
Listeria monocytogenes and S. Enteritidis and the yeast Candida albicans (Evans et 
al., 1995; Sugiarto & Yu, 2004). Determination of the full amino acid sequence of the 
AvBDs revealed the absence of the negatively charged propiece reported in classical 
defensins, which is thought to inactivate the positively charged mature sequence 
allowing the storage of defensins in granules. Its absence in chicken defensins 
suggested that the chicken uses some other mechanism to neutralize the positive 
charges of the AvBDs whilst they are stored in granules (Brockus et al., 1998). In 
2001, an epithelial /3-defensin named gallinacin 3 was also characterised. This /3- 
defensin was expressed in epithelial organs such as the lungs, bursa and intestine 
(Zhao et al., 2001). Therefore, at the beginning of this project these four AvBDs were 
selected to study their role in the chicken’s innate immune response, along with three, 
at that time, novel AvBDs characterised in this laboratory, AvBDs 4, 5 and 14. Since 
2004, the chicken genome sequence became available and ten novel /3-defensins have 
since been described, including AvBDs 4 and 5 (Higgs et al., 2005; Lynn et al., 2004; 
Xiao et al., 2004). However, AvBD14 has yet to be described in the literature.
In this chapter, the genomic and evolutionary characteristics of AvBDs, including the 
novel AvBD14, will be analysed. In addition, the genomic sequences and the cDNAs
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of AvBDs 1 ,2 ,3 ,4 ,5  and 14 will be characterised. The AvBDs cDNAs were then 
cloned into an appropriate expression vector, pTriExl.l, to express their mRNA in 
COS-7 cells and protein using a baculovirus system.
3.2 Results
3.2.1 Determination of the genomic sequences of AvBDs 1/la, 2, 3,4 and 5
In the absence of monoclonal antibodies specific for the AvBDs, in order to 
characterize their expression in response to microbial infection, real-time quantitative 
RT-PCR (Taqman) was used to measure mRNA levels. In Taqman assays, either a 
primer or the probe is designed to cross exon boundaries to specifically amplify 
mRNA. However, at the start of the project, for gallinacins 1, la, 2 and 3 only the 
mRNA sequences were available. Therefore, specific primers (Table 2.3) were used to 
amplify the respective sequences from genomic DNA of line N and 6\ chickens. After 
optimization of the PCR, the annealing temperature required to amplify AvBD 
genomic DNA was 58°C. The genomic sequences obtained showed that the AvBD 
genes were composed of three exons and two introns (Figure 3.1) and the five genes 
have the exon junctions in the same frame and the same signal peptide lengths (20 
amino acids). The third exon was too short to design primers and probes properly, and 
they were therefore designed across the first exon/intron boundaries using ABI Prism 
Primer Express software (Table 2.5).
3.2.2 AvBDl and gallinacin l a  are polymorphic variants of the same gene
The peptide sequences of AvBDl and gallinacin l a  differ by only three amino 
acids due to three nucleotide substitutions. The proofreading enzyme Pfu was used in 
PCR and the genomic sequence obtained from the two inbred lines was shown
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Figure 3.1; Gene sequences and predicted peptide sequences of AvBDs 1,2 ,3 , 4 and
5. For the gene sequences, exons are in upper case and introns in lower case.
AvBDl (Gal l a  form)
ATGCGGATCGTGTACCTGCTCCTCCCCTTCATCCTCCTCCTGGCCCAGGGTGCTGCAGgtgaggtgtgagttctgtggggttctccatat 90 
M R I V Y L L L P F I L L L A Q G A A G
cccaggaggtggcttgtcagggatgggtaacgactaggagggctctgatcagttggttcaggagggagggaagatttaggttggatatca 180
gggggaagttctttacagagagagaggtgaggtgctggaacagctgcccagagaggctgtggatgccccgtccatccctggaggtgttca 270
aggccaggttggatggggccctgggcagcctgggctggtgttagatgtggaggttggtggccctgcctgtggtgggtgggttggagcttc 360
atgatccttgaggtcccttccaacccaaccattctgtgattctgtggtttggatgagtggctgggcttttgggtttggtgctttgtgcao 450
gtgttagactgagatccatgggacagccactctagaaccacacacagcttgtacaggtatcccacactcattttcttttggtctgtgcag 540
GATCCTCCCAGGCTCTAGGAAGGAAGTCAGATTGTTTTCGAAAGAATGGCTTCTGTGCATTTCTGAAGTGCCCTTACCTCACTCTCATCA 630 
S S Q A L G R K S D C F R K N G F C A F L K C P Y L T L I S  
GTGGGAAATGCTCAAGATTTCACCTCTGCTGCAAAAGgtaagctttggaattagggatgaaattggatctgctaccacgatggcagaaat 720 
G K C S R F H L C C K R
agctgttgttgtgtttgatccccaaacctagctactggctttgggctatatatgatccagggcaggggcttggggaggaaaggagaaggt 810
gctaggaccggtcctttaaaggaactggaggaaccccagatcagacactggcctccccattgccctcagttacacggggctgcctggctt 900
gctggtttcacaaatgcttccccagttggtgcagagtggagactctcccctgggtagtgtgaggcacagaacccattccctgatgtctct 990
gcaaaaccttggaaaccaagctgaaaccaagctgtctgctatgcaggctgcttactacctgcattgagattagtgtcaatgtgtcagtgt 1080
tatccaggagaagtgatgcatagtgagagacagaaaaaggagaataaaaagaggtgacctcacagagtgttttcttcctgcagAATATGG 1170
I W
GGCTGA 1176 
G *
AvBD2
ATGAGGATTCTTTACCTGCTTTTCTCTCTCCTCTTCCTGGCACTCCAGGTTTCTCCAGgtaagatgaaagaggaattaaaggggaggata 90 
M R I L Y L L F S L L F L A L Q V S P G
acgactgggttatggggaagggtttgcagacccgctttgtgagctcacctttcaacgtggccaaaccctcacagcagtccttaaggcagc 180
tgagtgagtggagctgccttgccttgcagaatcagagggaacttggttgctgttgttgcagGGTTGTCTTCGCCCCGGCGGGACATGCTG 270
L S S P R R D M L
TTCTGTAAAGGAGGGTCCTGCCACTTTGGAGGGTGTCCCAGCCATCTAATCAAAGTCGGAAGCTGCTTCGGGTTCCGTTCCTGCTGCAAA 360 
F C K G G S C H F G G C P S H L I K V G S C S R F Y L C C K  
TGgtgagtttgaccttcactgacgttcatccatcgcgtaagtggacaaatgcattttacccaagatgctgctgaatgttcggtcttggat 450 
W
ttatgaaggaaacagtacattacgagggcagcctggtgtaagttgctagtagggctttacagttgtctttctcctgagatgtgctgctga 540
ggtgtacaccatgatgtgtccaggcacaaagggtaaagtatggccatagatgccagccacgtgcagtcccagctctttgcttataagtcc 630
cagcccttatagctcctctgccagggggttttgtattttcagaactgggctgttatggtgcatggggaacaaaagggttgcgctgcaggg 720
tgaacacggatctgagtgcagttgagtctgtgcaaaaagtgaaactgcatcaaaagaaaatctaatgccattgggactgaacgcactcac 810
cccaaggccaggggataccaattcagttccctgcttttcccggagcgatagcaaagcactcctcccagtcagatgggactgcacaaggct 900
gtcccaatccgacttgcatgtgacaataggtattttggaatgtatataaccaagaggaagacgtgcatggattgagagcgagtagggaag 990
gaatgtaaatacaaaaacaatctgatttctttgtctgtttgtgcagGCCTTGGAATGCATAA 1052
P W N A *
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AvBD3
ATGAAGATCCTGTACCTGCTCATCCCCTTCTTCCTCTTGTTTCTCCAGGGTGCTGCAGgtgagaggggaagatggggtgaggtgtgagcc 90 
M R I V Y L L I P F F L L F L Q G A A G
catatcagtagggtcttccctgttctgggaagaaattgcctttgttggaacaacacagaggttgggaggcaatgacataaattctgtgag 180
tgccccttccaagagatgcagaaacaccccataaatagaagcctggcttggtgtgtgttggaaggagttctggctgcaggttgcaatcct 270
gtgtccagctgctcctctatgggtgtctctgaatgagcacccattggcaaggctgaggtttgggcagcagcaaaacatcataaaaacatt 360
aaggttgtaagaaacctcaaagatcatacagtctaaccatctacctactaccagtattacccgttaaaccatgcccctaagtactacatc 450
tatcctatcataaaacacctccaaggacagtaatcaccacttccctgggcagcctgttctaatgcattaccactctttcagaggtgacct 540
gaacctcccctgggctaaattaacgccattccctcatccttcagtgggacctgtgcagggatgggatagagccataggtggcttttgact 630
cagtgggatgactgagacacaatgctgtcccattttggccagtagtgtctcagctgagtgccccaaagagtccttgccctgagccatgac 720
ctctttgagggttgggtttccatcagaggtcccttgaactctgggtgcagtagtgacaggtatgcaaggagtgccccagttgccagctcc 810
actggcccaggaagaggtggacatgaaggtgggatggacatacaggtggggagcctgcacacgtctccttggagctcctgctggtctttc 900
ccatctgctgtcttgggttcccacactggtgtgaaagaatccttctaggtgagacaccttgctctgaaagacccaaatattagtctctgc 990
catccatttttacaatatattctccctgtatgactttccatgtaccagGAACTGCCACCCAGTGCAGAATAAGAGGAGGATTCTGTCGTG 1080
T A T Q C R I R G G F C R V
TTGGGAGCTGCCGCTTCCCACACATAGCTATTGGGAAATGTGCAACATTTATTTCCTGCTGTGGAAGgtaagatctggattcctggctga 1170 
G S C R F P H I A I G K C A T F I S C C G R  
gaaaagggatccctcctttgcctattgaaatagctgtcatacatctctctctcgccaacatctagcaggcaatatctggcatatgtttgg 1260
actagatgatcttagaggtcttttccaacctacatgtttctatgataaatgcaccacaagaagcccaggaagggaaaagccctcgtgggt 1350
ttggaggagccctgtgtgaggctgaaggaaccccatgctcagtcagcagccatccattcttcttagagtcccactcatcatttgcagggg 1440
gatctcccaggattggagatgatcagggatgttgtcatagaatcatagaattgctaaggttggaaaagacccacaggatcatccagtcca 1530
accattcgcccttcaccaatggttctcgctaaaccatgtccctcaacacaacatccaaacgctctttgaacaccaccaggctcggtgact 1620
ccaccacctctctgggcagcccactgcagtgcctgaccaccctttcagacaagtattatttcctaacgtccagcctgaaccttccctggt 1710
gcagcttgaagccattccctctagtcctatcactgtcacccaagagaagaggccgacccccagctccctacaacctcccttcaggtagtt 1800
atagagagcaataaggtctcccctgagcctcctcttctccagactgaacaatcccagctccttcagcggctcctcataatgtttgtgatg 1890
ttgctgcaaagacctggactgagggctagcaccactaatcggagcatgagttccaataagccatgagtggtaagggctggagttaccctt 1980
tgaacattgacaggggaggtttaggttggatattaggaagaagcttttcacccagagggtggtgatgcactgaacaggttgcccaaggag 2070
gctgtggatgccccatccctggaggcattcaaggccaggctggatgtggctctgggcagcctggtctgctggttggcgaccctgcacata 2160
gcagggggttggaactggatgatcactgtggtccttttcaacccaggccgttctatgattctaaaattcaatcaggtcccaaggcttgtt 2250
tgtccctggagaggagatgagagagcagggagaagcgagttgcatgcaggtgacacacttgtctgttttctctgtagAGCATATGAGGTT 2340
A Y E V
GATGCCCTGAATTCTGTGAGGACATCGCCCTGGCTTCTCGCTCCTGGAAACAACCCCCATTGA 2403 
D A L N S V R T S P W L L A P G N N P H *
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AvBD4
ATGAAAATCCTTTGCTTTTTCATCGTGCTCCTCTTTGTGGCAGTTCATGGAGCTGTGGgtaaggagtaagtgaaagcgtgaggctgtata
M K I L C F F I V L L F V A V H G A V G
caagccgtatgatattggtgtctcataaaggtcttctgtcccctttgggaggtggcccagtttggatattagtaaaaattctcataagga
gcagtgctgcagtggcacagctgcccaggggggcggtggggtcaccatccctggaggtgttcaaatgtggagatgtggcgctgagggaca
tagtgggcagtgggcacggtgggggtggggttggacttggggatcttataggtcttttccaacctgagtgattctatgattccatgaata
gggtggtaagtgtcctccaggtgattatggatgggaaaagactgtgacggattgagaaagagaagggagaagtgggagaaatatcgtatc
tgcaacagtctccctttttcttttctttctttttttcaatttttcttttctcttttttaaatactgcagGCTTTTCCCGTTCTCCAAGAT
F S R S P R Y
ATCACATGCAATGTGGATATCGCGGGACCTTCTGCACCCCTGGGAAATGCCCTCATGGGAATGCTTACCTGGGGCTATGCCGTCCCAAGT 
H M Q C G Y R G T F C T P G K C P Y G N A Y L G L C R P K Y  
ATTCTTGCTGTAGATGgtaagattaagacttgactatggctaaactgacttcccagattttaagttctatatggtgggattttccccttc 
S C C R W
aacttaggtgtgaaaaccctgtactcttctttcttttgcatagGTTGTAG 770
L *
AvBD5
ATGCAGATCCTGACTCTCCTCTTTGCTGTCCTCCTCCTGATGCTCCGGGCAGAACCAGgtgagatatacatacgttgtgggagggtggtg
M Q I L P L L F A V L L L M L R A E P G
tgtttgccctttgttgatattttgtaggggataatggagggtttgatgatgattggtcatagaatcatagaatggcctgggttgaatgat
catccagtttcaacccccctgctatgtgaagggtcaccaaccagcagaccaggctgcccagagccacatccagcctggccttgaatgcct
ccagggatggggcatccacttactgtggtacccaatggatttccattggaaagtttgccttggctggtagaaaaaaaggaagaataggca
gcccaggggtgtggggagagctttccacttgtgttcagcaaggagacagtcagggtgcaccgatgttggctgtacaggggcagaaggctg
cgctcacagctgggcagaactgtgctgaggtgttctccttctgctctctgcagGGCTGTCCCTTGCTCGAGGATTACCCCAGGACTGTGA
L S L A R G L P Q D C E
GCGCCGTGGGGGCTTCTGCTCCCACAAGTCATGTCCTCCAGGGATCGGCCGCATTGGCCTCTGCTCCAAGGAAGACTTCTGCTGCCGGAG
R R G G F C S H K S C P P G I G R I G L C S K E D F C C R S
gtaggctcagcgctgcctgatgcggggtggctgcttcctgttggggttgggggtgaggtccttgaagaagggaaataacacacagcccaa
tggcatgggggcatccccgggtccctgctactgcgttatccaaactgggagatgctgctggggctgcagcaatccggtgtcctccttcca
ccactaatgttggcagcccagccaccacctgtagagagcatggggactcttctcaggcttccaccagccccagaaccgtagttcagaagc
agtcccaaagggagatgggcattttaactgagggttctggcctcatagagttgggatgaacactgccacacctttcctcccacagCCGAT
R W
GGTATTCCTGA 1001 
Y S *
90
180
270
360
450
540
630
720
90
180
270
360
450
540
630
720
810
900
990
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to code for gallinacin 1 a. Interestingly, the chicken genome sequence codes for 
AvBDl (Figure 3.2). As well as the three nucleotide differences in the coding 
sequences, there were also nine nucleotide differences in the introns, seven in the first 
intron and two in the second intron. There is only one gene in the chicken genome 
with the potential to encode AvBDl or gallinacin l a  and I propose that the two 
sequences represent polymorphic variants of the same gene.
3.2.3 A novel chicken /3-defensin, AvBD14
The cDNA of the novel AvBD was first identified by Dr N. Bumstead and its 
gene sequence was then determined after using specific primers (Table 2.3) to amplify 
the gene from genomic DNA of line N and 6j chickens. After optimization of the 
PCR, the annealing temperature required to amplify the genomic DNA of AvBD 14 
was 55°C. The genomic sequence obtained showed that the AvBD 14 gene was 
composed of two exons and one intron (Figure 3.3).
The thirteen AvBDs identified to date have been localised to chicken chromosome 3 
and they appear to be the result of gene duplication events. Indeed, AvBDs 6 and 7 
share the same signal peptide and have high similarity in their coding sequence as 
well as their intronic sequences (Figure 3.4). AvBD genes are generally composed of 
three exons and two introns, except those for AvBDs 11,12 and 13, which have two 
exons and one intron (Figure 3.5). The AvBD14 genomic DNA sequence (Accession 
no. AM402953) has been recently identified in the current version of the genome 
sequence, part of its sequence being localised in contigl7.130, on chromosome 3 at 
one end of the avian beta-defensin locus. An alignment of the relevant sequences 
showed only three nucleotide differences in the intronic sequence in 402 nucleotides 
(Figure 3.6). However, AvBDs gene alignments did not allow the identification of 
promoter regions of chicken defensins (see Appendix 6).
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Figure 3.2: Comparison of the gene sequences and predicted amino acid sequences 
of AvBDl/la from line 61 and N chickens (N/6) and the red jungle fowl, the source 
of the chicken genome sequence (genome). For the gene sequences, exons are in 
upper case, introns in lower case. Differences between the two sequences are 
highlighted.
N/6
Genome
N/6
Genome
ATGCGGATCGTGTACCTGCTCCTCCCCTTCATCCTCCTCCTGGCCCAGGGTGCTGCAGqtgaggtgtgagttctgtggggttctccatat 90 
ATGCGGATCGTGTACCTGCTCCTCCCCTTCATCCTCCTCCTGGCCCAGGGTGCTGCAGgtgaggtgtgagttctgtggggttctccatat 90 
M R I V Y L L L P F I L L L A Q G A A G  
M R I V Y L L L P F I L L L A Q G A A G
N/6
Genome
cccaggaggtggcttgtcagggatgggtaacgactaggagggctctgatcagttggttcaggagggagggaagatttaggttggatatca 180 
cccaggaggtggcttgtcagggatgggtaacgactaggagggctctgatcagttggttcaggagggagggaagatttaggttggatatca 180
N/6
Genome
gRgggaagttctttacagagagagaggtgaggtgctggaacagctgcccagagaggctgtggatgccccgtccatccctggaggtgttca 270 
gggggaagttctttacagagagagaggtgaggtgctggaacagctgcccagagaggctgtggatgccccgtccatccctggaggtgttca 270
N/6
Genome
aggccaggttggatggggccctgggcagcctgggctggtgttagatgtggaggttggtggccctgcctgtggtgggtgggttggagctto 360 
aggccaggttggatggggccctgggcagcctgggctggtattaaatggggaggttggtggccctgcctgtggtgggtgggttggagcttc 360
N/6
Genome
atgatccttgaggtcccttccaacccaaccattctgtgattctgtggtttggatgagtggctgggcttttgggtttggtgctttgtgcac 450 
atgatccttggggtcccttccaacccaaccattctgtgattctgtggtttggatgagtggctgggcttttgggtttggtgctttgtgcgc 450
N/6
Genome
gtgttagactgagatccatgggacagccactctagaaccacacacagcttgtacaggtatcccacactcattttcttttggtctgtgcag 540 
gtgttagactgagatccatgggacagccactctagaaccacacacagcttttacaggtatcctacactcattttcttttggtctgtgcag 540
N/6
Genome
N/6
Genome
GATCCTCCCAGGCTCTAGGAAGGAAGTCAGATTGTTTTCGAAAGAATGGCTTCTGTGCATTTCTGAAGTGCCCTTACCTCACTCTCATCA 630 
GATCCTCCCAGGCTCTAGGAAGGAAGTCAGATTGTTTTCGAAAGAGTGGCTTCTGTGCATTTCTGAAGTGCCCTTCCCTCACTCTCATCA 630 
S S Q A L G R K S D C F R K N G F C A F L K C P Y L T L I S  
S S Q A L G R K S D C F R K S G F C A F L K C P S L T L I S
N/6
Genome
N/6
Genome
GTGGGAAATGCTCAAGATTTCACCTCTGCTGCAAAAGgtaagctttggaattagggatgaaattggatctgctaccacgatggcagaaat 720 
GTGGGAAATGCTCAAGATTTTACCTCTGCTGCAAAAGgtaagctttggaattagggatgaaattggatctgctaccacgatggcagaaat 720 
G K C S R F H L C C K R  
G K C S R F Y L C C K R
N/6
Genome
agctgttgttgtgtttgatccccaaacctagctactggctttgggctatatatgatccagggcaggggcttggggaggaaaggagaaggt 810 
agctgttgttgtgtttgatccccaaacctagctactggctttgggctatatatgatccagggcaggggcttggggaggaaaggagaaggt 810
N/6
Genome
gctaggaccggtcctttaaaggaactggaggaaccccagatcagacactggcctccccattgccctcagttacacggggctgcctggctt 900 
gctaggaccggtcctttaaaggaactggaggaaccccagatcagacgctggcctccccattgccctcagttacacggggctgcctggctt 900
N/6
Genome
gctggtttcacaaatgcttccccagttggtgoagagtggagactctcccctgggtagtgtgaggcacagaaccoattccctgatgtctct 990 
gctggtttcacaaatgcttccccagttggtgcagagtggagactctcccctgggtagtgtgaggcacagaacccattccctgatgtctct 990
N/6
Genome
gcaaaaccttggaaaccaagctgaaaocaagctgtctgctatgcaggctgcttactacctgcattgagattagtgtcaatgtgtcagtgt 1080 
gcaaaaccttggaaaccaagctgaaaccaagctgtctgctatgcaggctgcttactacctgcattgagattagtgtcaatgtgtcagtgt 1080
N/6
Genome
N/6
Genome
tatccaggagaagtgatgcatagtgagagacagaaaaaggagaataaaaagaggtgacctcacagagtgttttcttcctgcagAATATGG 1170 
tatccaggagaagtgatgcatactgagagacagaaaaaggagaataaaaagaggtgacctcacagagtgttttcttcctgcagAATATGG 1170
I W 
I W
N/6
Genome
N/6
Genome
GGCTGA 1176 
GGCTGA 1176 
G *
G »
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Figure 3.3: Gene sequence and predicted peptide sequence of AvBD14. For the gene 
sequences, exons are in upper case and intron in the lower case.
ATGGGCATATTCCTCCTGTTTCTTGTTCTCCTGGCAGTACCCCAGGCTGCACCAGgtaag 60 
M G I F L L F L V L L A V P Q A A P E  
cgtaaatataatcaaaggtcatttttatgtttgggaaacagggaactgttctgcaaatga 120
agaatgaactcatggcacattgacgtgatgcttggtgctggatctggtagacgagtgttg 180
agtaggcaaactctggttggcactttcagggctggaggggagaacctcacaatctgcaac 240
tcatgaatgctttcagacatggcagcaaaactcaacagtgggttcacgttcctcttgctg 300
aactgacctgtgctacctgcaggctgagctggtagcatggagaccagccttcttcacact 360
tggaaatccaatggaagagtctcacaggttctttttctccattacagAGTCGGACACTGT 420
S D T V
CACATGTCGGAAGATGAAGGGCAAGTGTTCGTTCTTGCTGTGTCCTTTCTTCAAGAGATC 480 
T C R K M K G K C S F L L C P F F K R S  
CAGTGGTACCTGCTACAATGGACTGGCAAAGTGCTGCAGACCCTTTTGGTGA 532
S G T C Y N G L A K C C R P F W *
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Figure 3.4: Comparison of the genome sequences (Gal6/ Gal7) and amino acid sequences (G6 
aa/G7 aa) of AvBD6 and 7. For the gene sequences, exons are in upper case and introns in lower 
case. The similarities between sequences are highlighted.
Gal 6 ATG AG G ATC C TTTAC C TG C T GCTGTCTGr ’CCTCTTTG TG QTGQ TÇÇACÏGGTGTTGCAGgtc
Gal7 ATG AG G ATC C TTTAC C TG C T G CTGTCTGnrCCTCTTTG TG G TG C TC C AC îGGTGTTGCAGgt<
G6 aa 
G7 aa m m o s Bl
II
Gâl 6 
Gal7
Gal 6 
Gal7
Gal 6 
Gal7
Gal 6 
Gal7
Gal 6 
Gal7
Gal6
Gal7
Gal6
Gal7
:tgtgagaacctcgtccaattcaacaaggggaagtgcagagtcctgccHttggggaagaacaaccccagcaccagga
rtgtgagaacctcgtccaattcaacaaggggaagtgcagagtcctgccHttggggaagaacaaccccagcaccagga
agacagctgHa
eatgctgca§g
agcagctfflgcaggaaaggagctgggggtcctggtgggcatcaagttgggcatgagtgagccatgtgcccttactgttaagagagctaac
cagccagHtt:
90
90
20
20
180
180
270
191
agttatcttggctgcagtgggcaaagcctcagcaggagcccaggagaggtgatcctttccttgtcttcaactctgttgaggccacacctg 360 
gagtgctggacctggttctgagccccccagcacaggagagacctacacactggagagagcccagcacagggcctccaagttgcagcaggg 450 
cttggagcagctgtgctgggtggagaggctgtgagagctggggctgcttgattcagagcaggggcagctcagggggtcccaccacaacca 540 
tcaatccccacaggaggttcaaagggatggggcactgctccacagtgtccggggcagtccaaggacacagggcagtgccctggcacaggg 630 
agcagagagaagtggggatccttgtgactctgatttggggagaggaattagagaggaglagagaatgtgcatccacttttgctca
agagaatgtgcatccacttttgctca
na s hj icH
E0 u S3 S
ggtl
aac|rS3 Ü S 3 133l»PH' 3 5 3  S3
Ittttttcl
Gal 6 
Gal7
Gal 6 
Gal7
Gal 6 
Gal7 
G6 aa 
G7 aa
tgaatta^HcacagaatacHac^fflt gggcaagcaaaggctctBaBttHatcat gj 
atqtcacflBSiqaaaacctqflitaBBlacaatctaaqqctatctcBt Wcaflcatt
tacagcagata
tacaqcaqata
N R W A
G W R S
IgaclRt :caaH
|acE8 c c | latoB
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Figure 3.5: Genomic organisation of the AvBDs on chicken Chromosome 3
(adapted from Higgs et al., 2005)
AvBD13 AvBD12 AvBD11 A vB D IO  AvBD9 AvBD8 AvBD 7 AvBD6 AvBD 2 AvBD1 AvBD3 AvBD5 AvBD4
«  «  «  »  »  «  »  »  »  «  «  «  «
li II I lil HQ
17.135 17.134
Legends:
1 Exon
□ Contig
»  or « Direction of transcription
A vB D 1 4
- ib -
1 7 . 1 3 0
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Figure 3.6; Comparison of the AvBD14 partial gene sequence from line 61 and N 
(AvBD14) and the red jungle fowl (the chicken genome) (Contigl7130). For the
gene sequences, exons are in upper case, introns are in lower case. Differences 
between the two sequences are highlighted.
Contigl7130 ggtggattccccaccccactgcatcccatcecatcccatcccatcecatcccatccctta 60 
AvBD14
Contigl7130 aaatcccatcccatcccatcccaacccatatgagtgtttttgggggctttaactcatttt 120 
AvBD14
Contigl7130 tctgctgttttttgtttgtttgtttgtttttaatctttagcaagtttcttggcaaccctt 180 
AvBD14
Contigl7130 ggaactaagcctggacactgctggtttaagcagcagtctgtcatccaactcggtttccag 240
AvBD14
Contigli130 agttctctatagatccccagtgtgtgatgcctgtctctctgtgccctatgcttccctctt 300 
AvBD14
Contigui30 gatacttgcatatgaacagtgacccaaacctgtgtgctcagggatgtgctgctggctggg 360 
AvBD14
Contigl7130 gagccaagctactctctctgattttagaaggagtgtatctgggatctctgtctccagtac 420 
AvBD14
Contigl7130 tgatttttaccaactatggaagaactttgcatccttcatccttacatttaagcagcccct 480 
AvBD14
Contigui30 gaatgaaaaaaggggtgcatggcctacagcctatttttcctcttggtgtgctaaatagcc 540 
AvBD14
Contigl7130 attcacatctccagtgaagcaaaatatagacagtggtgaaatcacctctgcacatggcat 600 
AVBD14
Contigl7130 ggcatgggctggcacaggatggcatagtggcatggggtgtctgccccatttttgcaggct 660 
AvBDl4
Contigui30 tattgaggtggggcatgttgtgctatgcatccacacaggaattgtaattagaggttacaa 720 
AvBD14
Contigl7130 gacacgtccttcaaagctgttatttataagattgctaaatccctggtgatcacattcatc 780 
AvBDl4
Contigl7130 aaagctttataaagagaggctcattccttcctcttggtctcagcagcttcagggcgacac 840 
AvBD14
Contigl7130 gacaatgtcaaccaaagccATGGGCATATTCCTCCTGTTTCTTGTTCTCCTGGCAGTACC 900 
AvBDl4 ATGGGCATATTCCTCCTGTTTCTTGTTCTCCTGGCAGTACC 41
Contigl7130 CCAGGCTGCACCAGgtaagcgtaaatataatcaaaggtcatttttatgtttgggaaacag 960 
AvBDl4 CCAGGCTGCACCAGgtaagtgtaaatataatcaaaggtcatttttatgtttgggaaacag 101
Contigui30 ggaactgttctgcaaatgaagaatgaactcatggcacattgacgtgatgcttggtgctgg 1020 
AvBDl4 ggaactgctctgcaaatgaagaatgaactcatggcacattgacgtgatgcttggtgctgg 161
Contigl7130 atctggtagacgagtgttgagtaggcaaactctggttggcactttcagggctggagggga 1080 
AvBDl4 atctggtagacgagtgttgagtaggcaaactctggttggcactttcagggctggagggga 221
Contigui30 gaacctcacaatctgcaactcatgaatgctttcagacatggcagcaaaactcaacagtgg 1140 
AvBDl4 gaacctcacaatctgcaactcatgaatgctttcagacatggcagcaaaactcaacagtgg 281
Contigl7130 gttcacgttcctcttgctgaactgacctgtgctacctgcaggctgagctggtagcatgga 1200 
AvBD14 gttcacgttcctcttgctgaactgacctgtgctacctgcaggctgagctggtagcatgga 341
Contigl7130 gaccagocttcttcacacttggaaatccaatggaagagtctcacaggttctttttctcca 1260 
AvBDl4 gaccagccttcttcacacttggaaatccaatggaagagtctcacaggttcattttctcca 401
Contigl7130 t 1261
AvBDl4 ttacagAGTCGGACACTGTCACATGTCGGAAGATGAAGGGCAAGTGTTCGTTCTTGCTGT 461
Contigl7130
AvBDl4 GTCCTTTCTTCAAGAGATCCAGTGGTACCTGCTACAATGGACTGGCAAAGTGCTGCAGAC 521
Contigl7130
AvBD14 CCTTTTGGTGA 532
87
3.2.4 Characterisation and cloning of AvBD cDNAs
The cDNA of HD 11 macrophage-like cells and tissues such as the spleen, 
lung, bursa of Fabricius and bone marrow from chicken lines N, 6i and 72 at 1, 6 and 
7 weeks of age were used to obtain defensin cDNAs. The primers used to obtain these 
cDNAs are listed in Table 2.3. AvBDl (Gal l a  form) and AvBD2 cDNAs were 
obtained from lung tissue of 1 week old line N chickens, with an annealing 
temperature of 58°C. AvBD3 cDNA was obtained from spleen tissue of 7 week old 
line N chickens, with an annealing temperature of 85°C. AvBD4 and AvBD 14 were 
obtained from a pool of spleen cDNA (provided by Prof John Young, IAH), with an 
annealing temperature of 55°C. Finally, AvBD5 cDNA was obtained from HD11 
macrophage-like cells cDNA with an annealing temperature of 58°C (Figure 3.7). The 
additional bands obtained were probably unspecific amplification of genomic DNA as 
the RNA samples extracted from tissues were not treated with DNase. In order to 
express AvBD mRNAs and AvBDl (Gal l a  form), 2,3 and 4 peptides, appropriate 
restriction sites were inserted by PCR to ligate the AvBD cDNAs into the Ncol 
restriction site of the pTriEx.1.1 expression vector (Figure 3.8). After cloning into 
pTriEx 1.1, the cDNA sequences were checked by sequencing and either used to 
produce AvBD peptides in a Baculovirus system, or to express AvBD mRNAs in 
COS-7 cells for Taqman standards.
3.2.5 Evolutionary analysis of chicken /3-defensins
The vertebrate defensins are classified in three subfamilies, a-, /3- and 0- 
defensins, with only /3-defensins identified in chickens. A phylogenetic tree with other 
vertebrate /3-defensins, such as human, bovine and mouse, shows that individual 
AvBDs cluster with different groups of mammalian defensins (Figure 3.9). /3- 
defensins are a major subfamilies, which arose before the divergence of birds and
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Figure 3.7: Electrophoresis gel of defensin cDNAs. Arrows indicate the AvBDs 
eDNA sequence that have been purified; AvBDl (198 bp); AvBD2 (195 bp); AvBD3 
(243 bp); AvBD4 (185 bp); AvBD5 (189 bp); AvBDl4 (180 bp); Ma, Marker.
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Figure 3.8: Schematic diagram showing the cloning strategy for the AvBD 
cDNAs into pTriEx 1.1 expression vector.
Construct used to produce Construct used to express
AvBD1, 2, 3 and 4 peptides AvBD1, 2, 3, 4, 5 and 14
using Baculovirus system mRNAs using COS cells
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mammals from a common ancestor. The a-defensins, identified only in mammals so 
far, may have evolved after this divergence. The release of the chicken genome 
allowed the identification of ten more sequences coding for /3-defensins (Figure 3.10). 
The nomenclature used is based on Lynn et al. (2007). AvBDl 1 is the sequence 
described by Xiao et al. (2004) only and AvBDl4 is the novel sequence described 
here. AvBDl3 has two different sequence predictions. The sequence underlined with 
a dotted line was predicted by Xiao et al. (2004), while the Higgs et al. (2005) 
prediction did not contain this sequence. The main characteristic of AvBDs is the 
presence of six cysteines that form three pairs of disulphide bridges. In addition, the 
tripartite sequence common to other /3-defensins was also identified with a signal 
peptide, a small propiece and finally the mature peptide, that contains specific features 
such as a short sequence, a cationic net charge, a lack of glycosyl modification and 
the tertiary structure of a /3-sheet dimer.
3.3 Discussion
Defensins are antimicrobial peptides and are an important component in mucosal host 
defences to prevent the invasion of enteric pathogens (Wilson et a l, 1999). The 
vertebrate defensins are classified in three subfamilies, a-, /3- and 0-defensins, that 
could derive from a common evolutionary origin. Indeed, only /3-defensins have been 
identified in the two “old” classes of vertebrate, reptile and avian (Sugiarto & Yu,
2004), and the clustering of AvBDs, the chicken’s /3-defensins, with mammalian /3- 
defensins, as observed in phylogenetic trees, suggested that this might be the original 
defensin family (Xiao et a l, 2004). In addition, comparative analysis revealed that 
chicken /3-defensin gene cluster is syntenic with two clusters on human 8p22 and 
8p23.1 and their orthologous loci in other mammalian species including rat,
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Figure 3.9: Phylogenetic analysis of vertebrate /S-defensins. Phylogenetic tree 
generated with Phylip software. MBD, mouse /3-defensin; HBD, human /3-defensin; 
BNBD, bovine neutrophil /3-defensins; LAP, lingual antimicrobial peptide; EBD, 
enteric /3-defensin and AvBD, avian /3-defensin. HBD1, NP 005209; HBD2, 
AF040153; HBD3, AF295370; HBD4, AJ314835; MBD1, AH005574; MBD2, 
AJ011800; MBD3, AF093245; MBD4, AF155882; MBD5, AF318068; MBD6, 
AB063109; MBD27, AY591384; MBD30, DQ141309; MBD36, AY591385; 
BNBD3, AF016396; BNBD4, AF014107; LAP, NM203435; EBD, AF016539; LAP, 
NM203435; AvBDs accession numbers are listed in Table 1.4.
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Figure 3.10: Amino acids pile-up of the avian j5-defensins. The multiple sequence 
alignment was generated with Clustal X (1.83). The dotted line represents the part of 
AvBD13 sequence predicted by Xiao et al. (2004) but absent from Higgs et al. (2005) 
prediction.
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mouse and dog (Patil et al, 2005) suggested that all vertebrate /3-defensins are 
evolved from a single gene.
The prepropeptide of defensins is composed of a signal sequence, a propiece and a 
mature sequence. The main differences between a- and /3-defensins concerns the 
cysteine pairings and the length of the structural features, particularly the propiece, 
which is smaller in /3-defensins. In addition, the anionic propiece confers a charge 
balance to the propeptide for a-defensins. However, the /3-defensin propiece is shorter 
and lacks the negative charge to neutralize the mature peptide, particularly chicken /3- 
defensins, and therefore the biosynthesis and intracellular trafficking of /3-defensins 
must be different to a-defensins (Selsted & Ouellette, 2005).
The peptide sequences of AvBDl and gallinacin l a  have three amino acid differences 
due to three nucleotide substitutions, making them difficult to differentiate by RT- 
PCR. Single nucleotide polymorphisms (SNPs) have been identified across the entire 
chicken genome (Wong et al., 2004) and a nonsynonymous SNP has been recently 
identified in AvBD5 (Hasenstein et al., 2006). It seems reasonable that AvBDl and 
gallinacin 1 a  are polymorphic variants of the same gene. AvBDs are diverse in their 
structures and their potency against different pathogens, suggesting that AvBDs have 
been subject to adaptive evolution to increase their diversity in response to the 
constant increase in diversity of microbial pathogens. Therefore, the sequence 
differences between AvBDl and gallinacin l a  may be explained by adaptive 
evolution. However, it would be interesting to compare the activity and efficiency of 
the two different forms against different pathogens.
Following the release of the chicken genome sequence (version 2.1- August 2006) 
(Wong et al., 2004), ten AvBD sequences were identified via bioinformatics. My 
novel avian /3-defensin, AvBD 14, remains only partially characterised in the genome.
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AvBD14 was first identified in BAC bW094K17 from the the Wageningen library in 
this laboratory, which was subsequently sequenced at the Beijing Genomics Institute. 
BAC bW094K17 Contigl4 also encoded for two new AvBDs, published since then as 
AvBDs 4 and 5, and also the published AvBDs 1 and 3. Therefore, the BAC 
bW094K17 Contigl4 identified in this laboratory in July 2002 corresponds to Contigs 
17.130,17.131 and the beginning of 17.132 in the chicken genome to date (Figure 
3.5). The determination of the novel AvBD14 genomic sequence by PCR indicated a 
gene organisation of two exons and one intron, as is the case for AvBDs 11,12 and 
13, the other AvBD genes all having 3 exons and 2 introns. However, this gene 
structure could be incorrect as the full gene sequence of AvBD 14 is absent in the 
chicken genome sequence and the third exon of AvBD genes tends to contain only a 
few nucleotides, which cannot be identified by bioinformatics approaches alone.
In summary, genomic DNA sequences for AvBDs 1, 2, 3, 4, 5 and 14 have 
been characterised. The corresponding cDNAs have been isolated and successfully 
cloned in the pTriExl.l expression vector for expression in COS-7 cells to generate 
AvBD mRNA standards for Taqman analysis. In addition, AvBDs 1,2, 3 and 7 have 
been cloned correctly into pTriExl.l to express these AMPs in the Baculovirus 
system.
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Chapter 4 - Expression of AvBDs 1,
2,3 and 4
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4.1 Introduction
Defensins have been identified in all mammals so far studied, as well as poultry, 
insects, invertebrates and plants (Ganz, 2003b). They are synthesised in granulocyte 
cells or secreted by epithelial cells and contribute to host defence against microbial 
colonisation and infection.
Defensins are expressed either constitutively or in response to infection. In mammals, 
the of-defensins are generally synthesised and stored in granules in mature leukocytes. 
They are also synthesised by Paneth cells in an inactivate form (Raj & Dentino,
2002). Immature defensins consist of a tripartite prepropeptide with a precursor 
sequence of 90-100 amino acids containing an amino (N)-terminal signal sequence of 
about 19 amino acids, an anionic propiece of about 45 amino acids and a carboxy (C)- 
terminal mature cationic defensin of about 30 amino acids. The negative charge of the 
propiece usually neutralises the positive charge of the mature defensin preventing the 
premature interaction of defensins with the membranes of neutrophils and Paneth 
cells. The process of maturation involves enzymes such as the metalloproteinase, 
matrilysin, in mice (Wilson et al., 1999) or three forms of trypsin in human (Ganz, 
2003b). Conversely, /3-defensins are synthetised by epithelial tissues only in mammals 
and the “prepro-/3-defensins” have a very short propiece suggesting that intracellular 
transportation of o*- and /3-defensins is different.
The avian /3-defensins stored in heterophil granules consist also of tripartite 
prepropeptide sequences with a precursor sequence containing an N-terminal signal 
sequence, a basic or neutral propiece and a mature cationic defensin of about 40 
amino acids. However, the avian /3-defensin propeptide is unable to neutralise the 
mature peptide. AvBDl is not negatively charged whereas AvBD2 has only one
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negative charge. Therefore, some other mechanism must be involved in neutralising 
premature activity in these /3-defensins (Brockus et al., 1998).
The post-translational modification of defensins is important to consider when 
producing AvBDs. Different methods have been used to produce human /3-defensins. 
Despite their antimicrobial activity, their production was attempted in an E. coli 
expression system (Piers et al., 1993). However there are only a few descriptions of 
using this system successfully to produce defensins and the correct folding of proteins 
with a high numbers of cysteines is difficult to obtain using bacteria as the expression 
host (Harder et al., 2001). Therefore, despite success in expressing human /3-defensin 
3 and human a-defensin 1 in E. coli, this method has not been used to produce 
AvBDs. Similarly COS-7 cells, Pichia pastoris and Bacillus subtilis have been used 
to produce human defensins, but all gave low levels of expression only detectable by 
Western blotting (Chen et al., 2006). Recently, human defensins tend to be produced 
synthetically (Yang et al., 2004). In addition to its efficiency, this system allows the 
production of the mature peptide only and should create the proper disulphide bridges 
for correct folding of the defensin peptide. Finally, recombinant baculovirus-infccted 
insect cells have been used to produce human defensins. Both human a- and /3- 
defensins have been expressed with success (Liu et al., 2002; Valore et al., 1998) and 
the system expressed the mature form of the peptide directly into the supernatant 
(Bals et al., 1998). Based on these observations, I chose this expression system to 
produce AvBDs using a bacmid (BaclO:KOi629) baculovirus DNA, improved by 
Professor Ian M. Jones at the University of Reading (Zhao et al., 2003), which was 
previously used with success to express the envelope glycoprotein E2 of bovine viral 
diarrhoea virus (BVDV) (Pande et al., 2005).
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This Chapter presents the strategy used to produce AvBDs 1 (Gall a  form), 2, 3 and 4 
peptides (Figure 4.1). Because of their low molecular weight and the importance of 
obtaining correct folding to properly test their activity, no tags were added to the 3' 
end of the AvBD cDNAs as previously described (Gueguen et al., 2006; Satchell et 
al, 2003; van Dijk et al., 2007). In addition, the absence of monoclonal antibodies 
against AvBDs necessitated the choice of a multi-step purification method to obtain 
the AvBD peptides, including cationic exchange followed by Reverse Phase-High 
Performance Liquid Chromatography (RP-HPLC).
4.2 Methods
4.2.1 Expression of and purification strategy for AvBDs 1,2, 3 and 4
AvBD cDNAs were cloned in pTriEx 1.1 transfer vectors into the Nco\ 
restriction site downstream of a start codon to express the target gene. The pTriEx 1.1 
vector contains flanking baculovirus sequences allowing the production of viable 
virus only if a recombination event occurs between the bacmid, BaclO:KOi629, and 
the transfer vector. Therefore, transfection with the transfer vectors and the previously 
linearized bacmid yielded recombinant baculovirus coding for AvBDs.
A small-scale, followed by a large-scale, expression experiment was carried out at the 
University of Reading in Proflan Jones’ laboratory. The small-scale expression 
would estimate the magnitude of scale-up required to produce the desired amount of 
protein, while the large-scale expression yieded protein for subsequent purification. 
The purification selected was a multi-step purification including cationic exchange 
chromatography, followed by RP-HPLC. Ion exchange chromatography is based on 
absorption and reversible binding of charged sample molecules to oppositely charged 
groups attached to an insoluble matrix. The pH value at which a peptide is neutral,
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Figure 4.1 : Schematic diagram showing the production strategy for AvBDs 
peptides. The star (*) represents the different AvBD numbers.
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carrying no net charge, is called the isoelectric point (pi). When exposed to a pH 
below its pi, the peptide will carry a positive charge and will bind to a cation 
exchanger, whereas when the peptide is exposed to a pH above its pi, it carries a 
negative charge and will bind to an anion exchanger. AvBDs are naturally positively 
charged and this characteristic is essential for their activity, particularly their 
antimicrobial activity. Therefore, cationic exchange chromatography was performed 
and the protein eluted with a continuous salt gradient at constant pH between 6 and 8. 
The elution step of the ion exchange chromatography can also be carried out by 
changing the pH, which will change the protein charges gradually and allow the 
collection of very sharp peaks in a minimal elution volume. However, this method 
could denature and inactivate AvBDs. Finally, the samples were further purified by 
RP-HPLC. In reverse phase chromatography, the stationary phase is non-polar and 
the mobile phase is moderately polar. The retention time is the result of the interaction 
of the non-polar components of the solutes with the stationary phase, allowing the 
polar molecules to elute more readily. This chromatography allows a good separation 
of the ionic proteins according to their hydrophobicity, which is roughly inversely 
proportional to solute size. The retention time increases with the hydrophobic surface 
area and so the addition of trifluoroacetic acid (TFA) to the mobile phase, acting as an 
ion pairing agent to neutralize molecule charges, improves the chromatography.
4.2.2 Detection strategy for AvBDs 1,2,3 and 4
4.2.2.1 Tris-Tricine SDS-PAGE
One of the methods used to identify the correct expression of the AvBD 
peptides was SDS-PAGE. A 16.5% Tris-Tricine gel, separating proteins with a 
molecular weight range of 4-30 kDa, was used to assess avian /3-defensin production
1 0 1
in supernatants after small-scale expression. In addition, the Tricine buffer system 
allowed the separation of small SDS-coated proteins from SDS micelles.
4.2.2.2 Antimicrobial assay
Defensins were first described as AMPs. Their antimicrobial activity is based 
on non-specific interaction of the positively charged peptide with the negatively 
charged bacterial membrane. This specific characteristic was therefore used to detect 
AvBDs throughout the multi-step purification process.
The antimicrobial assay was carried out with a defensin-sensitive strain, E. coli 
BUE55 and human /3-defensin 3 (HBD3) as a positive control, provided by Dr D. 
Devine, University of Leeds. The optimisation of the assay was performed with 
HBD3 at different concentrations. The data showed (Figure 4.2A) that the best 
concentration to detect a significant killing activity repeatedly was 20 pg/ml and this 
concentration was therefore used in each assay with HBD3 as the positive control. 
Thereafter, the killing activity tended to decrease with decreasing HBD3 
concentration (Figure 4.2A). The baculovirus system expressed around 3-5 /xg/ml of 
human neutrophil peptide-1 (HNP-1) Qf-defensin, which could be detected by the 
antimicrobial assay despite the low percentage of killing activity obtained with these 
concentrations. The negative control used to determine the percentage of killing of 
HBD-3 was sterile distilled water, while the negative control used to determine the 
killing activity of samples was buffer or media, in which the samples to be tested were
contained.
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Figure 4.2: Antimicrobial assays. A. Antimicrobial activity of HBD-3 against E. 
coli BUE55. Negative control contained sterile distilled water only. Results are 
expressed as % ± S.E.M. (n=3). B. Antimicrobial assay of supernatant and cluate 
to compare AvBDl, 2 and 3 activities with cluatc of the virus control. The
supernatant was obtained after infection with AvBDl, 2, 3 or virus control (VC) 
recombinant baculoviruses and represent the medium obtained alter centrifugation 
(e.g. 2.17 Expression of AvBDs in Baculovirus system- small and large-scale 
production). The eluate was obtained after cationic exchange chromatography, CM 
Sepharose™ Fast Flow (e.g. 2.19.1 Cationic exchange chromatography). The negative 
control was distilled water. The full test was carried out only once.
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4.2.2.3 Mass-spectrometry analysis
The detection of AvBDs expressed from insect cells was also carried out using 
a Q-Tof Premier (Waters) mass spectrometer to determine their presence and the 
purification quality according to their molecular weight. The Quadrupole/Time-of- 
flight (Q-Tof) instruments allow the identification of small molecules in a complex 
sample. Indeed, with the combination of the quadrupole, which acts as a mass 
selective filter, and the Tof, which detect the ions according to their charge and their 
velocity, the Q-Tof instruments demonstrate good selectivity and determine the exact 
mass of the molecule. The addition of liquid chromatography to the Q-Tof Premier 
instrument allows the separation of the compounds chromatographically before they 
are introduced to the ion source and mass spectrometer, enhancing sensitivity, mass 
accuracy and speed.
4.3 Results
4.3.1 Small-scale expression of AvBDs 1,2, 3 and 4
The predicted molecular weights of the AvBDs containing the prepropeptide 
or the mature peptide only were all less than 10 kDa (Table 4.1). However, the 
supernatants obtained after small-scale expression and run on a 16.5% Tris-tricine gel 
did not give any strong bands corresponding to the predicted avian /3-defensin 
molecular weights (Figure 4.3). A similar gel was then silver-stained but it did not 
show any differences (data not shown). Bands higher than 10 kDa present in the test 
samples but not in the uninfected control might represent viral proteins. Based on 
previous publications, electrophoresis gels are usually used to check the purity of
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Table 4.1: Avian j3-defensin peptide sequences and their physico-chemical 
parameters. The mature peptide is in bold. MW, molecular weight; pi, isoelectric 
point.
Prepro- Mature
Amino acid sequence __^ P t'd e ___peptide
MW
(kDa)
Pi MW
(kDa)
Pi
AvBDl
(Galla)
MRIVYLLLPFILLLAQGAAGSSQALGRKSDCFRKNGFCAFL
KCPYLTLISGKCSRFHLCCKRIWG
7.3 9.8 4.7 9.7
AvBD2 MRILYLLFSLLFLALQVSPGLSSPRRDMLFCKGGSCHFGGC
PSHLIKVGSCFGFRSCCKWPWNA
7.1 9.4 4.3 8.9
AvBD3 MRIVYLLIPFFLLFLQGAAGTATQCRIRGGFCRVGSCRFPIII
AIGKCATFISCCGRAYEVDALNSVRTSPWLLAPGNNPH
8.5 9.4 6.4 9.2
AvBD4 MKILCFFIVLLFVAVHGAVGFSRSPRYHMQCGYRGTFCTPG
KCPYGNAYLGLCRPKYSCCRWL
7.2 9.5 4.5 9.3
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Figure 4.3: Tris-Tricine SDS-PAGE of supernatants obtained after centrifugation of 
insect cells infected with AvBD recombinant viruses for 3 days (e.g. 2.17 Expression 
of AvBDs in Baculovirus system) to detect AvBDs that can be secreted directly in 
the supernatant (Bals et al„ 1998). The gel was then Coomassie stained. 10 and 5 /d 
of supernatants were mixed with 5 and 2.5 fi\ of SDS-loading buffer respectively and 
the mixture was then loaded into the electrophoresis gel. Ma, marker; AvBDl, avian 
/3-defensin 1; AvBD2, avian j3-defensin 2; AvBD3, avian /3-defensin 3; AvBD4,
Avian /3-defensin 4; NI, non-infected insect cells as control.
Ma AvBDl AvBD2 AvBD3 AvBD4 NI
25 kD a----- ,
20 kD a------
15 kD a-----
10 kDa
106
defensins after purification. Therefore, large-scale expression followed by purification 
was performed.
4.3.2 Large-scale expression and small-scale purification of AvBDs 1 and 2
Purification was carried out with both the supernatant and the pellet obtained 
from the large-scale expression of AvBDl. SP Sepharose High Performance is a 
strong cation exchanger. The functional groups are coupled to the matrix via 
chemically stable ether linkages. Buffer pH and ion strength are critical for the 
binding and elution of material in ion exchange chromatography. According to the 
cation exchange chromatography protocol, for HiTrap SP HP, the starting pH for 
cation exchange must be at least 1 pH unit below the isoelectric point, pi, of the 
substance to be bound. Predicted AvBD pis were around 9 (Table 4.1). For this 
purpose, Bicine buffer, pH 8, was used to equilibrate the column and to adjust the 
samples to the composition of the start buffer by diluting the sample with the start 
buffer. A peak for each sample, supernatant and pellet was obtained with a slight 
difference in retention time (Figure 4.4). Indeed, the peak obtained from the pellet 
sample eluted later than that from the supernatant. The samples were then further 
purified by RP-HPLC and the different peaks obtained tested for their antimicrobial 
activity (Figure 4.5). The RP-HPLC pattern of the supernatant was different to the 
pellet. The pellet sample had two distinct peaks, while the supernatant sample had one 
distinct peak. The antimicrobial assay for the different samples showed killing activity 
against E. coli BUE55. The samples were, therefore, run on a 16.5 % Tris-Tricine gel. 
However, both Coomassie staining and silver staining did not reveal protein bands of 
the expected size (data not shown). Consequently, the positive samples were then 
analysed by mass spectrometry but none of them contained a peptide corresponding to
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Figure 4.4: Cationic exchange chromatography, HiTrap SP HP, at pH 8 for 
AvBDl. The insect cells were infected with AvBDl recombinant virus for 3 days and 
centrifuged 20 min at 5,000 x g to obtain the supernatant and the pellet. Both samples 
were then mixed with the start buffer (50 mM Bicine, pH8) as described in 2.19.1 
Cationic exchange chromatography section. The elution was a continuous ionic 
gradient of 0 to 0.5 M NaCl that started from the fraction 1 and finished at the fraction 
28. The flow rate was 5 ml/min with a gradient volume of 10 x column volumes and 
the detection was UV traces at 280 nm. The eluate was collected in 2 ml fractions.
The percentage represents the antimicrobial activity of the peak’s samples. The 
negative control allowing the calculation of the killing activity for each peak 
contained buffer B only (0.5 M NaCl-50 mM Bicine, pH 8).
Supernatant
80%
_  86 %
Pellet
5 I 6 9 | IO || | 12 IS 14 15 16 | 17 | If j I» 1 20 1II..22 j 21 24 2$ 2<S 21 J * .
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Figure 4.5: Reverse-phase HPLC fractionation of cationic peptides. The pool of 
fractions containing proteins after the cationic exchange chromatography were further 
analysed by RP-HPLC as described in 2.19.2 Reverse Phase-HPLC section. The 
percentage represents the antimicrobial activity of the peak’s samples. The negative 
control allowing the calculation of the killing activity of each peak contained 0.01% 
acetic acid only.
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the molecular weight expected for AvBD 1. Two peptides of 7.9 kDa and 8.1 kDa 
respectively were obtained. Based on previous publications (Bals et al., 1998; Valore 
et al., 1998), the equilibration and elution buffers were changed to ammonium acetate, 
pH 7, to purify AvBD2 from the supernatant and the subsequent result compared to 
AvBD2 and 3 supernatants purified with bicine.
After cationic exchange chromatography was performed with bicine, pH 8, and 
ammonium acetate, pH 7, both peak samples and flow through were tested for 
antimicrobial activity (Figure 4.6). The killing assay showed that the antimicrobial 
activity was mostly found in the flow through at pH 8, while the peak obtained at pH 
7 had a killing activity of 93%, with 0% in the flow through. RP-HPLC analysis of 
AvBD2 eluted with ammonium acetate pH 7 revealed the presence of a peak in 
fraction 7, which was, interestingly, not present in the blank run. However, although 
the antimicrobial activity analysis of sample 11, used as negative control, did not 
show any antimicrobial activity, fractions 5 and 7 did not show any killing activity 
either (Figure 4.7). In addition, mass spectrometric analysis of fractions 5 and 7 did 
not reveal any peptides corresponding to the molecular weight of AvBD2. Therefore, 
correct expression of the avian /3-defensin was called into question again. The 
recombinant virus was therefore analysed to verify the correct insertion of the AvBD 
cDNA into the virus DNA.
4.3.3 Recombinant virus checking
BAC10:KOi629 bacmid contains a restriction enzyme cleavage site, Bsu36\, in 
ORF1629 that encodes an essential gene involved either in nucleocapsid packaging or 
modification of the virion RNA polymerase (Zhao et al., 2003). Therefore,
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Figure 4.6: Cationic exchange chromatography, HiTrap SP HP, at pH 8 for 
AvBDs 2 (red trace) and 3 (grey trace) and at pH 7 for AvBD2 (blue trace). The
insect cells were infected with AvBD2 recombinant virus for 3 days and centrifuged 
20 min at 5,000 x g to obtain the supernatant. The sample was then mixed with the 
start buffer (50 mM Bicine, pH8 or 32 mM ammonium acetate, pH 7) as described in
2.19.1 Cationic exchange chromatography section. The elution was a continuous ionic 
gradient of 0 to 0.5 M NaCl that started from the fraction 1 and finished at the fraction 
28. The flow rate was 5 ml/min with a gradient volume of 10 x column volumes and 
the detection was UV traces at 280 nm. The eluate was collected in 2 ml fractions.
The percentage represents the antimicrobial activity of the sample peaks. The negative 
control allowing the calculation of the killing activity of each peak contained buffer B 
only (0.5 M NaCl-50 mM Bicine, pH 8 or 0.5 M NaCl-32 mM ammonium acetate, pH 
7).
C o n t r o l  + (HBD3 at 20 pg/ml) 91%
AvBD1
pH 8
pH 7
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Figure 4.7: RP-HPLC of AvBD2 cluatc. The pool of fractions containing proteins 
after the cationic exchange chromatography were further analysed by RP-HPLC as 
described in 2.19.2 Reverse Phase-HPLC section. The percentage represents the 
antimicrobial activity of the AvBD2 eluate peak’s samples. The negative control 
allowing the calculation of the killing activity of each peak was fraction 11. Between 
dotted lines are the fractions used for antimicrobial assay.
AvBD2 eluate
0 %
1 1 2
interruption of ORF1629 makes the virus non-viable in vivo and a viable genome can 
only be obtained by recombination with a suitable transfer vector, meaning that the 
BAC10:KOi629 bacmid is able to produce 100% recombinant virus following 
transfection (Zhao et a l, 2003). Despite this, the virus DNA was extracted and 
amplified with AvBD-specific primers to check the correct insertion of the gallinacin 
cDNAs into the viral genome. Bands corresponding to AvBD 1, 2 and 3 
cDNAs were obtained, but AvBD4 did not yield a band (Figure 4.8). The correct 
reading frame was then checked by amplification with primers specific to pTriEx 1.1 
and sequencing of the products. AvBDs 1, 2 and 3 were in the correct reading frame 
but AvBD4 was again not obtained.
4.3.4 Large-scale purification of AvBDs 1, 2 and 3
The purification strategy was carried out as described by Bals et al. (1998) by 
using the same cationic exchange chromatography matrix, CM Sepharose™ Fast 
Flow. The base matrix of Sepharose Fast Flow ion exchangers is highly crosslinked 
agarose which gives the ion exchangers high chemical and physical stability. CM 
Sepharose Fast Flow is a weak cation exchanger containing a carboxy methyl group 
as the ion exchange group. In order to differentiate the peaks obtained from RP- 
HPLC, which could be the AvBD expected or viral proteins, a recombinant 
baculovirus coding for chicken IL-22 was used as negative control. The 1L-22 
recombinant virus was constructed by Uday Pathania (from this laboratory) in Prof 
Ian Jones’ laboratory at the University of Reading and was successful in producing 
bioactive chicken IL-22 (data not shown).
The samples from the cationic exchange chromatography were obtained after a one- 
step elution and no differences between the negative control eluate and the AvBDs
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Figure 4.8: Elcctrophcris gel of AvBD eDNAs from recombinant virus DNA. PO,
low titre virus DNA; PI, high titre virus DNA; C, PCR control. AvBDl (198 bp), 
AvBD2 (195 bp), AvBD3 (243 bp), AvBD4 (185 bp).
AvBDl AvBD2 AvBD3 AvBD4
PO P1 c PO P1 C PO P1 c PO P1 C
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eluates were observed (Figure 4.9). Fractions 9 and 10 were used for RP-HPLC 
analysis and a few differences in the peaks obtained were observed between the 
control and AvBD samples (Figure 4.10). In addition, antimicrobial assays of the 
peaks present in the AvBD purifications and absent in the negative control 
purification showed some killing activity (Figure 4.10). Unfortunately, mass 
spectrometry did not identify any peptide corresponding to the molecular weight of 
the avian /3-defensin prepropeptide or the mature peptide.
The antimicrobial assay was also carried out by using AvBDs and control 
supernatants before and after cationic exchange chromatography. The results showed 
killing activity before and after the first purification step but the antimicrobial 
activities of the AvBD and control samples were relatively similar (Figure 4.2B).
4.4 Discussion
Expression of recombinant AvBDs would allow the development of bioassays 
to assess their antimicrobial activity against different pathogens or their chemotactic 
activity for macrophages and lymphocytes, but also the production of antibodies to 
detect their expression in tissues. AvBDl, 2 and 3 recombinant baculoviruses were 
successfully produced. However, the absence of a AvBD4 band after amplification of 
the virus DNA excluded the AvBD4 recombinant baculovirus from further 
purification. Because the recombination process was well characterised and was able 
to produce 100% recombinant virus, the PCR of AvBD4 virus DNA was called into 
question. After investigation, the primers used were in fact not appropriate for the 
annealing temperature used for this experiment. The pTriEx 1.1 specific primers did 
not yield any AvBD4 products either and very low amounts of AvBDs 1,2 and 3, 
suggesting a lack of PCR optimisation. Therefore, AvBD4 recombinant virus may
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Figure 4.9: Cationic exchange chromatography, CM Sepharose™ Fast Flow, of 
AvBD 1, 2, 3 and control virus supernatants. The insect cells were infected with 
AvBDl, 2, 3 recombinant virus and control virus (1L-22 recombinant virus) for 3 days 
and centrifuged 20 min at 5,000 x g to obtain the supernatant. The sample was then 
mixed with the start buffer (32 mM ammonium acetate, pH 7) as described in 2.19.1 
Cationic exchange chromatography section. The elution was a one step elution with 
32 mM ammonium acetate/0.8 M NaCl, pH 6 buffer. The flow rate was 10 ml/min 
and the detection was UV traces at 280 nm. The eluate was collected in 5 ml fractions.
1«U
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Figure 4.10: Reverse Phase-HPLC analysis of AvBDl, 3 and virus control 
eluates. The pool of fractions containing proteins after the cationic exchange 
chromatography were further analysed by RP-HPLC as described in 2.19.2 Reverse 
Phase-HPLC section. The virus control is the IL-22 recombinant virus. The arrows 
represent the sample peaks absent in the virus control analysis. The percentage 
represents the antimicrobial activity of the sample peaks. The negative control 
allowing the calculation of the killing activity of each peak contained 0.01% acetic 
acid only.
Virus control
AvBDl
AvBD3
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have been obtained successfully, as with like AvBDl, 2 and 3 recombinant viruses 
and an optimisation of the PCR from virus DNA would be necessary.
Although AvBDl, 2 and 3 recombinant viruses were obtained, the respective AvBD 
peptides were not successfully purified. The expression system used to produce 
AvBDs has been used previously in our lab to successfully produce chicken IL-22, 
with the product detected by western blot and bioactivity also demonstrated (data not 
shown). Perhaps the avian /3-defensins were not purified because they were expressed 
at very low levels. The transcription of target genes using the pi 0 promoter is usually 
high, therefore a low yield of expressed product might be due to translation and post- 
translational causes. However, the lack of reagents to detect AvBDs was a limitation 
in obtaining AvBDl, 2 and 3. 16.5% Tris-Tricine SDS-PAGE allows an optimal 
separation of proteins <30 kDa but Coomassie staining has a low limit of detection,
0.1-0.5 pg of protein. Silver staining is more sensitive, detecting 1-5 ng of protein, but 
lower weight molecules tend to be less stained than high molecular weight proteins. 
Therefore, the SDS-PAGE method was possibly too insensitive to detect AvBDs, 
which are <5 kDa. In order to detect the presence of defensins throughout the 
purification process, the antimicrobial activity of defensins was used. The killing 
activity of /3-defensins is non-specific via the interaction of the peptide, which is 
positively charged, with the bacterial membrane, which is negatively charged. Using 
the IL-22 recombinant virus as a control, the virus control supernatant before and after 
the cationic exchange chromatography showed similar antimicrobial activity to the 
supernatant obtained after infection with the AvBDl, 2 and 3 recombinant viruses 
(Figure 4.2B). Because IL-22 never demonstrated any killing activity, the 
antimicrobial assay indicates the inhibition of E.coli growth, which may be caused by 
any virus or insect cell protein and give false positives. For this purpose, mass
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spectrometry was used to detect AvBD peptides in samples presenting antimicrobial 
activity. In addition, the molecular weight could indicate whether the avian /3-defensin 
peptide was secreted in the supernatant as prepropeptide or mature peptide. 
Unfortunately, no AvBD forms were detected in samples with positive antimicrobial 
activity. Alternatives to detect expressed peptide at low yields could be considered in 
future, such as the addition of tags at the 3' end of the cDNA, which can be removed 
after purification so as to not affect the folding and therefore the activity of the 
recombinant protein (Satchell et al., 2003).
The characteristics of defensins limit the choice of expression and purification 
strategies. Their antimicrobial activity limits the choice of heterologous systems, 
whilst their relatively small size and the importance of the correct folding limit the 
purification and detection strategies. The most efficient and successful method, which 
tends to be more and more used, is to chemically synthetise defensins (Boniotto et al., 
2006; Sayama et al., 2005; van Dijk et al., 2007). However, lower cost methods have 
been recently improved, such as an E. coli system (Peng et al., 2004). This system 
synthetises a new coding sequence of the target defensin using favoured codons for E. 
coli, appropriate restriction sites to clone the gene in the expression vector, a cleavage 
site between the propiece and the mature sequence to obtain the mature peptide and 
another final cleavage site at the end of the sequence to separate the peptide from the 
fusion protein (Peng et al., 2004). Despite good levels of expression, 1.3 g/1, which 
were then improved to 2 g/1 by using a cell-free system, the expression system 
remains complex and labour intensive. Interestingly, AvBD9 mature peptide was 
produced with success in HEK293-EBNA cells as a fusion protein with human 
growth hormone that facilitates the purification by using affinity chromatography and 
was then removed from the recombinant AvBD9 by cleavage. Unfortunately, the
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antimicrobial activity of the recombinant AvBD9 was lower than that of synthetic 
AvBD9 (van Dijk et ah, 2007).
In conclusion, the production of avian ß-defensin peptides remains labour 
intensive and/or costly, and although killing activity was demonstrated, purification of 
the actual defensin peptides was unsuccessful. The role of defensins in the innate 
immune response of the chicken was therefore examined by measuring their mRNA 
expression levels in a variety of in vitro and in vivo systems.
120
Chapter 5 -  Avian /3-defensin mRNA 
expression in chickens infected with
Salmonella
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5.1 Introduction
Salmonella entérica remains one of the most important agents of food-borne 
disease in man, with around 30,000 cases of salmonellosis notified per year in the UK, 
arising mainly from the consumption of infected poultry meat and eggs (reviewed by 
Barrow, 2000). The serotypes of this facultative intracellular pathogen can be divided 
into two groups according to the nature of the disease caused and the host specificity. 
The range of diseases caused depends on the host species infected and also on the 
expression of a variety of virulence determinants, some of which are encoded by 
Salmonella Pathogenicity Islands (McClelland et al., 2001; Parkhill et al., 2001). 
Despite the absence of clinical signs in adult chickens, the broad host range S. 
entérica serovars Enteritidis and Typhimurium colonise the alimentary and 
reproductive tracts and contaminate poultry carcasses and eggs, which enter the 
human food chain. The restricted host range serotypes, S. Pullorum and S. Gallinarum 
in the chicken, are no less invasive but do not induce a rapid inflammatory response 
(Henderson et al., 1999; Kaiser et al., 2000) and do not colonise the intestine. These 
bacteria can cause mortality rates of more than 50% in domestic poultry (Jones et al., 
2001; Shivaprasad, 2000). This ability to cause severe systemic disease seems to 
require interaction with the intestinal epithelia (Barrow et al., 1994; Pascopella et al., 
1995) and may be at least in part due to the lack of a IL-1/3- and IL-6-induced innate 
inflammatory response in the early stages of infection (Kaiser et al., 2000). Therefore, 
host defense mechanisms play a central role in differential responses to Salmonella 
infections exhibited by different lines of chickens.
The host genetic background plays an important role in the outcome of infection. 
Resistance to systemic salmonellosis (Bumstead & Barrow, 1988) differs between 
inbred lines of chickens and at least is largely controlled by the SALI locus. Lines C,
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l i  and 151 are susceptible to S. Enteritidis, S. Typhymurium, S. Gallinarum and S. 
Pullorum infection, while lines Wl, 6\ and N are resistant to systemic salmonellosis 
(Wigley et al., 2002). Inbred lines also differ in their susceptibility to intestinal 
colonisation with S. Typhimurium, although this has no relationship to the SAL1- 
mediated resistance to systemic disease, nor to the MHC (Barrow et al., 2004). The 
susceptibility/resistance phenotype, measured as variations in the duration and amount 
of bacterial excretion, is expressed within 24 hours of experimental infection of six- 
week-old birds. The resistance is autosomal and dominant, but the responsible genes 
have yet to be characterised. An increase in numbers of circulating heterophils, the 
avian equivalent of the mammalian neutrophil, was observed in a resistant chicken 
line, line 6j, following infection, suggesting the involvement of the innate immune 
response (Barrow et al., 2004).
In the present study, inbred lines 6i and N, previously characterized for their 
resistance to systemic disease and their differences in levels of Salmonella 
colonization, were selected to analyze avian /3-defensin expression. Line 6\ and line N 
chickens are resistant and susceptible to Salmonella serovar Typhimurium 
colonisation respectively (Barrow et al., 2004; Beal et al., 2005). An important 
difference in response between the lines was the number and activity of circulating 
heterophils, suggesting the involvement of these cells and their secreted components, 
such as AvBDs, in resistance to gut colonization. Therefore, AvBDs 1/laand 2, 
originally isolated from heterophils, were chosen to study their mRNA expression in 
resistant and susceptible chickens following Salmonella colonization. However, a role 
for j8-defensins expressed by epithelial tissues cannot be ruled out and AvBD3 and 5
were therefore also studied.
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The differential response of inbred lines to Salmonella serovars suggests the 
involvement of a common mechanism of resistance. As mentioned earlier, line I 2 and 
line 61 are susceptible and resistant to salmonellosis. Therefore, avian /3-defensin 
expression was also analysed in these two other lines, line 61 and line 72, following 
infection with different Salmonella serovars.
5.2 Results
5.2.1 Tissue expression profiles of AvBDs in uninfected chickens
Avian /3-defensins are difficult to purify from tissues or leukocytes. They are 
also difficult to express in heterologous expression systems. As a consequence, 
bioassays to assess their function are not readily available, and there are no anti- 
AvBD monoclonal antibodies. However, we can analyse their expression at the 
mRNA level, an approach which has already been used for human and mice defensins 
and shown to be an appropriate reporter to analyze their differential expression in 
epithelial tissues (Jang et al., 2004; O'Neil et al., 1999; Salzman et al., 2003a; Uehara 
et al., 2003; Zaalouk et al., 2004).
The avian /3-defensins measured were differentially expressed in the tissues tested 
(Figure 5.1). Some avian /3-defensins, such as AvBDs 1,2 and 3, were widely 
expressed and AvBDs 1 and 2 tend to be more highly expressed than AvBD3. By 
contrast, AvBDs 4, 5 and 14 were expressed only in certain tissues. In line N chickens 
AvBD5 was not expressed in the gut but it was expressed in the caeca and caecal 
tonsils of line 61 chickens. AvBD4 was only expressed in the caecal tonsil, bone 
marrow and lung of both lines, and the spleen of line 61 chickens. AvBD14 was only 
expressed in the skin and spleen of both lines (Figure 5.1). In addition, some tissues,
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Figure 5.1: Quantification of AvBD mRNA levels in different tissues of 6-\veck- 
oid line 6| and line N chickens. Samples were collected as described in the section 
2.12 Experimental plan. Results are expressed as corrected 40-Ct ± S.E.M. (n=3).
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such as jejunum, did not express any of the avian /3-defensins tested, while the bone 
marrow and the lung expressed all bar AvBD14. Interestingly, the skin seems to 
express only AvBDs 5 and 14 in both lines and a low level of AvBD3 in line 6i only. 
Finally, differences in avian /3-defensin mRNA expression levels were also observed 
between lines. Line 6\ chickens showed no expression of AvBDs 1 and 3 in the ileum 
and bursa respectively. Line N chickens showed lower expression of AvBDl in the 
caeca, AvBD2 in the bone marrow and no expression of AvBD3 in the skin, of 
AvBD5 in the caeca and caecal tonsil and of AvBD4 in the spleen (Figure 5.1). 
Regarding to Salmonella colonization, caecal tonsil is an important tissue to analyse. 
Indeed, chickens do not present lymphoid nodes but caecal tonsil contains lymphoid 
aggregates suggesting that this tissue localized at the entrance of caecal, which is 
highly colonized, might play a role in the regulation of commensal flora.
5.2.2 Expression of avian /3-defensins in heterophils
Heterophils were not isolated from the tissues from which the RNA isolated 
above, was isolated. Avian /3-defensin mRNA expression was therefore assessed in 
heterophils isolated from line I 2 chickens and heterophils of two commercial lines, A 
and B, which also differ in their resistance to systemic salmonellosis (kindly provided 
by Dr C. Swaggerty & Dr M. Kogut, USD A, College Station, Texas). Heterophils 
expressed the mRNA of all the avian /3-defensins tested except AvBDl 4. In addition, 
AvBDl was more highly expressed than AvBD3 (P< 0.05), AvBD4 and AvBD5 (P< 
0.005) in line B chickens and AvBDs 4 and 5 (P< 0.05) in line A chickens (Figure 
5.2A). However, expression of all five AvBDs was not altered in heterophils 
stimulated with S. Enteritidis compared to unstimulated heterophils (Figure 5.2B).
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Figure 5.2: Quantification of avian /3-dcfensin mRNA levels in heterophils of 
commercial lines, A and B, and inbred line 72 chickens (A) and stimulated >vith 
S. Enteritidis (SE) (B). The RNA samples were obtained as described by Swaggerty 
et al., 2004. Results are expressed as corrected 40-Ct ± S.E.M. (A, A SE, B and B SE, 
n=3; I 2, n=l). Asterisks represent a statistically significant difference in avian /3- 
defensin expression between AvBDl and AvBDs 3, 4,and 5 (* for P<0.05 and ** for 
P0.005), according to the Analysis of Variance (ANOVA) general linear model test 
with Minitab software.
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Figure 5.3: Salmonella levels in the caeca of line 6\ and line N chickens following 
oral infection with 108 CFU of S. Typhimurium (A) or S. Gallinarum (B). The
bacterial count is described in 2.13 Bacterial enumeration section. Results are 
expressed as the mean of the log CFU per g of caecal content ± S.E.M. (A, n=3; B, 
n=5).
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5.2.3 Avian /3-defensin expression in the caecal tonsils of line 61 and N chickens 
infected with S. Typhimurium and S. Gallinarum
5.2.3.1 Bacterial enumeration
S. Typhimurium was detected in the caeca of line 6\ and N chickens 1 day 
post-infection (dpi) (Figure 5.3A). At 7 dpi, line 6i chickens were clearing S. 
Typhimurium from the caeca, but the bacteria persisted in the gut of line N chickens. 
The differences observed between both lines were not confirmed by a statistical t-test 
(P=0.07), probably since the number of birds per group (n=3) was very small.
By contrast, S. Gallinarum was detected in the caeca of both lines from 2 dpi and 
remained at low levels for the duration of the experiment (Figure 5.3B).
5.2.3.2 Expression of AvBDs in chickens infected with S. Typhimurium
In order to determine if there is a role for avian /3-defensins in the mechanisms 
responsible for the difference in S. Typhimurium colonisation observed between 
resistant and susceptible lines of chickens, RNA was extracted from caecal tonsils 1, 2 
and 7 dpi and analysed by real-time quantitative RT-PCR. The ileum and caeca were 
also analysed but the low level and reproducibility of mRNA expression of some 
AvBDs rendered the interpretation of results difficult in both lines. The caecal tonsil 
gave reproducible results, as AvBDs were expressed at high levels throughout the 
infection.
AvBDl mRNA was expressed throughout the infection in both lines, but it was down- 
regulated following infection in line N chickens, compared to levels in control birds, 
at 1 dpi (P ^ ).005), then slightly down-regulated at 2 dpi (P<0.05) and finally 
normally expressed at 7 dpi (Figure 5.4A). AvBD2 was expressed at 1, 2 and 7 dpi in 
line 6i chickens, but only at levels seen in control birds, while in line N chickens
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Figure 5.4; Quantification of avian /8-defensin mRNA levels in caccal tonsils of 
line 61 and line N chickens infected with Salmonella Typhimurium F98. The
tissue samples were collected as described in the section 2.12 Experimental plan. 
Results are expressed as corrected 40-Ct ± S.E.M. (n=3). Asterisks represent a 
statistically significant difference in avian /3-defensin expression between uninfected 
(control) and infected chickens (* for P<0.05 and ** for P<0.005), according to 
Student’s t-test. 6 wk C, 6 weeks old chicken uninfected; 7 wk C, 7 weeks old chicken 
uninfected; dpi, days post-infection.
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avian /3-defensin2 was first normally expressed at 1 dpi, then down-regulated at 2 dpi 
(P<0.005) and finally undetectable at 7 dpi (Figure 5.4B). AvBDs 3 and 5 were 
normally expressed at 1 and 2 dpi in both lines but were undetectable in line N 
chickens at 7 dpi (Figures 5.4C and 5.4D). AvBD4 was the only avian /3-defensin 
tested to be constitutively expressed throughout the infection (Figure 5.4E). However, 
down-regulation of avian /3-defensin mRNA expression was not only observed in the 
susceptible line, as AvBD5 expression was slightly down-regulated at 7 dpi (P<0.05) 
in the resistant line (Figure 5.4D). Overall, the expression of all the avian /3-defensins 
tested was constitutive in both lines for control birds, with the exception of the 
absence of AvBD3 and 5 mRNA expression in 7-week-old and 6-week-old uninfected 
line N control chickens, respectively (Figures 5.4C and 5.4D).
5.2.3.3 Expression of avian /3-defensins in line 6i and N uninfected chickens
Because AvBD3 and 5 mRNA expression were not observed in 7-week-old 
and 6-week-old uninfected line N chickens, respectively, in the initial experiment, 
avian /3-defensin expression was analysed weekly in uninfected chickens from 1 -9 
weeks of age (Figure 5.5). Expression of avian /3-defensin mRNA tended to decrease 
in line 6i chickens for the first 3 weeks of age but was then expressed fairly 
constantly. By contrast, the avian /3-defensin mRNA expression pattern in line N 
chickens was different for each avian /3-defensin tested. AvBDl mRNA expression in 
line N closely matched the expression observed in line 6i chickens (Figure 5.5A). 
AvBD2 mRNA was constantly expressed for the first 3 weeks, undetectable at 4 
weeks and expression finally decreased slowly from 6 weeks of age (Figure 5.5B). 
AvBD3 mRNA expression tended to increase for the first 2 weeks, and then decreased 
slowly until 5 weeks of age but was undetectable at 7 and 9 weeks of age
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Figure 5.5: Quantification of avian /3-dcfensin mRNA levels in caccal tonsils of 
line 6| and line N chickens from 1-9 weeks of age. Samples were collected as 
described in the section 2.12 Experimental plan. Results are expressed as corrected 
40-Ct± S.E.M. (n=3).
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(Figure 5.5C). AvBD5 mRNA expression tended to be constant but was undetectable 
at 3, 6 and 9 weeks of age (Figure 5.5D). Finally, AvBD4 mRNA expression 
increased for the first 3 weeks of age, was undetectable at 4 and 9 weeks of age and 
tended to be constantly expressed from 5 to 8 weeks of age (Figure 5.5E).
5.2.3.4 Expression of AvBDs in chickens infected with S. Gallinarum
Line 6i chickens can clear S. Typhimurium from their gut but not S. 
Gallinarum, which anyway colonises poorly. Avian /3-defensin mRNA expression in 
the caecal tonsil and the caeca was therefore analysed following S. Gallinarum 
infection of line 6j birds. Avian /3-defensin mRNAs were expressed throughout the 
infection in the caecal tonsil, with AvBDl and 2 mRNAs generally expressed at 
higher levels than the mRNAs for AvBDs 3,4 and 5 (Figure 5.6A). In the caeca, 
AvBDs 1,2,3 and 5 had the same expression pattern as observed in the caecal tonsil, 
but AvBD4 was only expressed at 1 and 2 dpi (Figure 5.6B). AvBD3 and 5 mRNAs 
were expressed at a higher level in the caecal tonsil than in the caeca (Figure 5.6). 
Interestingly, some avian /3-defensins were differentially regulated in the caecal tonsil 
during infection. AvBD2 and 3 mRNA expression levels were up-regulated at 2 dpi, 
while AvBD3 mRNA expression levels were down-regulated at 7 dpi (Figure 5.5A), 
compared to levels in control caecal tonsils.
5.2.4 Expression of avian /3-defensins in the caecal tonsil and spleen of line l i  
chickens infected with S. Enteritidis and S. Pullorum
In comparison to line 6\ and N chickens, which are resistant to salmonellosis, line l i  
chickens are susceptible to Salmonella infection. Line I 2 chickens were infected with 
two types of Salmonella, S. Enteritidis, a broad-host range serovar, and S. Pullorum, a 
host-specific serovar, to compare the innate immune response of the susceptible line.
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Figure 5.6: Quantification of avian jS-defensin niRNA levels in the caccal tonsil 
and caeca of line 61 chickens infected with Salmonella Gallinarum 9. Samples 
were collected as described in the section 2.12 Experimental plan. Results are 
expressed as corrected 40-Ct ± S.E.M. (n=3 for controls; n=5 for infected, except for 
AvBD4 where n=3). Asterisks represent a statistically significant difference in avian 
/5-defensin expression between uninfected (control) and infected chickens (* for 
P<0.05), according to Student’s t-test. 6 wk C, 6 weeks old chicken uninfected; 7 wk 
C, 7 weeks old chicken uninfected; dpi, days post-infection.
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S. Enteritidis has the same phenotype as S. Typhimurium including gut colonization 
and induction of a strong immune response, but taxonomically is closely related to S. 
Gallinarum and S. Pullorum (Li et al. 1993). By contrast, S. Pullorum does not 
colonize the gut and is considered as less virulent, causing pullorum disease 
(diarrhea),than 5. Gallinarum that causes typhoid fever in chickens.
5.2.4.1 Bacterial enumeration
S. Pullorum was detected in lower amounts than S. Enteritidis in the caeca of 
line 72 chickens 24 hours and 1 week post-infection (pi) and 1 week pi in the spleen 
(Figure 5.7). In caeca, S. Pullorum remains lower than S. Enteritidis 2 and 4 week pi, 
while the numbers of S. Enteritidis tend to decrease and reach the same level as S. 
Pullorum at 2 and 4 week pi.
5.2.4.2 Expression of avian |3-defensins in chickens infected with S. Enteritidis 
and S. Pullorum
Caecal tonsil and spleen from chickens non-infected and infected with S. 
Enteritidis and S. Pullorum were provided by Dr P.Wigley and Ms L. Chappell. Avian 
/3-defensin mRNA expression was therefore assessed in both the caccal tonsil and 
spleen at 24 hours, 1,2, 3 and 4 weeks pi. In the caecal tonsil, AvBDs 1, 2,3 and 5 
were constantly expressed in control birds and birds infected with either serovar 
(Figure 5.8). A similar pattern was seen in the spleen (Figure 5.9), except that AvBD5 
was up-regulated at 24 hours pi in line l i  chickens infected with S. Pullorum (Figure 
5.9D). AvBD14, which is specifically expressed in the spleen and skin, did not show 
differential expression of mRNA levels in the spleen in response to S. Entcritidis and 
S. Pullorum infection (Figure 5.9E).
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Figure 5.7: Salmonella levels in the spleen (A) and caeca (B) of line 72 chickens 
following oral infection with 108 CFU of S. Pullorum and S. Entcritidis. The
bacterial count was carried out as described in the section 2.13 Bacterial enumeration. 
Results are expressed as the mean of the log CFU per g of spleen or caecal contents ± 
S.E.M. (n=5).
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Figure 5.8: Quantification of avian /3-defensin niRNA levels in the caccal tonsils 
of line 72 chickens infected with Salmonella Pulloriim and Salmonella Entcritidis.
Samples were collected as described in the section 2.12 Experimental plan. Results 
are expressed as corrected 40-Ct ± S.E.M. (n=5).
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F ig u r e  5 .9 :  Q u a n t i f i c a t i o n  o f  a v i a n  jS -d e fe n s in  m R N A  le v e l s  in  t h e  s p l e e n  o f  l in e  
72 c h i c k e n s  in f e c t e d  w i t h  Sa lm onella  P u l l o r u m  a n d  Sa lm onella  E n t c r i t id i s .
Samples were collected as described in the section 2.12 Experimental plan. Results 
are expressed as corrected 40-Ct ± S.E.M. (n=5). Asterisks represent a statistically 
significant difference in avian /3-defensin expression between uninfected (control) and 
infected chickens (* for P<0.05), according to Student’s t-test.
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5.3 Discussion
Defensins are AMPs and are an important component in mucosal host 
defences to prevent the invasion of enteric pathogens (Wilson et al., 1999).
Expression of avian /3-defensin mRNA was analysed to determine their role in 
controlling Salmonella infection in the small intestine of two inbred lines of chickens 
showing differential susceptibility to S. Typhimurium colonisation, line 6\ being 
resistant and line N susceptible (Barrow et al., 2004). The absence of expression of 
AvBD2,3 and 5 mRNAs in the susceptible line post-infection suggests that chicken 
defensins may play a role in the clearance of S. Typhimurium. AvBD5 was down- 
regulated in both lines. Down-regulation of defensin expression has previously been 
demonstrated in the mouse following infection with S. Typhimurium in Pancth cells 
(Salzman et al., 2003a) and with Cryptosporidium parvum, a protozoan parasite, in 
mice intestinal epithelial cells (Zaalouk et al., 2004), suggesting that suppression of 
epithelial defensins is a virulence strategy of small intestinal pathogens to invade the 
gut.
In human, most /3-defensins are constitutively expressed in epithelial tissues such as 
the lungs, skin and intestine (Eckmann, 2005), as observed for the avian /3-defensins 
(Lynn et al., 2004; Xiao et al., 2004). However, heterophils are present in the 
intestine of pre- and immediately post-hatch chicks, suggesting that the gut is a site 
for granulopoiesis (Bar-Shira & Friedman, 2006). Therefore, AvBDl and 2, originally 
isolated from heterophils (Evans et al., 1994), might be expressed either by gut 
epithelial cells and/or in heterophil granules. In addition, heterophils from different 
lines of chickens expressed AvBDl, 2, 3,4 and 5 mRNAs, confirming that avian /3- 
defensin expression seen in tissues could be from heterophils, except AvBDl4. This 
avian /3-defensin was the only defensin of those tested which was not expressed in
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heterophils at the mRNA level, confirming its specificity of expression in the skin and 
spleen. However, mRNA expression does not reflect protein levels. Avian /3-dcfcnsins 
can be stored in granules in heterophils and so mRNA expression of avian /3-defensins 
does not necessarily signify their production and release in response to bacterial 
infection. In addition, epithelial cell expression of certain defensins in mammals alters 
with age (Meyerholz et al., 2004; Yoshimura et al., 2006). This could be a factor in 
the absence of AvBDs 3 and 5 expression in uninfected control birds in the first 
experiment at certain ages.
Avian /3-defensin mRNA expression in uninfected chickens up to 9 weeks of age was 
different between line N and line 6\ chickens. The regulation of defensin expression is 
poorly understood, even in mammals. Human /3-defensin 2 (HBD-2) differs from the 
other human /3-defensins, as it is not only constitutively expressed but also induced in 
response to pathogen infection or stimulation with the pro-inflammatory cytokine 
IL-1/3 (McDermott et al., 2003; O'Neil et al., 1999). In vitro, the mechanism by which 
IL-1/3 up-regulates HBD-2 involves the activation of the transcription factor NF-kB as 
well as activation of signaling proteins, particularly PKC, p38 MAPK, JNK and PI3K 
(Jang et al., 2004). The ERIC pathway is involved in hBD-2 and -3 expression and 
JNK plays a crucial role in defensin expression in response to Helicobacter pylori 
(Boughan et al., 2006). In mice, the p38 MAPK pathway is also involved in the 
production of a-defensins (Salzman et al., 2003a). The differential expression of avian 
/3-defensins between lines and the differential expression pattern of the avian /3- 
defensins studied in the susceptible line might in part explain the susceptibility of line 
N chickens to S. Typhimurium colonization. Indeed, AvBDl and 2 mRNA expression 
increased during the first two weeks of life of unvaccinatcd Ross broiler chicks (Bar- 
Shira & Friedman, 2006), suggesting that avian /3-defensin expression patterns depend
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on the chicken line studied. In addition, line N chickens also showed in previous 
studies a decrease in number and circulating heterophils (Barrow et al., 2004) and a 
low antigen-specific proliferation of splenocytes, suggesting the involvement of T cell 
responses in the clearance of S. Typhimurium in this resistant line (Beal et al., 2005). 
This suggests that the genetic background controlling the innate immune response of 
line N chickens is presumably the main cause of their susceptibility to S.
Typhimurium colonisation.
S. Gallinarum is a host-specific serovar causing fowl typhoid in poultry. This 
bacterium is less invasive than S. Typhimurium and does not trigger an inflammatory 
response (Kaiser et al., 2000), thereby presumably allowing the development of 
systemic disease. Line 6i chickens are resistant to S. Typhimurium colonization but 
susceptible to S. Gallinarum infection. However, avian /3-defcnsins were expressed 
constitutively during both infections suggesting that the killing activity of these 
peptides is not essential to clear the pathogen. Indeed, if the antimicrobial activity of 
avian /3-defensins was responsible for the clearance of S. Typhimurium, S. Gallinarum 
could be expected to repress avian /3-defensin expression to be able to cause systemic 
disease. In addition, the bactericidal activity of human defensins is inhibited in 
physiological fluids and solutions at high salt concentrations (Bals et al., 1998; 
Goldman et al., 1997), suggesting that defensins may have other biological functions. 
HBD-2 chemoattracts immature dendritic cells and memory T cells (Yang et al.,
1999) as well as inducing a cytokine response, particularly IL-6,1L-8 and IL-10 
(Boniotto et al., 2006), thereby linking the innate and adaptive immune responses. 
Because of these possible roles for defensins in the immune system, it was not 
surprising that mammalian defensins, such as porcine j3-defensin 2, HBD2 and at- 
defensins, are differentially regulated in response to Salmonella infection in vitro and
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in vivo (O'Neil et al., 1999; Salzman et al., 2003a; van Dijk et al., 2006). Therefore, 
the slight up- and down-regulation of certain avian /3-defensins observed during 
infection with both Salmonella serovars suggests that, like mammalian defensins, they 
may have additional roles in the innate immune response.
Avian /3-defensin mRNA expression was also analysed to compare the effects of S. 
Enteritidis and S. Pullorum infection in line 72 chickens, which are susceptible to 
salmonellosis. S. Enteritidis, like S. Typhimurium, rarely produces disease in chickens 
and colonises the gastrointestinal tract, while S. Pullorum mainly causes clinical 
disease in young chickens. In addition, the colonisation pattern of host-specific 
Salmonella and broad host-range serovars are relatively similar in chicken lines 
resistant (line N) and susceptible (line li)  to salmonellosis, with higher amounts of S. 
Typhimurium and S. Enteritidis than S. Gallinarum and S. Pullorum in the chicken 
gut. The constant expression of avian /3-defensin mRNA in both the caecal tonsil and 
spleen showed that the AMPs were not a major component in the differential infection 
of Salmonella, confirming the results with S. Gallinarum and S. Typhimurium in line 
6i chickens, which are resistant to salmonellosis. However, the time-points selected 
might not be appropriate, as gallinacin 9 was up-regulated at 24 hours pi but a 48 
hours time-point was missing, while the differential expression of avian /3-defcnsins 
tended to be between 24 h and 7 days pi in the previous experiments. Heterophils are 
an important component in controlling S. Enteritidis infections (Kogut et al., 1994) 
and they play a crucial role in the response to salmonellosis (Henderson et al., 1999). 
However, the lack of differential avian /3-defensin mRNA expression between 
resistant and susceptible lines in response to salmonellosis coincides with the lack of 
difference in heterophil phagocytic activity previously observed (Wigley et al., 2002), 
suggesting a minor role for heterophils in the resistance and susceptibility of chicken
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lines to salmonellosis. However, there is differential expression of cytokine and 
chemokines following phagocytosis of S. Enteritidis by heterophils (Kogut et al.,
2003). In addition, heterophils from commercial lines, line A and line B, respectively 
resistant and susceptible to S.enteritidis-induced mortality, showed differential 
expression of the pro-inflammatory cytokines IL-6 and IL-18, the pro-inflammatory 
chemokine CXCLÌ2 and the anti-inflammatory cytokine TGF-/34. Interestingly, the 
pro-inflammatory cytokines and chemokine were up-regulated in the resistant line, 
while the anti-inflammatory cytokine was down-regulated (Swaggerty et al., 2006). 
Line A and B heterophil samples were also tested for avian /3-defensin expression in 
this study, but no difference in avian /3-defensin expression between the resistant and 
susceptible lines was observed, suggesting that avian /3-defensins expressed by 
heterophils do not play a role in resistance to salmonellosis. In contrast, the up- 
regulation of the anti-inflammatory cytokine, TGF-/34, was also observed in the 
spleen of line N chickens (Beal et al., 2004) suggesting that the up-regulation of TGF 
/34 may increase susceptibility to Salmonella infection.
In summary, we observed differential expression of certain avian /3-defcnsins 
in response to Salmonella infection. As human /3-defensins are an important 
component of the innate immune system, it will be interesting to investigate the 
regulation of avian /3-defensin expression and their biological functions in the innate 
immune response to further understand the chicken’s response to Salmonella
infection.
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Chapter 6 - Discussion
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6.1 Defensins are components of innate immunity in the gastrointestinal tract
Defensins are important components of innate immunity, playing multiple 
roles such as having antimicrobial activity against a variety of microorganisms, 
recruiting phagocytic cells, activating adaptive immunity by recruiting T cells and 
immature dendritic cells and inducing dendritic cell maturation (Yang et al., 2004). 
Regulation of innate immunity is complex and involves cells, mediators and effector 
molecules that specifically recognise a pathogen and remove it. However, when the 
innate components are unable to stop the infection, they can also stimulate adaptive 
immunity to induce a strong response. The specificity of pathogen recognition is even 
more important in tissues colonised by commensal bacteria such as the intestinal tract. 
Indeed, the mammalian gastrointestinal tract contains Paneth cells that release AMPs 
constitutively on stimulation with bacterial components, such as LPS, lipoteichoic 
acid, lipid A and muramyl dipeptide (Ayabe et al., 2000), to limit the invasion and 
adherence of pathogenic and commensal bacteria (Wehkamp et al., 2007). Paneth 
cells localised in the base of the small intestinal crypts of Lieberkvihn are granulated 
cells that protect stem cells, which give rise to other cell lineages including 
enterocytes, goblet cells and enteroendocrine cells (Bry et al., 1994; Cheng &
Leblond, 1974). The mechanism leading to stimulation of Paneth cells to degranulate 
and thereby secrete lysozyme (Erlandsen et al., 1974), defensins (Cunliffe et al.,
2001) and secretory phospholipase A2 (Nevalainen et al., 1995), by direct interaction 
with microorganism components or via other epithelial cells, is still unclear. However, 
the degranulation event is independent of TLR4 signalling components in TLR4- 
deficient mice (Tanabe et al., 2005), while TLR9 expressed by Pancth cells is 
involved in degranulation when stimulated with its ligand, CpG DNA (Rumio et al., 
2004). In addition, a TLR-independent signalling pathway, the intracellular sensing
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system of NOD proteins, was discovered to be expressed in Paneth cells, and NOD2- 
deficient mice showed a reduction of a-defensin expression by Paneth cells 
(Kobayashi et al., 2005), suggesting a complex regulation between the different 
signalling pathways to control the degranulation of Paneth cells in response to 
lumenal bacterial components.
In the chicken, the presence of Paneth cells in the intestine and the caeca remains to 
be determined. Chicken heterophils, the functional equivalent of mammalian 
neutrophils, can be observed in the intestine of pre- and immediately post-hatch 
chicks (Bar-Shira & Friedman, 2006). The development of the gut and its colonisation 
is different between species that forage an adult type diet compared to others that are 
fed with the parents’ milk (Turk, 1982). Chicken heterophils may contribute to the 
control of commensal flora at the early stage of the gut development particularly in 
the caeca, which is a major site of bacterial colonisation (Barnes, 1979), as they are 
able to divide outside the bone marrow and to produce mediators and effector 
molecules such as cytokines, chemokines, presenilin 1 and /3-defensins (Bar-Shira & 
Friedman, 2006). In contrast, in mammals neutrophils have their origin in multi- 
potencial stem cells in bone marrow and migrate from the blood stream to the gut in 
response to infection (Hachicha et al., 1998). Like Paneth cells, heterophils express a 
wide panel of TLR mRNAs, including TLR1/6/10, TLR2 type 1, TLR2 type 2, TLR3, 
TLR4, TLR5, and TLR7, which were functionally active in response to their agonists 
(Kogut et al., 2005). Paneth cells and human neutrophils express odefensins, while 
chicken heterophils express /3-defensins. AvBDl and 2 peptides were first isolated 
from heterophils and this study has shown that AvBD3,4 and 5 mRNAs are also 
expressed by heterophils, suggesting that heterophils are an important component in 
chicken gastrointestinal immunity.
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Epithelial cells are a natural barrier limiting the invasion of commensal and pathogen 
bacteria. In mammals, gastrointestinal cells express AMPs such as /3-defensins, 
constitutively or in response to infection (Ganz, 2003b). In chickens, AvBDs are also 
expressed constitutively or induced by pathogens, such as AvBD4 in the small 
intestine, particularly the caeca and caecal tonsil, suggesting a protective role for 
gallinacins in the epithelial integrity of the chicken intestinal tract.
6.2 AvBD expression and genetic organisation
Heterophils express all the avian /3-defensins tested, except AvBD 14. AvBD 14 
was identified in BAC bW094K17 Contig 14 in our laboratory. This BAC also 
encodes AvBDs 1, 3,4 and 5. However, AvBD14, which seems to be composed of 
two exons, is not fully sequenced in the chicken genome. Thirteen genes coding for 
AvBDs were identified on chicken chromosome 3. The genetic organisation showed 
similar features with the human and mice defensin loci. Indeed, the CTSB gene, 
coding for Cathepsin B, and a human EST sequence were localised on either side of 
the chicken defensin cluster. These conserved genes were first identified in defensin 
gene clusters on human chromosome 8p22 and mouse chromosome 14C3 (Xiao et al.%
2004). It would be interesting to sequence BAC bW094K17 fully and to align it with 
the avian /3-defensin locus in the chicken genome to fill the gaps between contigs 
17.130,17.131 and 17.132 (Figure 3.5).
Expression of avian /3-defensin mRNAs was constitutive in a variety of tissues 
including lung, bursa, bone marrow, spleen, skin (for AvBD5 and 14), ileum, caeca 
and caecal tonsil. However, the absence of monoclonal antibodies to AvBDs limits 
the development of bioassays to visualise the secretion of avian /3-dcfcnsins by 
tissues, particularly in the intestinal tract. Indeed, defensins secreted by neutrophils,
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heterophils and Paneth cells are stored in granules before being released, whilst the 
storage or direct secretion of defensins by epithelial cells remains to be determined. 
The mRNA level of defensins does not therefore necessarily reflect secretion of the 
defensin peptide into the lumen.
Because of the characteristics of defensins, the production of defensin peptides 
requires particular expression methods. The defensin genes encode a prepropetide, 
which is then cleaved to obtain a mature peptide able to attach to and form a pore in 
the cell membrane of the target microorganism. In addition, the correct folding of 
defensins depends on the formation of three disulphide bridges, which is difficult to 
achieve using E. coli expression systems. Systems that produce the mature peptide 
synthetically are mostly used because of their efficiency in obtaining high levels of 
biologically active defensins. Baculovirus expression systems have been used several 
times to produce human /3-defensin peptides by inserting a cleavage site between the 
propiece and defensin mature peptides, but interestingly the baculovirus system also 
expressed the mature peptide directly. However, the low level of active defensin 
obtained limited its detection and purification was labour intensive. Recently, AvBD9 
mature peptide was successfully expressed in mammalian HEK293-EBNA cells as a 
fusion protein with human growth hormone, which facilitated purification using 
affinity chromatography and was then removed from the recombinant AvBD9 by 
cleavage (van Dijk et al., 2007). Unfortunately, the antimicrobial activity of the 
recombinant AvBD9 was lower than that of synthetic AvBD9. The sequence coding 
for the mature peptide was directly inserted in the expression vector by modifying the 
N-terminal of AvBD9. Despite the presence of a higher number of positive charges on 
the surface of the recombinant AvBD9 than the synthetic AvBD9, the modification of 
the recombinant AvBD9 N-terminal affected its antimicrobial activity (van Dijk et al.,
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2007). The success of AvBD9 production, using a relatively simple expression and 
purification system, should allow the successful production of other avian /3-defensins 
by cloning the avian /3-defensin full cDNA sequence with a cleavage site between the 
propiece and the mature peptide, as previously carried out for human /3-defensins 
produced in a baculovirus expression system (Bals et al., 1998; Goldman et al., 1997). 
This construct would produce a high level of purified biologically active avian /3- 
defensin.
Defensins were first identified as AMPs by their microbicidal activity against a 
variety of microorganims such as bacteria and viruses. However, complementing roles 
in immune defense were observed for both a- and /3-defensins. Indeed, a mouse c*- 
defensin, cryptdin 3, secreted by Paneth cells promotes ion fluxes in epithelial cells 
(Merlin et al., 2001) and induces expression of the chemokine IL-8 (Lin et al., 2004). 
A human /3-defensin, HBD2, was identified as being chemoattractant for dendritic 
cells (Yang et a l, 1999). In addition to their involvement in immune defence, 
defensins are constitutively expressed or induced in response to infection or 
inflammation. HBD1 is constitutively expressed in the colon, whilst HBD2 is 
produced in inflammatory bowel disease (O'Neil et al., 1999; Wehkamp et al., 2003a) 
or in response to bacterial infections, such as with C. jejuni (Zilbauer et al., 2005) or 
H. pylori (Wehkamp et al., 2003b). The different biological activities and expression 
patterns of the multiple defensins may suggest that each defensin is produced either to 
regulate the commensal flora by using its antimicrobial activity or to modulate 
immune defence in response to pathogen infection. For this purpose, the production of 
avian /3-defensin peptides could help to define first their antimicrobial and 
chemotactic activity and then their specific role in immune defence in response to a 
variety of pathogens such as Salmonella.
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6.3 Avian /S-defensin expression in response to Salmonella infection
Chickens can be infected either by broad host range Salmonella serovars, such 
as S. Typhimurium and S. Enteritidis, or host-specific serovars, such as S. Pullorum 
and S. Gallinarum, which cause systemic salmonellosis. Previous studies of inbred 
White Leghorn chicken lines showed differences in resistance and susceptibility to 
Salmonella infection. Susceptible chickens, including lines I 2, C and 151, had a higher 
mortality and morbidity rate than resistant chickens, including lines Wl, N and 61. On 
post-mortem examination large necrotic lesions were observed in susceptible birds. 
Resistance to salmonellosis was determined to be genetically dependent and at least in 
part encoded by the SAL\ locus (Wigley et al., 2002). Different lines of commercial 
birds, lines A and B, also showed differential resistance to S. Enteritidis infections, 
with line A more resistant to systemic S. Enteritidis infection than line B. Fewer line 
A chickens died after S. Enteritidis infection compared to line B and more heterophils 
migrated to the site of infection in the resistant line (Swaggerty et al., 2005). 
Heterophils, as discussed above, are equivalent to mammalian neutrophils, and are an 
important component of innate immunity as they are able to modulate the 
inflammatory response through the phagocytosis of infectious agents (Desmidt et al., 
1996; Kogut et al., 2001) and the secretion of cytokines and chemokines (Kogut et al., 
2003). Heterophils from line A and B chickens showed differential expression of the 
pro-inflammatory cytokines and chemokines IL-6, IL-18 and CXCLi2 and the anti­
inflammatory cytokine TGF-/34. Interestingly, the pro-inflammatory cytokines and 
chemokine were up-regulated in the resistant line, while the anti-inflammatory 
cytokine was down-regulated (Swaggerty et al., 2006). In this study, line A and B 
heterophil samples were also tested for avian j3-defensin expression, but no difference 
in avian jS-defensin expression between the resistant and susceptible lines was
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observed, suggesting that AvBDs expressed by heterophils do not play a role in the 
resistance to salmonellosis.
A second component of the cellular innate immune response, macrophages, showed 
differential effectiveness between the resistant chicken line W1 and the susceptible 
line li. Macrophages from the resistant line showed a stronger oxidative response to 
Salmonella compared to macrophages from the susceptible line (Wigley et al., 2002). 
In addition, the pro-inflammatory chemokines CCLi2 and CXCLil were up-regulated 
macrophages from the resistant line challenged with S. Gallinarum and S. 
Typhimurium (Wigley et al., 2006). Interestingly, IL-6 and IL-18 expression were 
also higher in macrophages from the resistant line than those from the susceptible line 
following challenge with both serovars (Wigley et al., 2006), as observed previously 
in heterophils (Swaggerty et al., 2006). IL-18 combined with IL-12 initiates Thl 
adaptive responses (Mastroeni & Menager, 2003), which are involved in the clearance 
of intracellular pathogens such as Salmonella, Mycobacteria and trypanosomes 
(Holscher, 2004). The cellular innate components, macrophages and heterophils, from 
the resistant-line chickens respond therefore more effectively and rapidly in the 
initiation of adaptive immune responses (Wigley et al., 2006), which could explain 
the clearance of Salmonella in the spleen and liver of the resistant line as previously 
observed (Wigley et al., 2002). However, the clearance of Salmonella from the 
resistant line might be also caused by an increase of macrophage antibacterial activity 
through the expression of AvBDs. The expression of avian /3-defensins by chicken 
macrophages remains to be determined but human macrophages express /3-defensin 1 
and 2 mRNAs (Duits et al., 2002). Despite the absence of differential expression of 
AvBDs in heterophils of line A and B chickens, it could be interesting to analyse the
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expression of AvBDs in macrophages from resistant and susceptible chicken to 
determine their role, if any, in chicken systemic salmonellosis.
Interestingly, chicken lines resistant to salmonellosis can also show differential 
susceptibility to S. Typhimurium colonisation. When chickens were infected at 6 
weeks of age, line 6\ chickens were able to clear S. Typhimurium from the intestinal 
tract, while the bacterium tends to persist in the gut of line N chickens. The AvBD 
expression analysis showed the absence of AvBD2, 3 and 5 mRNA expression in the 
susceptible line post-infection, suggesting that chicken defensins may play a role in 
the clearance of S. Typhimurium. Down-regulation of defensin expression has 
previously been demonstrated in the mouse following infection with S. Typhimurium 
in Paneth cells (Salzman et a l, 2003a) and with C. parvum, a protozoan parasite, in 
mice intestinal epithelial cells (Zaalouk et al., 2004), suggesting that suppression of 
epithelial defensins is a virulence strategy of small intestinal pathogens to invade the 
gut. However, avian (3-defensin mRNAs were also analysed in heterophils, which are 
an important component of the innate immune response involved in the chicken 
resistance to salmonellosis. In addition, heterophils were discovered in the intestine of 
pre- and immediately post-hatch chicks, suggesting their involvement in the control of 
intestinal microorganisms (Bar-Shira & Friedman, 2006). The absence of avian /3- 
defensin expression in the line N chickens may be therefore at the level of heterophils 
or intestinal epithelial cells. For this purpose, heterophils from resistant and 
susceptible chicken lines could be isolated and challenged with S. Typhimurium to 
determine whether the down-regulation of AvBD mRNA expression observed was 
specifically in heterophils. Determination of how avian /3-defensin expression is 
regulated might help understand chicken resistance to salmonellosis and to S. 
Typhimurium colonisation. Several mammalian TLRs are involved in the expression
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of defensins and, interestingly, heterophils express a wide panel of TLRs. In addition, 
IL-18, which is important in initiating an inflammatory response, is up-regulated in 
heterophils and macrophages of chicken lines resistant to salmonellosis. Interestingly, 
human intestinal epithelial cells express IL-18 and up-regulate interleukin expression 
in response to C. parvum. The presence of the IL-18R, expressed by IECs, suggested 
the involvement of IL-18 epithelial host defence during infection and was confirmed 
in vitro by inducing the expression of a-defensin 2 and LL-37, but not Of-defensin 3 
(McDonald et al., 2006). Therefore, it will be interesting to analyse the effect of IL-18 
on avian /3-defensin expression in chickens resistant to salmonellosis.
6.4 Future prospects for defensin research
Antimicrobial molecules are ancient small cationic molecules encoded by the 
host that are considered as antibiotic-like effectors of innate immunity. They are 
composed of inorganic disinfectants (e.g. hydrogen peroxide and nitric oxide), small 
AMPs (e.g. defensins and cathelidicins) and large AMPs (e.g. lysozyme and 
phospholipase A2) (Yang et al., 2002). Defensins display antimicrobial activity 
against a wide range of bacteria, fungi and viruses, and are considered as effectors of 
innate antimicrobial immunity. However, defensins are more than just antibacterial in 
immunity and are able to chemoattract a variety of inflammatory, immune and other 
cell types, including neutrophils, macrophages, monocytes, lymphocytes and dendritic 
cells in vitro and in vivo, thereby contributing as immunological adjuvants to the 
activation and regulation of adaptive immunity against pathogen infection (Yang et 
al., 2002). By binding chemokine receptors such as CCR6, murine /3-defensin 2 and 3, 
fused with nonimmunogenic tumor antigens, have yielded potent antitumor vaccines. 
Indeed, the induction of an adaptive response to weakly immunogenic tumor antigens
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could be enhanced by fusion with /3-defensins to target the delivery of such antigens 
to receptors of APCs, particularly immature dendritic cells, to obtain protective 
antitumor immunity (Biragyn et al., 2001). The fusion of murine /3-defensin 2 and 3 
with a B cell lymphoma epitope and used as DNA vaccines in mice, generated potent 
humoral responses and the successful development of antitumor immunity. In 
addition, the involvement of receptors other than CCR6 is not excluded, as the murine 
/3-defensin 2 and 3 fusion constructs generated different immune responses. The 
murine /3-defensin 3 fusion construct generated higher antibody titres than the murine 
/3-defensin 2 fusion construct, but did not induce antitumor immunity, unlike murine 
/3-defensin 2 in one of the models tested, the A20 tumor model. However, the use of 
chemokine fusion constructs that selectively activate immature dendritic cells induced 
protection, particularly chemokines that activate CCR6 on immature dendritic cells, 
while chemokines that activate CCR7+ mature DCs did not elicit antitumor activity, 
suggesting that immature dendritic cells are targeted by the DNA vaccines tested 
(Biragyn et al., 2001). /3-defensins were also injected into newborn piglets infected 
with Bordetellapertussis (Elahi et al., 2006). This pathogen is responsible for acute 
respiratory tract infection in young children and infants worldwide (Crowcroft et al., 
2003). The development of a pertussis porcine model allowed investigation of the role 
of porcine /3-defensin 1 (pBD-1) against respiratory infection with B. pertussis. pBD-1 
has significant homology with human /3-defensin 2, and its expression was observed 
in 4-week-old pigs resistant to B. pertussis, while newborn piglets developing severe 
bronchopneumonia did not express pBD-1. Interestingly, the injection of pBD-1, 
which displayed antimicrobial activity against B. pertussis, conferred protection 
against pertussis suggesting that the defensin was acting as a natural antibiotic or by 
modulating the innate immune response like human /3-defensin 2 (Elahi et al., 2006).
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Defensins could be therefore good candidates for drug development. However, most 
of the defensins playing a role in immune response regulation tend to be induced in 
response to pathogen infections, suggesting that the use of probiotics to activate the 
induction of these endogeneous antibiotics could be another alternative for the 
treatment of infections. Probiotics are live microbes with beneficial effects on human 
health (Isolauri et al., 2002), which act by interfering with pathogens (Reid et al.,
2001) and through the modulation of mucosal immunity including the production of 
immunoglobulin A and cytokines (Isolauri, 2001), suggesting that probiotics may 
prevent the invasion of commensal and pathogen microorganisms (Ouwehand et al.,
2002) . Recently, the probiotic bacterium E. coli Nissle 1917, which is apathogenic, 
immunomodulatory and able to colonize the gut (Hockertz, 1991; Lodinova- 
Zadnikova & Sonnenbom, 1997), was shown to induce the production of human /3- 
defensin 2 in Caco-2 intestinal epithelial cells in a time-and dose-dependent manner 
(Wehkamp et al., 2004). This finding suggests that probiotics may stimulate innate 
defences to protect the epithelial barrier against commensal and pathogenic 
microorganisms.
In conclusion, the chicken genome has been revealed to code for a large 
family of avian /3-defensins which are constitutively expressed at the mRNA level in 
different tissues. However, a novel AvBD, to date not annotated in the chicken 
genome, was also discovered and is specifically expressed in the spleen and skin. 
Despite the observation of slight up- and down-regulation of certain AvBDs at the 
mRNA level in response to systemic salmonellosis or to S. Typhimurium infection, 
suggesting a role for the AvBDs in the modulation of the immune defence, more 
studies to determine how AvBDs are regulated and their functions at the peptide level
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remain to be carried out. Indeed, avian /3-defensins might play an essential role in 
chicken immunity, as observed is for mammalian defensins, which are considered as 
innate antibiotics and immunomodulatory molecules. Therefore, a better knowledge 
of AvBD function may permit development of specific treatments against Salmonella 
infection.
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Appendix 1: pCR2.1-TOPO vector map ( I n v i t r o g e n ) .
lacZi - ATG
M1 Reverse Primer
CAG GAA ACA GCT ATG AC
GTC CTT 73T CGA TA? TG
Hind III Kpn I S iii I to e tl I Sp6 |
I I I I I
AT3 ATT ACG CCA AGC TTG GTA COG AGC TCG CAT CCA CT A 
TAC TAA TGC OTT TCO AAC CAT GGC TOT AGC C'TA OTT GAT
STA ACG OTC 
CAT TGC CGG
Bs.'XI i  i-oR I
GCC AGT GTVg ' cTG g!aA TTC GCC 
CGG TCA CAC GAC CTT AAG CGG
Fit R I ^
TCC
ACG
FcoRV
I
AGA TAT CCA TCA 
TCT ATA OTT AGT
asix i
i
Not I 
I
Xho I 
I
Nsl I Xb j | I I Apa I
CAC TGG CGG CCG CTC GAG CAT GCA TCT AGA GGG CCC AAT TCG CCC TAT
GTG ACC GCC GGC GAG CTC GTA CGT AGA TCT ccc GGG TTA AGC GGG ATA
t
T7 Promoter M13 Forward (-20) Primer
Comments for pCR"-2.1-TOPO' 
3031 nucleotides
L a c Z u  fragment: bases 1-547 
M13 reverse priming site: bases 205-221 
Multiple cloning site: bases 234-357 
T7 promoter/priming site: bases 364-383 
M13 Forward (-20) priming site: bases 391-406 
fl origin: bases 548-985 
Kanamycin resistance ORF: bases 1319-2113 
Ampicillin resistance ORF: bases 2131-2991 
pUC origin: bases 3136-3809
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Appendix 2: pTriEx-1.1 vector map ( N o v a g e n ) .
CM V io e n h a n c e r  re g io n 1 U 7 S M U I
C h ic k e n  ac t in  p r o m o te r  reg io n 1110-1720
V e r te b ra te  t r a n s c r ip tio n  s ta r t 1727
T 7 p r o m o te r 2ir.O -21or,
T 7 t r a n s c r ip tio n  s ta r t 2107
la c  o p e ra to r 2171-2101
p lO  p r o m o te r  re g io n 220Tw2318
p lO  tra n s c r ip t io n  s ta r t 2 2 1 0 -2 2 5 0
M u ltip le  d o t t i n g  s i t e s  
(N e o  I - D m  HO
2 3 3 1 -2 5 1 2
1 ISV *T ag ' c o d in g  s e q u e n c e 2 1 1 1 -2 1 7 0
1 Iis* T ag " c o d in g  s e q u e n c e 2  IS. U2r»u0
R ab b it g iu b ili te r m in a to r  re g io n  27*01-2800
T7 te rm in a to r 2801-2851
p U C  o rig in 378 0
blit c o d in g  s e q u e n c e 1371-5230
Bpm l(4&22) v
Drxl 1(3826) 
BspLUn l(2rlfi)
Sgf I(3w4)
Sph l(2rtG2)
Rea tose l(2bG:i) 
Cla K?9Q2)
3-ORF
site
3-ORF
site
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Appendix 3: Optimising primer concentrations for TaqMan assays.
1. Procedure:
Having designed a suitable pair of TaqMan primers, the concentration at which 
they are used in the TaqMan assay needs to be optimised before running an assay to 
quantify mRNA expression in test samples.A range of primer dilutions need to be 
prepared for optimisation, ranging from 1.0 -  0.1 pM (final concentration), and details 
are given in the table below.
[Primer] Diln. [HM] [Final] pM F
(100 pM stock)
R
(100 pM stock)
d e pc -h2o
I 1:2 50 1.0 2.5 2.5 5.0
II 1:2.5 40 0.8 2.0 2.0 6.0
III 1:3.3 33 0.6 1.5 1.5 7.0
IV 1:5 20 0.4 1.0 1.0 8.0
V 1:10 10 0.2 0.5 0.5 9.0
VI 1:20 5 0.1 0.25 0.25 9.5
The 96-well plate was then filled as follow:
1 2 3 4 5 6
Primer
A I
1:10 1:100 1:1000 "TïïÔ* 1:10* NTC
B II
C III
D IV
E V
F VI
G
2.5 pi DEPC-H20  is added to the NTC wells. Then, 7.5 pi Master mix is added to each 
well, and 0.5 pi of each of the various primer dilutions to the appropriate wells (I to VI). 
Finally, 2.5 pi of each RNA standard is added to each well, as appropriate (10'1 to 10"^  in 
wells 1 to 5).
2. Example of result ob tamed:
The primer concentrations I & II (across the 5 dilutions of standards) were 
compared, and verified that they are almost identical. Then primer dilutions II & III and 
so on, were compared. When the shape of the curve begins to change at the exponential 
part of the curve (i.e. altering the Ct value), it indicates that the primer has become 
limiting and so the next highest primer concentration is optimal (see Figure).
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Figure: AvBD 3 primers optimisation - probe at 0.1 pM; primers from 1 pM to 0.1 pM; 
RNA dilution from 10'1 to 10-6.
0 2 4 6 8 10 12 14 16 18 20 22 24 26 28 30 32 34 36 38 40
C y c le
With a AvBD 3 probe concentration at 0.1 pM, the AvBD 3 primers concentration 
selected was 0.8 pM.
3. Results:
Probe concentration pM Primers concentration pM
AvBD 1 0.1 1
AvBD 2 0.1 1
AvBD 3 0.1 0.8
AvBD 4 0.1 0.8
AvBD 5 0.1 0.8
AvBD 14 0.1 0.6
28S 0.1 0.6
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Appendix 4: Schematic diagram of real-time quantitative PCR (from Eurogentec/ EGT 
Group)
forward
primé/
<D
DouMfOy*
Reverse
primer
1- The reporter (R) and the 
quencher (Q) dyes are 
attached to the probe.
____________ %______ t ,
<D r -------------------------------------------- s'I*---------------------------------------3-
.......................   5*
2- When both dyes are 
attached to the probes, 
reporter dye emission is 
quenched.
3- During extension,
Taq/DNA polymerase, which 
also has a 5’ exonuclease 
activity, cleaves the reporter 
dye from the probe.
<s>
______ft
y ............................
4- Once separated from the 
quencher, the reporter dye 
emits its characteristic 
fluorescence.
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Appendix 5: Bacmid, BAC10:KOi629 map (Zhao et al., 2003). Bacmid contains 1. the F 
replicon (KanR) from E.coli allowing the viral genome to be amplified in E.colr, 2. a 
chloramphinicol acetyl transferase cassette (CM) inserted in the ORF1629 involved either in 
nucleocapsid packaging or modification of the virion RNA polymerase; and 3. a single 
Bsu36I restriction site to provide a linear viral DNA. The knockout strategy of ORF1629 
allows to not initiating virus infection unless a recombination with an appropriate 
transfection vector.
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Appendix 6: Nucleotides pile-up to characterise possible promoter regions of the avian 
/3-defensins. Alignments carried out with CLUSTAL W (1.83).
AvBD6 ----------GTCTTGTTCTCTGAATACCATG-GCAGGCTGTGGGTGAAAGAT-TCAT-C 4 7
AvBD7 -----------GCTCATACTTTTATTGATATTCATGGGTCAAAGATAGCATTC-TGGTAC 4 8
AvBD3 ACCCATTCACATATTTGACTAACTCTTAAGTAAATAAGTTTGTCCTGATGTCC-CAAGCT 59
AvBDl -------------TGTTGCTGTTTCT— GGCCACCAAGACCTCCCCGTCCACT-TGCTCC 4 4
AvBD4 ----------GAAATGTTTGTTGGCTGCAGAAGGAGATCTAGGAGGAAATTTG-TCTTGG 4 9
AvBD2 -------GATTGCTTTTAAATGTCTCTTGTCAGCTGGGAACAGATTTGGTTGT-TTTTGG 52
AvBDl 1 --------------------------- AGACAGTAAACACTGCAGCAGCACCT-TGGCCC 32
AvBD12 AATTTCTCAGAAGCCAGAGCTGGAATGGCCTTTTTGGCAGGAAAATCACAGCC-AGGTTT 59
AvBD9 ---------------GTATGCTTGCAGTGCCCCGTGGCTGGGAAGGGGACAGT-CTGTGA 4 4
AvBDl0 ------------- CATTGCTTTCCCTCAGTAAGAGGGATGGGGAGACAATGCTACAGGAC 4 7
AvBD14 -------GAGCCAAGCTACTCTCTCTGATTTTAGAAGGAGTGTATCTGGGATCTCTGTCT 53
AvBDl3 --------------- AAACGTGTGCAGAGACTGGGAGCTGGAAATGAGAAAAATACGAAA 4 5
AvBD8 ----------TGATTTTGTGCTTATGGAAACATTGCCTATTAGTTATAAAAGAGACCTAG 50
AvBD5 --------CATTTTGCCAACCAACAATGGCTGACATACAGCGAATTCTTATGCAGAGTGG 52
AvBD6 AGCCTA— TGTTG--- GTTTCAGAGTAACACATCATGTACTGA-AT----GGGT— GTC 94
AvBD7 AACTGG— GGTTGAAAGGGACTGTAGGAATTTCTAGTCTCAAAA-GTCCTGGAGG— GTC 103
AvBD3 GAGCTA--GAAGG--- TCCTTCGAGGAGCCTGGGTAAGACAGA-GTGATTGGGC--AGG 110
AvBDl TCCCTG--GGGCA--- GGGCTGCATGGGGCTGTGGCAGTGAGA-GCG-- GGGC— TGG 92
AvBD4 AAATAG— TTCTG--- GAATTGAACAAAAAAGCGGTGGTTGGA-CTAGATGACC— TTC 100
AvBD2 AATTTG— GAGTTTCCATTCCTGAGTGATCATCTGTAGACTAAA-GCTGAAGATC— ATG 107
AvBDl1 TCTCTT--ACACTCAACATCATCAATGACCCAACGTCATTCCCA-GAT--- GCT--TTC 83
AvBD12 CAGTTG— GAGCAAATATTCACAGGAGCTCAGATAGAAACAAATCACTCCCGGCT— TGC 115 
AvBD9 CAACAC--CATGTCCAAGAGCCACGGGGCATCAGCACACCTGCATGGTTTACAGT--ATT 100 
AvBDl0 TCATTA— GCAAGCAATAGGTCCAGGGACAATGCTGGGACTGGGCTCCAACAGCT— GAC 103 
AvBDl4 CCAGTACTGATTTTTACCAACTATGGAAGAACTTTGCATCCTTCATCCTTACATTTAAGC 113 
AvBD13 CACTTTGATCCTGCAAACTCTTGGGTGGGTTTCCAACG-TCACATGCTGGAGTCT--ACA 102
AvBD8 GAAAAA-- ATTGCTTAAATTATAAGAACTGGATACAATTTGAAGGATAACAATTAATTT 107
AvBD5 TGATGAAAGCTTGTCATTCATGGGGCTGAATGGAGATGTCATCCCGTGCGGCGTCTTCCC 112
AvBD6 AAAAA-- GAGAATTCTTAGTGCAAGAA-GGCCA-AAACTCAAAAAATCAAAGATAGAAT 149
AvBD7 AGTGA-- GGAGATGGTGAGGCCTGGTT-GCCTGCAGATACATTCAGGAACGTTTTGAAT 159
AvBD3 GTGGT-- TTCAGCAGCCAGCTTTGAAC-TGCCTGCACTGGTAGGCAGTGCCAATTAAAC 166
AvBDl GGAGT-- TCTGTTATT— GCTGGGTGT-GACCATGAGTGG-ATGATGTGCCAGGATGTC 14 5
AvBD4 ATGGTCTTTCCAACCTTAATGATTCCTT-CTCTACTCTTGCTTTAGAAAGGTTTGAGAAC 159
AvBD2 AGCAAATTGCTTTTGCTAAGTTTCAA-- CACTGCGAAATGAACACGTTATTTCTGTCAT 164
AvBDl1 TCCCCCACCAAAACAGT-GGCTTATTTT-CTCCACGTGGCCCATTAGCAATTAATAAA—  139 
AvBDl2 AGCAGCTCCAGAGACTTTCTTTGCAGGT-TGCCACCGCTCAGCCCATCATCTCTCCGGGC 174 
AvBD9 ATGGATCACA GGAACCCACCTCCCTCCT-GCTCCAATCCTGTGTCCTCTCTGGGTGCAGC 159 
AvBDIO TCCCAAGTCCTATGCATGTTCCATGCCC-GTGCCCATGCTGGAACAAATCTGCA-ATAGC 161 
AvBDl4 AGCCCCTGAATGAAAAAAGGGGTGCATG-GCCTACAGCCTATTTTTCCTCTTGGTGTGCT 172 .
AvBD13 AACGCA--CCAACAGCCAGGCTGGGTCA-GCCCCCACATCCTGTCTCCAGCAGCAAACAG 159 
AvBD8 TTATTTTACTTTTAATTTATTTTGTTAT-AATTCAAAAATATAAATAAAATATCTGAAGT 166 
AvBD5 AGCAGCTCTCAAGTGAAGCATAGAGAGCACGCTTCACTGGAGGAGAGGAACACAGAGCTC 172
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AvBD6
AvBD7
AvBD3
AvBDl
AvBD4
AvBD2
AvBDl1
AvBD12
AvBD9
AvBDIO
AvBDl4
AvBD13
AvBD8
AvBD5
AvBD6
AvBD7
AvBD3
AvBDl
AvBD4
AvBD2
AvBDll
AvBD12
AvBD9
AvBDIO
AvBDl4
AvBD13
AvBD8
AvBD5
AvBD6
AvBD7
AvBD3
AvBDl
AvBD4
AvBD2
AvBDll
AvBDl2
AvBD9
AvBDIO
AvBD14
AvBD13
AvBD8
AvBD5
-TTGGGAACAATAGGGGA-TGAA----AGGGACTGTAGGAGCTTCTAGTCTTGAAAGTC 202
ATCTGCAACTTCACTCAAGTTCA----TTGTATCACATCAGCTTTTGGTTTGGGTCATT 214
CTTCATACAGTGTGGCAGCTCCAGGTACAAGCATTTCCCTGACTCTCAAAGCCCAGATCC 226 
TTTTGTGAGCCTGGGGAAACGGAGGTGTTTGGGTGGAGTGG--TTTGGGTGGCCAG--CT 201
GTGCTTCGTGTTGCCTTGCATGAATGTAGTAAGAATTGTCATGTTCTGGTTTCTGAA--  216
TTATAAGCTCGGATGTAGAACCACCTCACTGTGCTCAGTGGGGTTTATTTATTAGATAAA 224 
-TTGAAGTTAACAAGTAA--CGAAGCCCTTGGGGTGGGTCGGTTTTGAGAAGCAGCCTTC 196 
ACTTTGCTGGTGGAGGACGAAGAAACCCCTGCACCTCATTTTTCCTGGCAACCCACCCAC 234
CCATCAGCTGTCACAGGGCATGTGAGCACAGGGTGTCATTTGGTCCTTGTTCAGGT-- C 216
CAGAGGTTTGGGGCTTGGCTGATAGCCCCATTATACAACTGGCCGTCACGGTCAGT---  217
AAATAGCCATTCACATCTCCAGTGAA-GCAAAATATAGACAGTGGTGAAATCACCTCTGC 231 
GAGCAGACTCCCCAGTGCTTGTTGCGGTTTGTTGACAGAAACCTGCTGGTATTTTTTCCT 219 
CCATGGGATTCAAATGCA— GGAGTCTTCAGTGCAGATGATACTGTTTGTTTTTGCATGT 224 
CTTTGTGCTGGGAGAGAGGGTTGCGTGCCAAGGCTAACGGATGGGGATGAAGTGTGTCCC 232
T T AG AAG C T C AAAG AAG AG GAGATGGT GAG GCCTGGTTGCCTG C AG AT AC AT T C AAG G AC 262 
CGGAGCGTTGGGTCAAAGAGAGATGATTGGGCCTTGTTGCCTGGAGTCACATTCAGGGAC 27 4 
TTCGTTGTCTCTAGTCTGGTGATGGGCTTTGCATGAGTGTTGGCACGAGCATCTCCTGAT 286
TTGCATGGATGTGTAGCACCAACTAACCCTACATG---- TAGTGTG-GCATCTCCAGGT 255
TTAACAACTTCCACAGAGCAGGTTCAATTTATTGCAGTGTATTGCAACATGTCAAGCAAT 276 
ACGTTGAACCGGGCATGAGGTGTTGTCTGTATTTTG--GCCAAGGAGTATTTGCAAAGCG 282 
CTGGAGGCATGGTGAGGAGGTATGGTTACCTCTCTGCTGGCTTTTGTGACCCTCTGTCAT 256
CCAAAATACCAGCTGCCAGGTAGAGGAAGCA-------- AAAGTGAAGCAAACCAGCAT 285
AGGCATCTTCAAATGTGTTGGGTTGCAACATCTTCATACATCACCAATCTCTACAGTCAT 276
-- GGAAATTCACTGTTGCAGATTGCAACATTTTCACCAGACATTTCACTGCAGCCCGCG 274
ACATGGCATGGCATGGGCTGGCACAGGATGGCATAG-TGGCATGGGGTGTCTGCCCCATT 290 
TTTTTTTCTTTCTTTTTTGCTTTTTTTTTTTTTTTGCTTTTTTTTTTTTCCTCCACCCTG 279 
AATGGAGAGAAGATCACTATATTTTGAATTTTATAG--ATATAAAACACATTTTCTTGAT 282 
AAGAAGCGTCCAGCAAACCACAGCGCTGTGTTTCTCTTTCGCAAGGCAGGATGACACAAG 2 92
TATTTGAATATCTGCAACTTCACTCAAGTTG-ATTGTATCACACTGGATTTTGG-TGTGG 320 
AATTTGAATATCTGCAACCTCATGTGAGTTC-ATTGAATTGTATAAGATTTTGG-TGTGG 332 
-GTTCAGATATCCTCTACTGTGCTTGAAAT--ACTATTTTACTTCATCCCTTAATTGTGA 343 
-ACAAACATATCCGTGACT--TCCAGAGCC— TGGATCTTCTATTGATCCTCG--TGTAA 308 
--TTAGGATAAACGTCTACTTAATTAACATG-GTAATTAAAAGTTGGATTTAAAATG-GC 332
TGGCAGGAAATCTGA------ ATTAGAACAG-CTTAATAAACACAAATCCTGAGATATGT 335
TGTTCGGGCTTAGCC------ GTGTGCAGCG-GTCAAGCTGTACTCGTTGCTC— CGTGG 307
TGTTTGGAGCTGCGGCGCTGGGTCAGAACGACACAGAGGATTGCTGAGCGCTGAATGTCA 345 
AGGGCAAAGAACTCTCACCACTCCTCCTCCCCTGAAGTGTCTGCACTGTCCAGACCCACA 336 
ATATGGGGGATAACCAATTGCTTGACAAAAG-GTTGGGTGCAGTTACTTATTGACAGGGC 333 
TTTGCAGGCTTATTGAGGTGGGGCATGTTGTGCTATGCATCCACACAGGAATTGTAATTA 350
CACATGAGGTGTCCGA----- GAGCGGGCAGTTCCCAGAGCAACTGTTTGCTG-TCATGT 333
CATATGAAATGTGCATCCCTTAAAAAAGTGATATTTCAATAGGCAGTTTCTAGAAAATTT 342 
AGCCGGGGCTGAAGGCCTAGGGGGAAAGCCATTCCGTGTCATCTCTGACAGGGGAAGAAA 352
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AvBD7
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AvBDl
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AvBD13
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AvBDll
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AvBD8
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AvBD6
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AvBD3
AvBDl
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AvBD2
AvBDll
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GTCA-TTTGAGGCATGTTAGAAGCAGTTGCTCAACTCTCAG-- TCGG----- GAGATAA 371
GTCA-TTTGAGGCATGTTATAAGCAGTTGCTCAATTCTCAG-- TCGG----- GAGATAA 383
TCAACTTTGGGGACAGCCAGTTGTGAGGTCATAGAATTTTAGTCCTGGAAATTGGAGAAA 403
CTG— TTGGAATTGCGTTGGCTGTTGGCCCA-AGCACCT--- CCTGA---- TGTGTCAA 357
ATAGTTCTGCACAGAAGCTTCTGCCATGATCTTACGTGTGGTCCAGGGAACCCTTAAGAC 392 
ATT--TATATCCCATGCTGCTCCTTGCTTTCTTTCCCCCAGA--AATGCCCACAGAGCAT 391 
CCTGCCTTCCACATACCCTACTGCCAAAATCCCCTGGACAG— CCTGG— TCTGTTCCCA 363
CCG---- GGATATAATTAACTCCTGCCTGCTCCCTCCCTCCTCCAGG----- ATGCCAT 395
GCCTTTATAAGTGCAGGGACCAGCCATCTTCTGCCTCATACA— TCAG--- CTTCTGAAC 391
ACTCAGCCGTGAAACTTTCACAGTC-CCACAACCCCTATAAATGCCAG----- GCGCCTT 387
GAGGTTACAAGACACGTCCTTCAAAGCTGTTATTTATAAGATTGCTAAATCCCTGGTGAT 410
TGAAATGCACCTGAGATTGACAAAGTTCCCTTCGCTCTGGGAGCGTTA--- CACAACTCC 390
ACTCTGTTGCATAAAAGCTAACTGCAATTTGCAAGTTGTAGGTTGTAA------- GTCAT 395
CAGG-- AAAAGGTGCTTTGGGAACAATCGGTGGTGTCAGGGATACTGCCTGCGTGGCAG 409
CCATTCTGTGCCTTTTGGTCTTGTTGTGTCTGTCC-ATTGCAGATAAGGATTTCA----  425
CCATTCTGTGCCTTTTGATCTTGTTGTGTCTGTCC-ATTGCAGATAAGGATTTCA----  437
TTGTTCCTGGAAATGTTCCCAGGTTCTG-CATGGT-AGTGCACAAAATCATATCACTACC 461 
CTCTGCTGTGACATTTGATTAAGTAGAGACAGAAG-AGAGAAAACAAATATACCAGTGGT 416 
AAAGCACATGATTGTGAAGAAAGTGTATTCTATATGATTCTCAATGATAATTTCTGTCCT 452 
CCATGAGGTCATGGAGGTATTTCTGAATTTGAAGAAAATGTA-ATATAAATGCCGTTTTA 450 
AAGCTCTATAAAAACAAGAGTGCTCCTTGCTCCCCTGTTGCAGGACTCCAGCTGAGATCT 423 
CCCGCCTGCCAACGCCATGCAGAGGCTT-CTGCACAATCTCA--CGCTCAGCCCTGCTGC 452 
ACCGTCAGGCATCTTCACAGCTGCAAAGGCTATTCCACAGCAGAGGACAATCATGAGAAT 451 
CCCTTGCCTCTTCCTCAAACAAACGTCATCCTCCTTCGGTCTTCGAGGAATTGGGGCACG 447 
CACATTCATCAAAGCTTTATAAAGAGAGGCTCATTCCTTCCTCTTGGTCTCAGCAGCTTC 470 
CAGCCCTATAAATCCAGGATTTCCCTCTTCTCTAT— CTCCCTACAGCCCTTCTGGTGGT 448 
ACATGATGTTTGGGTCAA— TAGTCCATACAGAATAAATGCA— AGATTTTTTTGGTGGC 451 
GAGG-ACGCCAGCTGGGATCAAACTGCTGCTGCCAGCAAGAAAGGAACCTGCCCTGTTTT 468
-------------CATCCCATCCGTGGCCATGAGGATCCTTTA-CCTGCTGCTGT-CTGT 470
-------------CATCCCATCCGTGGCCATGAGGATCCTTTA-CCTGCTGCTGT-CTGT 482
C--- CCAGGCTTCTAAGCTGTTTCTGTTCTGCCATGTCCTT GTTGCTTTTGT-TCAT 514
A--- CTT— CTGACACGTTGTCTGTGCTAGAAAGTGTATCTTGTGTGGCCTTGGT-TTCT 4 70
T--- CAC— TCCTCAGCCCA-CTGTGTCTGTAGGTGGACAACATCTCAGTGTCGT-TT—  503
T--- CTGTACAGCTCAGAAGACTGTAGATTCCAGGGACTGCCT-GCCACATACAT-TTCT 505
T-- CTA-----CCATGAAGCTCTTCTCCTGCCTCATGGCT----CTGCTCCTCT-TCCT 470
T-- CCC------CAGCAGGACCAAAGCAATGAGGAACCTTTGTTTCGTGTTCATCTTCA 503
C--CTTTTCTTCCTTGTTG-CTGTTCTCTTCTTCCTCTTCCAGGCTGC----------- 4 96
C--AGTCCACAACTGAGCCATGAAGATCCTCTGCCTGCTCTTCGCTGT----------- 4 93
AGGGCGACACGACAATGTCAACCAAAGCCATGGGCATATTCCTCCTGTTTCTTGTTCTCC 530 
GGGACGCCCACCCACATTCAGCCATGAGGATCCTCCAGCTGCTCTTTGCCATCGTTGTCA 508 
AATTTTTTTTCCCCCTAGTGGCTGTTGTGTTTTGTGACACTGAATTTGGACATGAAGATC 511 
TTCTTCTCCCCACAGCTGTGACCCTCCGGGCATCTCCCAGCCATGCAGATCCTGA-CTCT 527
CCTCTTTGTGGTGCTCCAGGGT--------------------------------------  4 92
CCTCTTTGTGGTGC----------------------------------------------  4 96
CCACTCTGCAGCCTCGTGAGGAACCTGCTCCAGGCATCAGCCATGAAGATCCTGTACCTG 574 
CCCCTCTGTAGCCCTGTGAA-AACCCGGGACAGACGTAAACCATGCGGATCGTGTACCTG 52 9
-- CTCTGCAGTG— ACAGGATTTCCCAGTCTGCCTTCTGCCATGAAAATCCTTTGCTTT 558
TCTTCCTTTTCCC-- TGTAGCAGCTCAGCAGATCTGCAGCCATGAGGATTCTTTACCTG 562
CCTC--------------------------------------------------------  4 74
TCTCCCTGCTCGCTCACGGTAAGGCTGGGGGTGGCAA----------------------- 54 0
TGGCAGTACC--------------------------------------------------  54 0
TTCTCCTCCTCCAGGATGCGCCTGGTAAGGAC----------------------------- 54 0
CTTTACTTTCTCTTGGCCGTTCTCCTCAC-------------------------------- 54 0
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AvBD5 CCTCTTTGCTGTC-----------------------------------------------  54 0
AvBD6 ------------------------------------------
AvBD7 ------------------------------------------
AvBD3 CTCATCCCCTTCTTCCTCTTGTTTCT----------------  600
AvBDl CTCCTCCCCTT------------------------------- 54 0
AvBD4 TTCATCGTGCTCCTCTTTGTGGCAGTTCATGGAGCTGTGGGT 600
AvBD2 CTTTTCTCTCTCCTCTTCCTGGCACTCCAGGCTTCTCC----  600
AvBDll ------------------------------------------
AvBD12 ------------------------------------------
AvBD9 ------------------------------------------
AvBDl0 ------------------------------------------
AvBD14 ------------------------------------------
AvBD13 ------------------------------------------
AvBD8 ------------------------------------------
AvBD5 ------------------------------------------
